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ABSTRACT
A general method for fixed effect regression estimation in 
proportional hazards models was introduced by Cox (1972). In the past 
twenty years, this method has been widely used and applied to survival 
regression models throughout the clinical trial literature.
Problems arise with the Cox model when there is more than one 
observation of failure time for each patient or when we are interested in 
failure observations within a cluster. In each case, the independent 
event times assumption in the Cox model is no longer valid since 
dependence between failure time observations that come from the same 
patient or within each cluster is anticipated.
The aim of this thesis is to develop random effect survival 
models which extend Cox’s partial likelihood method to handle multivariate 
failure time data based on the Generalised Linear Mixed Model (GLMM) 
approach.
The GLMM approach, on the one hand, preserves the cancellation 
property of the baseline hazard function in the partial likelihood 
expression. On the other hand, it provides predictions of random effects. 
Such predictions are useful to identify a high risk family or high risk 
individual when considering a genetic disease.
Further theoretical developments of the GLMM, where the random 
components are correlated, are expounded. Computable expressions are 
obtained for the likelihood function and its derivatives and also for the 
information matrix. Such developments serve as the basis of the 
estimation and inference procedure in the random effect survival models.
Various random effect survival models are developed for the 
analysis of different types of multivariate failure time data. The 
Chronic Granulomatous Disease (CGD) data, the litter matched tumorigenesis 
experiment data and the Dubbo study data are used to illustrate the 
application of these various models. The GLMM method is found to be 
successful in analysing multivariate failure time data. Consistent 
results are obtained when comparing with other methods. Simulation 
results further confirm the implementability of current method.
The development of the GLMM with correlated random components 
and the various random effect survival models established to analyse 
different types of multivariate failure time data are new and original 
techniques.
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CHAPTER ONE
INTRODUCTION
1.1 UNIVARIATE SURVIVAL ANALYSIS
Much research has been done on survival analysis, with various models 
being developed to analyse survival data. In survival analysis, the 
response variable is usually the death time of an individual in the study 
population. The main concern is to estimate the underlying death density 
function or equivalently the survivor function of the study population 
based on these death time observations.
There are two major types of models: non-regression and regression.
In the former, there are both parametric and non-parametric methods for
the estimation of death density or survivor function. For parametric
methods, different distributions are used to model the survivor function. 
Some commonly used distributions are exponential, Weibull, Gamma and log- 
logistic. On the other hand, the Kaplan-Meier estimate is a non-
parametric estimator of the survivor function. When regression models in 
survival analysis are considered, it is important to set up the
relationship between the hazard of death and the explanatory variables as 
well as estimating the survivor distribution.
In the 1970’s, a wide range of regression models in survival analysis 
were proposed. These may be classified broadly as the proportional 
hazards model and the accelerated failure time model. Techniques of
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regression models used in survival analysis are well-documented in 
textbooks such as Kalbfleisch and Prentice (1980), Lawless (1982) and Cox 
and Oakes (1984). These may be classified as "univariate". Here, the 
term "univariate" refers to those survival data that have only one failure 
observation from each individual; and we can assume that the failure time 
observation of individuals are independent in the univariate situation.
1.2 COX’S PROPORTIONAL HAZARDS MODEL
In Cox (1972), a general method for fixed effect regression
estimation in proportional hazards models was introduced and applied to 
survival analysis. There have been some hundreds of publications in the
statistical literature applying and extending this basic technology and 
equally many applications in medical research. In fact, this method is 
now a standard medical research tool applied to survival regression
models.
In Cox’s proportional hazards model, a partial likelihood function is
constructed. By maximizing this partial likelihood with respect to the
regression parameters, we obtain the estimates of regression parameters
and their asymptotic variances.
A convenient feature of the Cox model is that the baseline hazard 
function is cancelled out in constructing the partial likelihood and is
then not involved in the estimation procedure of the regression
parameters. Because of this feature, the Cox model is sometimes called a
2
semiparametric method since the distribution of the baseline hazard 
function is unspecified.
1.3 THE MULTIVARIATE FAILURE TIME PROBLEM
Problems arise with the Cox model when there is more than one 
observation of failure time for each patient or when we are interested in 
the failure observations within a cluster. Examples are the survival data 
that treat the failure to be the serious infection of certain disease in 
patients or the occurrence of a genetic disease in the relatives of a 
single proband.
These kinds of survival data are termed multivariate failure time 
data, for which there will be a detailed explanation in Chapter 2. What 
needs to be mentioned here, however, is the problem in analysing 
multivariate failure time data. Many regression variables, which are 
unrecorded and unrecognised as risk variables, may each contribute 
marginally to the total variability. The accumulation of such effects is 
often termed the "frailty" of the patient/cluster and this "frailty" 
accounts for correlations between observations on the same
patient/cluster. This being so, when we consider the regression analysis 
in multivariate failure time data, the independence assumption in the
univariate survival analysis is no longer valid.
The main difficulty in analysing multivariate failure time data is
that the usual cancellation property of the baseline hazard function in
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the partial likelihood procedure is lost if the marginal failure time 
distribution is obtained by integrating out the frailty components.
1.4 DIFFERENT APPROACHES
There are quite different approaches to solving the difficulty 
outlined above. Detailed explanation of these will be given in Chapter 3, 
though a brief description of them here is useful.
The derivation of certain failure time distributions has been done by 
Hougaard (1984, 1986a, 1986b, 1991) and Aalen (1992). Clayton and Cuzick 
(1985a) have provided a multivariate generalisation of survival analysis 
for some types of data. Developments of frailty models were given by 
Clayton (1978, 1991), Oakes (1982, 1989), Wild (1983) and Klein (1992).
A method for stratified data was investigated by Prentice, Williams 
and Peterson (1981) and has been extended by Wei, Lin and Weissfeld (1989) 
by modelling the marginal distribution. Such a marginal modelling 
approach has been further developed by Lee, Wei and Amato (1992), Lin and 
Wei (1992) and Lee, Wei and Ying (1993). Related work on multiple times 
to tumour can be found in Gail, Santner and Brown (1981).
The counting processes approach or the martingale approach aims to 
generalize the traditional Cox’s model to the multivariate failure time 
problem based on the martingale and stochastic integral theory. The 
statistical theory of counting processes has been developed by Aalen
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(1976, 1978). Andersen and Gill (1982) developed the multiplicative
intensity model. This model may be seen as the multivariate version of 
Cox’s regression model based on the martingale approach.
Based on this approach, Gamma distributed frailty models in survival 
analysis were developed by Nielsen, Gill, Andersen and Sorensen (1992). 
Self (1993) considered a time independent and a time dependent gamma 
distributed frailty model to analyse multiple failure time data. These 
two models are applied to the Chronic Granulomatuous Disease (CGD) Data 
which appears in Fleming and Harrington (1991).
The Generalised Linear Mixed Model (GLMM) approach tries to combine 
the generalised linear model (GLM) technique of McCullagh and Neider 
(1989) and the linear mixed model (LMM) to obtain a broader unified class 
of models which allows the non-identity link function with random effects 
in the linear predictor.
Schall (1991) developed an approximate ML and REML estimation 
algorithm. Breslow and Clayton (1993) considered both the Penalised 
quasi-likelihood (PQL) and the Marginal quasi-likelihood (MQL). Other 
comparable developments can be found in Solomon and Cox (1992) and 
Wolfinger and O’Connell (1993) using the Laplace approximation and the 
Psuedo-likelihood (PL) method respectively. Based on the quadratic 
approximation in the region of maximum, McGilchrist (1994) presented a 
detailed derivation of the estimators and its possible application area.
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1.5 RESEARCH APPROACH
The approach adopted for this research follows the method described 
in McGilchrist (1994), and referred to as the GLMM mentioned above. 
Basically, the method starts with the Best Linear Unbiased Predictor 
(BLUP) of Henderson (1963, 1973, 1975), and then connects to the Residual 
Maximum Likelihood (REML) of Patterson and Thompson (1971). The link 
between BLUP and REML is outlined in Harville (1977) and is fully detailed 
in Thompson (1980), Fellner (1986, 1987) and Speed (1991).
In the framework of the GLMM, it turns out that random effect models 
in survival analysis can be seen as one application of the GLMM type of 
modelling as outlined in McGilchrist (1994). This thesis adopts the GLMM 
approach to develop the estimation and inference techniques in different 
random effect models in survival analysis.
When applying the GLMM method to random effect survival models, the 
cancellation property of the baseline hazard function in the partial 
likelihood expression is preserved. Another important feature of the GLMM 
approach is that other than the estimation of regression parameters, the 
prediction of random effects is also obtained. In some cases, the 
prediction of random effects are important and often of separate interest. 
The following example can be used to illustrate this importance: when 
considering a genetic disease it is as important to identify a high risk 
family or high risk individual as to estimate the risk variable 
parameters.
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1.6 AIM AND OUTLINE OF CHAPTERS
The aim of this thesis is to develop random effect survival models 
that extend Cox’s partial likelihood method to handle multivariate failure 
time data based on the Generalised Linear Mixed Model (GLMM) approach. 
Various random effect survival models are developed according to the 
different types of multivariate failure time data being classified in 
Chapter 2.
This Chapter is followed by a review of the multivariate failure time 
problem in survival analysis. The multivariate failure time data are 
classified into four types : (a) the failure occurrence in matched
components of a patient, (b) the occurrence of the same type of failure in 
the member of a family/cluster, (c) the recurrent events in the same 
patient and (d) the occurrence of different failure events in the same 
patient.
In Chapter 3, initially the well known univariate Cox regression 
model in survival analysis is discussed briefly. This is followed by a 
review of different approaches to the multivariate failure time problem. 
These approaches are classified into : (a) the frailty models approach, 
(b) the marginal modelling approach, (c) the counting processes approach 
and (d) the GLMM approach.
Chapter 4 provides a further generalisation of the GLMM which allows 
possible correlation between the random effects. Estimation of
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correlation parameters in the variance matrix of the random components as 
well as the fixed effect parameters , their asymptotic variances and the 
variance components are obtained. The development in this chapter serves 
as the basis of the estimation and inference procedure in the random 
effect survival models that established in the following chapters. 
According to the four types of multivariate failure time data, different 
random effect survival models are developed in Chapters 5 to 8.
Chapters 5 and 6 deal with Type III data (the recurrent events in the 
same patient). Chapter 5 provides three longitudinal models which are 
specialized for the time dependent frailty survival data and are developed 
to analyse the Chronic Granulomatous Disease (CGD) data set (Appendix I). 
In Chapter 6, the random effect at each failure time of a patient is 
treated as a time series process. In particular, the random effects are 
considered to follow an AR(1) process. The application of the AR(1) 
frailty model to the CGD data is also given.
Chapter 7 establishes the modelling of Type II data (the occurrence 
of the same type of failure in the member of a family/cluster). Two 
random effect survival models : (a) the baseline frailty model and (b) the 
random block frailty model are described. These can be used to analyse 
failure observations occurring in a cluster/family. A method to justify 
the usual exponential relative risk function is also proposed. The litter
matched tumorigenesis experiment data (Appendix I) is used to illustrate 
these developements. Some simulation results of both the baseline frailty 
model and the random block frailty model are also made available. 
Moreover, the techniques developed in this chapter can also be used to
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analyse Type I data (the failure occurrence in matched components of a 
patient). This will be explained in Section 7.5.
The competing risk frailty models are investigated in Chapter 8. 
They are developed for the analysis of Type IV data (the occurrence of 
different failure events in the same patient). The Dubbo study data 
(Appendix I) are used to illustrate these models. The data come from 
research on elderly people in Dubbo by the University of New South Wales 
Lipid Research Department, St. Vincent’s Hospital, Sydney. In the Dubbo 
study data, both time to hospitalization and death are important outcome 
measures. It is noteworthy that, for each individual, the hospitalization 
could be a recurrent event and the occurrence of death should be later 
than hospitalization. Therefore, we have to model the dependence 
structure that comes from the multiple failure time observations in each 
individual and also the possible relationship between an individual’s 
frailty in hospitalization and his frailty in death.
Chapter 9 details the difficulties faced during the research process, 
some unsolved problems and suggestions for further research. The three 
data sets, used to illustrate the random effect survival models developed 
in these Chapters, are provided in Appendix I. The corresponding APL 
programs for these models can be found in Appendix II.
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CHAPTER TWO
REVIEW: FOUR TYPES OF MULTIVARIATE FAILURE TIME DATA
As stated in Chapter 1, this thesis focuses on the extension of Cox’s 
partial likelihood method to multivariate failure time data based on the 
Generalised Linear Mixed Model approach. Essentially, Cox’s method 
assumes the failure time obervations to be independent, so that the
estimation and inference technique follows the description in Section 3.1. 
But, in practice, there are some failure time data appearing which do not 
satisfy the independent event times assumption.
In some clinical trials data, when the failure time is not restricted
to the death time, failure may refer to a recurrent serious infection,
repeated hospitalization, the experience of visual loss in the left and
right eyes in a patient, the occurrence of a genetic disease within the 
same family or the failure episode in the same cluster. These kinds of
failure time data are called multivariate failure time data since each 
individual may experience more than one failure or there may be more than 
one failure observation in each cluster/family.
These multivariate failure time data have a common feature, which is 
the dependence or the correlation between the failure times within the 
same patient/cluster. Therefore, the main concern in analysing 
multivariate failure time data is to study the dependence between failure 
times and the effect of possible explanatory variables on the failure 
times in the presence of dependence.
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The remainder of this chapter describes twelve multivariate failure 
time data sets taken from different studies. In each case, the objective
is to explain the presence of dependence between the failure time 
observations that appear in different studies and the methods that have 
been used to analyse these data. For this reason, mention is made of main 
points only; further detail can be obtained by referring to the papers 
referenced.
The multivariate failure time data are classified into four types:
(a) the failure occurrence in matched components of a patient,
(b) the occurrence of the same type of failure in the member of a 
family/cluster,
(c) the recurrent events in the same patient and
(d) the occurrence of different failure events in the same patient.
2.1 TYPE I : THE FAILURE OCCURRENCE IN
MATCHED COMPONENTS OF A PATIENT
In medical research, Type I data may be the experiences of visual 
loss in left and right eyes, or similarly, the time to failure of a right 
and left kidney.
Data set (1) — The Diabetic Retinopathy study
Diabetic retinopathy is a complication associated with diabetes 
mellitus consisting of abnormalities in the microvasculature within the
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retina of the eye. It is the major cause of visual loss in patients under 
60 years of age in the United States and many industrialized countries.
The Diabetic retinopathy study (DRS) conducted by the National Eye 
Institute in the United States began in 1971. The study was concerned 
with the effectiveness of laser photocoagulation in delaying the onset of 
blindness in patients with diabetic retinopathy. A total of 1742 patients 
with diabetic retinopathy in both eyes and visual acuity of 20/100 or
better in both eyes entered the study between 1972 and 1975. One eye of 
each patient was randomly selected for treatment (photocoagulation) and 
the other eye was observed without treatment. The patients were followed 
over several years for the occurrence of blindness in the left and right 
eyes. The study end point (blindness) was defined as being at the first
occurrence of visual acuity less than 5/200.
The main purpose of the study was to assess the effectiveness of the 
laser photocoagulation treatment in the presence of possible dependence
between the left and right eyes. Moreover, it was considered important to 
set up models to investigate the dependence between the two eyes within
the same patient and the relationship between the treatment effect and the 
type of diabetes.
A subset of the original data (N=197), which was the 50% sample of 
the high-risk patients as defined by DRS criteria, has been analysed by 
Huster, Brookmeyer and Self (1989) using a fully parametric model and an 
independence working model in the analysis of paired censored survival 
data.
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Further analysis of this subset of data has been done by Liang, Self 
and Chang (1993) using marginal modelling approach. Lin (1994) has 
provided a further discussion on this data set. Analyses of parametric 
and semiparametric frailty models in bivariate survival data have further 
been undertaken by Oakes (1994). In addition, two new methods, one 
building on the marginal models of Wei, Lin and Weissfeld (1989) and the 
other modifying the EM algorithm of Demsper, Laird and Rubin (1977) have 
been suggested in his paper.
2.2 TYPE II : THE OCCURRENCE OF THE SAME TYPE OF FAILURE 
IN THE MEMBERS OF A FAMILY/CLUSTER
Type II data may refer to the occurrence of a genetic disease among 
family members, the appearance of tumors in littermates exposed to a 
carcinogen, or more generally, the failure occurrence within a group with 
members who have experienced some common risk factors. The dependence 
structure is due to the fact that individuals within the same 
family/cluster share some risk factors due to genetic or environmental 
effects. Therefore, the individuals within the same family/cluster may be 
considered sharing a common, unobservable, random frailty.
Data set (2) — The litter matched tumorigenesis experiment
The litter matched tumorigenesis experiment data were described by 
Mantel, Bohidar and Ciminera (1977) and Mantel and Ciminera (1979). In
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the design, there were 50 male litters and 50 female litters. In each 
litter, one rat was treated with putative carcinogen while the other two 
rats served as controls.
The experiment was followed for 104 weeks and the failure time was 
the time to tumor occurrence or censoring as recorded to the nearest week. 
It was conceivable that the environmental conditions shared within litters 
would affect the risk of tumor formation. Therefore, the environmental
conditions in each litter may contribute to the hazard function as a 
random litter effect.
Analysis of this data set based on the martingale approach using EM 
algorithm has been done by Nielsen, Gill, Andersen and Sorensen (1992). A 
subset of the data which considered only the female litters has been 
analysed by Hougaard (1986b) using the parametric Weibull margins model 
and a Cox type model. Clayton (1991) also analysed this subset of data 
using Gibb’s sampling. In addition, a comparison of the estimated 
treatment effect and the likelihood ratio statistics in these various 
approaches has been provided by Nielsen, Gill, Andersen and Sorensen 
(1992).
Data set (3) -  The Schizophrenia study
The Schizophrenia study was first reported by Pulver and Liang 
(1991). This was a genetic epidemiology study of schizophrenia conducted 
by Dr. A.E. Pulver of John Hopkins University. 487 first-degree relatives 
(273 males, 214 females) of 93 female schizophrenic probands enrolled in
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the study. For a single proband, the number of relatives ranged from 1 to
12.
Two main covariates considered were the gender of the relative and 
the proband’s age, which was dichotomized at 16 years. The failure time 
was the age at diagnosis of effective illness for the relative. Here, the 
effective illness was defined as either depression, mania or both. 31
failure events were recorded out of the 487 relatives.
The main research question was whether the risk of effective illness 
of the relatives was associated with the age at onset of schizophrenia of 
probands while adjusting for the gender of the relatives. In this data 
set, it was anticipated that the relatives of the same proband share 
genetic effects and possibly environmental effects, so the times to 
effective illness were correlated among them.
The data set has been analysed by Liang, Self and Chang (1993) and 
Lin (1994). They both used the marginal approach to analyse the 
multivariate failure time data with a slightly different expression in the 
score function.
Data set (4) — The Framingham study
The Framingham study was a cohort of 2336 men and 2873 women, aged 
between 30 and 62, that began in 1948. Details of the study can be found 
in Dawber (1980). Individuals had their first examination at study entry 
and subsequently recalled and examined every two years. The failure time
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was the time to death. The various causes for death and the times to
cardiovascular disease and cancer were recorded.
During the follow up period, possible risk variables such as gender,
blood pressure, cholesterol levels, height and smoking behaviour were
recorded in detail as well. The research interest centred on the
assessment of the effect of various risk factors on the overall mortality, 
the cause-specific mortality and the time to the different types of
diseases.
Analysis and discussion of this data set has been provided by
Schatzkin, Cupples, Heeren, Morelock and Kannel (1984), Wolf, Abbott and 
Kannel (1987), Wolf, D’Agostino, Kannel and Belanger (1988) and Anderson, 
Castelli and Levy (1987) based on the independent event times assumption.
Klein (1992), however, did not employ the independent event times 
assumption when considering the random effects of Cox’s regression model. 
The estimation process was based on the EM algorithm by treating the
unobservable random frailty as missing value. Two possible cluster 
dependence structures were considered. The first cluster dependence 
structure was obtained by grouping individuals according to siblings and
the second cluster dependence structure considered each married couple to 
be a cluster. The frailty in the first grouping could be considered as 
the combined effect of shared genes between siblings and the early 
environmental effects on siblings while the frailty in the second grouping 
was considered to be the late environmental effects that were shared by a 
married couple.
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Data set (5) — The Skin Allograft study
The Skin allograft study data was first published by Batchelor and 
Hackett (1970). This study was concerned with the differences in survival 
times of skin grafts from 16 severely burned patients as these related to 
closely or poorly matched HL-A transplantation antigen system between 
patients and donors. The patients received skin allografts from 2, 3 or 4 
donors. Basically, the donors and the patients were matched for ABO blood 
groups. But they may have been either closely or poorly matched for the
HL-A transplantation antigen system.
By the end of the study, all the skin allografts would have been 
destroyed due to the immune response of the patient. It was therefore 
important that the allografts survived as long as possible so as to reduce 
the chance of infection in the patient and to provide the time for the 
skin to grow in the same donor.
The main interest was to see whether there was any difference in the 
survival times for closely and poorly matched allografts. Moreover, due 
to the heterogeneity in patients, the immune response might well differ 
between patients. Therefore, other than the possible risk factors (e.g. 
matching type, amount of bum), the random patient effect also needed to 
be considered.
This data set has been analysed by Holt and Prentice (1974) and 
Kalbleisch and Prentice (1980) have analysed a subset of the data. Both
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of these analyses used a model for survival in matched pairs. The 
counting processes frailty model approach to this data set was provided by 
Nielsen, Gill, Andersen and Sorensen (1991).
2.3 TYPE III : THE RECURRENT EVENTS IN THE SAME PATIENT
This type of data set is very common in medical research. Examples 
of multiple recurrent events are the sequence of asthmatic attacks,
epileptic seizures, infection episodes, tumor recurrences or bleeding
incidents in individual patients. The CGD data in Appendix I are of this
type. For this type of data set, the analysis of regression effects in
the presence of dependence is of concern. Such dependence is due to the 
multiple failure time observations that come from the same patient.
Data set (6) -  The CGD study
Chronic Granulomatous Disease (CGD), as described in Fleming and 
Harrington (1991), is a group of inherited rare disorders of the immune 
function characterized by recurrent pyogenic infections which usually 
present early in life and may lead to death in childhood.
Between October 1988 and March 1989, 128 eligible patients (most 
being children) with CGD were accrued by the International CGD Cooperative 
Study Group. The patients were followed for about one year. There were 
63 patients in the treatment group and 65 patients in the control group,
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with 203 serious infection/censoring observations recorded. The number of 
serious infections/censoring for the patients ranged from 1 to 8.
The aim of the trial was to investigate the effectiveness of y-IFN 
in reducing the number of serious infections in CGD patients allowing for 
the variation in other risk variables. Other risk variables were age,
sex, inheritance pattem, height, weight, hospital category, using
corticosteroids and using prophylactic antibiotics at times of study
entry.
This data set has been analysed by Fleming and Harrington (1991)
using the Cox model and Andersen-Gill multiplicative intensity model.
Both analyses are based on the information up to the interim cutoff. For 
the Cox model, only the time to first infection in each patient is used. 
The multiplicative intensity model is the multivariate version of the
traditional Cox model developed through the martingale approach.
The full data set was given in the Appendix of Fleming and 
Harrington (1991). A comparison of the marginal model, the Andersen-Gill 
Markov and semi-Markov model and the model proposed by Prentice, Williams 
and Peterson (1981) was provided by Lin (1994). Moreover, the application 
of the time dependent frailty model to this data set based on the counting 
processes approach was provided by Self (1993). An analysis of this data 
set using the Poisson regression model in the counting processes framework 
can be found in Lindsey (1995).
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Data set (7) — Kidney patient data
The kidney patient data detail recurrent infections in kidney 
patients using portable dialysis. At entry of study, a catheter was 
inserted and remained in place until infection occured at the point of
insertion. When infection occured, the catheter was removed and the 
infection would clear. Then, some weeks later, the catheter was 
reinserted.
The failure time is taken to be the time from the point of
reinsertion until the next infection occurs. Therefore, during the study, 
several infections may be observed in each patient. Such times are 
correlated when they are repeated observations of the same patient
Censoring occurs when the study ends or when the catheter is removed for 
some reason not connected with infection.
82 patients were enrolled in the study with the number of serious 
infections/censoring in a patient ranging from 1 to 8. The aim of the 
study was to relate the incidence rate of infection to risk variables,
such as age, sex and type of kidney disorder, and to explore the extent of 
variability among patients.
The recovery interval is assumed to be sufficiently long to make 
negligible carry over effects from one failure recurrence interval to the 
next. It seems reasonable to assume that patient frailty is a constant 
common factor in all observations on the same patient. Part of the data, 
the first 2 failure observations of 38 patients, has been analysed by
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McGilchrist and Aisbett (1991b) and McGilchrist (1993) to give BLUP and 
REML estimations respectively assuming the random frailty terms are 
independent and constant over time.
Data set (8) -  Bladder cancer data
This recurrent bladder cancer data set appeared in Byar, Blackard and 
the VACURG (1977) and Byar (1980). The study was conducted by the 
Veterans Administration Cooperative Urological Research Group.
At the beginning of the trial, patients who had superficial bladder 
tumors were enrolled. These tumors were removed transurethrally.
Patients were randomly allocated to one of the three treatments: placebo, 
thiotepa and pyridoxine. During the study, many patients experienced
multiple recurrences of tumors and these tumors were removed at each 
visit. One of the research objectives was to evaluate the effectiveness 
of thiotepa in reducing the rate of tumor recurrence in bladder cancer 
patients as indicated in Byar (1980).
Analysis of this recurrent bladder cancer data by modelling the 
marginal distribution can be found in Wei, Lin and Weissfeld (1989). In 
this paper, however, only part of the data was used, which included the 
placebo and thiotepa group. Also, only up to the fourth failure time
observations were considered in this paper. Moreover, a comparison of 
their method with that of Prentice, Williams and Peterson (1981) and 
Andersen and Gill (1982) was also presented. Recently, Lin and Wei (1992)
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analysed the same set of data by extending the idea of Wei, Lin and 
Weissfeld (1989) to accelerated failure time models.
Data set (9) -- ’’Late infections” in Bone marrow transplant data
Between July 1970 and December 1976, 89 patients with aplastic anemia 
or acute leukemia treated by syngeneic (13 patients) or allogeneic (76
patients) marrow transplantation were studied to determine the incidence 
of late infections. Details of this study were described by Atkinson et 
al. (1979).
All infections, except the upper respiratory infections and 
varicella-zoster infections, occuring after 6 months from marrow
transplantation were included. Possible risk variables were recorded for 
analysis. Of particular interest was the relationship between recurrent 
infections in long-term survivors and the chronic graft verse host disease 
(C-GVHD).
In this data set, each patient might experience more than one
infection. A subset of this data, the 76 patients receiving allogenic 
bone marrow transplantation data, were used to study the predictive 
factors for "late infection" in Prentice, Williams and Peterson (1981). 
In this paper, the method of stratification was employed to analyse this
subset of data. Moreover, models considering "Gap time" and "Total time" 
as the failure time measure to construct the stratified hazard function 
were proposed.
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Data set (10) ~  Others
In fact, there are quite a large number of recurrent failure time 
data sets. Examples are the Multiple tumors Carcinogenesis experiment
data given by Gail, Santner and Brown (1980), the Myocardial infarction 
data considered in Hougaard (1986a), the Bone marrow transplant data 
exmained by Storb et al. (1990) and Pepe and Cai (1993).
Moreover, 3 multiple failure time data sets were reported in the
epidemiology workshop held in the Monash University in July 1994. The 
first one was a project coordinated by the World Health Organisation 
(WHO). Beginning in 1984, the study recorded the subsequent cardiac
events of over 5000 patients who were admitted to hospital for the first 
time with suspected Acute Myocardial Infarction (AMI). Patients were 
followed up for up to 8 years.
The second data set considered the recurrent hospital admissions for
patients suffering from Lower Respiratory tract Illness (LRI). LRI is an 
important cause of mortality, morbidity and hospital admission in early 
childhood. The study was conducted by the Institute for Child Health
Research in Western Australia. One of the research objectives was to 
investigate the effect of possible risk variables on the rate of hospital 
admission in LRI patients.
The third recurrent data set came from 150 Childhood Acute
Lymphoblastic Leukaemia (ALL) patients. Data from these ALL patients were
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derived from medical records in the Prince of Wales Children’s Hospital, 
Sydney between 1983 and 1989.
2.4 TYPE IV : THE OCCURRENCE OF DIFFERENT
FAILURE EVENTS IN THE SAME PATIENT
In some medical research, we may obtain the failure time data of 
different events in the same patient. For example, in studying elderly 
people, we may consider two types of failures, the hospitalisation and 
death. Since these two types of failures are related, it is necessary to
develope survival models that allow more than one type of failure and 
establish the relationship between different types of failure.
Data set (II) -- The Dubbo study
The Dubbo study is a prospective study of the health of persons 
bom before 1930 living in the New South Wales country town of Dubbo. An 
introduction and some preliminary analyses of this data set have been 
given by Simons et. al. (1990) and Simons et. al. (1991).
There were 1237 men and 1568 women enrolled in the study. The mean 
age of men and women was 69 and 70 respectively. Extensive examinations 
were performed in 1988-89 covering medical, social, physiological and 
lifestyle variables.
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The study was followed for a period of 5 years, the two competing 
failure events were hospitalization and death. Note that the 
hospitalizations could be recurrent and the occurrence of death should not 
be earlier than hospitalizations. Research interest is to estimate the
risk variable parameters for both hospitalization and death as well as to 
find out the relationship between the random effects of the two types of 
failures.
Data set (12) -  Colon cancer study
929 stage C Colon cancer patients were enrolled between March 1984 
and October 1987. They were randomly assigned to observation, levamisole 
alone or levamisole combined with fluorouracil. Details of the study can 
be found in Moertel et al. (1990) and Fleming (1992).
The main research interest was to evaluate the role of levamisole
combined with fluorouracil as adjuvant therapy for resected colon cancer. 
In this study, both the cancer recurrence and the survival time were
considered to be important outcome measures.
Since the two types of failure, the cancer recurrence and death, may 
occur in the same patient, analysing techniques that will cope with the 
relationship between the two types of failure within the same patient need 
to be developed. An analysis of this data set based on the marginal
approach has been given by Lin (1994).
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CHAPTER THREE
REVIEW: DIFFERENT APPROACHES TO 
THE MULTIVARIATE FAILURE TIME PROBLEM
For the four types of multivariate failure time data mentioned in 
Chapter 2, the common feature is the dependence between the failure time 
observations that occurred within the same patient/cluster. With this 
dependence, extension of the traditional Cox method which assumed 
independence between events is needed. Methods used to analyse these 
multivariate failure time data should be able to handle such dependence. 
In the past twenty years, researchers have attempted to set up survival 
models which extend the univariate Cox regression model to solve the 
multivariate failure time problem.
In this Chapter, initially Cox’s well-developed regression model in 
survival analysis in the univariate case is described. In developing this
model, Cox proposed the partial likelihood method in the univariate case
(1972, 1975). Here, univariate means that there is only one failure time
corresponding to each individual and these observations can be assumed to 
be independent. Usually, in the medical context, the failure time refers 
to the survival time of patient. This is followed by a brief description 
of different approaches that have been used to tackle the multivariate 
failure time problem. They have been classified as (i) the frailty models 
approach, (ii) the marginal modelling approach, (iii) the counting
processes approach and (iv) the generalised linear mixed model (GLMM) 
approach.
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3.1 UNIVARIATE COX’S REGRESSION MODEL IN 
SURVIVAL ANALYSIS
In Cox’s proportional hazards model (Cox 1972), the hazard function 
for the failure time T of n individuals associated with a pxl vector of 
possibly time-varying covariates = [x{, ... yXnY is
3.1.1 h ^ )  = X(ti) g(xj;ß)
where ß is a p-dimensional vector of regression parameters 
Ä.(t) is the unspecified baseline hazard function
g(jc;ß) is a positive-valued function and in most situation it is 
chosen to be exp(x'ß)
The log-partial likelihood function (Cox 1975) is given by
3.1.2 /(ß) = Z D J/n g(*;ß) - / n l  g(xj;ß)]
i=l j€/?i
where
r
0 if patient i is censored
1 if patient i dies
is the censoring indicator
Rx is the risk set which is defined to be the set of individuals 
known to be alive just prior to
If g(jCj;ß) is chosen to be exp(;t'ß), then the log-partial likelihood 
is given by
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3.1.3 /(ß) = I  D ^ 'ß  - /nX exp(xjß)]
i = i je R{
The estimation of the regression parameters ß is given by maximizing 
the log-partial likelihood function in 3.1.2. Such a method is usually
called a semi-parametric approach since the baseline hazard function is 
completely unspecified. A great convenience of this method is that the 
baseline hazard function is cancelled out in the partial likelihood 
expression and then not involved in the estimation process of the 
regression parameters.
A
If we denote the maximum partial likelihood estimator of ß by ß, 
then, under some mild conditions, ß is asymptotically normally distributed 
with mean ß and variance estimated by I(ß)'1, where I(ß)'1 = -ö2/(ß)/aßöß/ 
is the observed information matrix from the log-partial likelihood
function. Consequently, the usual asymptotic results for likelihood ratio
tests based on this log-partial likelihood can be applied. For the
derivation of the asymptotic results, the maximum likelihood estimation of 
parametric regression models and the accelerated failure time regression 
models, refer to Kabfleish and Prentice (1980), Lawless (1982) and Cox and 
Oakes (1984).
3.2 THE FRAILTY MODELS APPROACH
Frailty models, following their introduction by Vaupel, Manton and 
Stallard (1979), have become common. Essentially, in the frailty models,
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an extra random component is introduced into the proportional hazards 
model to explain individual variability.
For example, when we consider infection episodes, the failure time 
observations within the same patient are correlated because these 
observations come from the same patient. Therefore, in the proportional 
hazards model, a random patient effect is introduced multiplicatively
into the hazard function. The hazard function is given by
3.2.1 h(t;i,j) = u{ X(t) g(ß)
where h(-), X(-) and g(-) have the usual interpretation as in 3.1.1 
represents the random frailty of the 1th individual
The idea is that individuals have different frailties, and that after 
eliminating the effects of the corresponding risk variables, those who are 
most "frail" will experience the highest rates of infection. Since the 
frailty term is a random component, the frailty distribution can be
modelled parametrically. Reviews on the heterogeneity in survival
analysis and the analysis of event history data have been introduced by 
Aalen (1988) and Clayton (1988) respectively. A classification of 
multivariate survival data and different modelling suggestions can be
found in Hougaard (1987). The relevance of these models in different
situations have also been discussed in this paper.
The frailty model development starts from the matched survival data 
analysis of Holt and Prentice (1974). In this semiparametric model, the
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association within a pair was treated as a separate nuisance hazard 
function and the covariate acted proportionally on that hazard for each 
pair. On the other hand, Clayton (1978) and Oakes (1982) provided a fully 
parametric model for matched survival data with Gamma distributed frailty. 
Besides the semiparametric nature, the main difference between the Holt- 
Prentice (HP) model and the Clayton-Oakes (CO) model is that the HP model 
applies the proportional hazards assumption to the conditional hazard 
rather than the marginal hazard.
Wild (1983) considered the Weibull specification in the baseline 
hazard function with the random component modelled as constant, 
independent Gamma distributed and unknown parameters. In this paper, the 
loss of efficiency problem in the HP model when there is appreciable 
censoring in the data, was also investigated.
In the bivariate situation, Clayton and Cuzick (1985a) considered 
estimation of the frailty parameter and covariate effects using a modified 
EM algorithm with the frailty assumed to be Gamma distributed. The
illustration of the EM algorithm technique for Cox’s regression model can 
be found in Clayton and Cuzick (1985b).
The extension of the fully parametric model of Clayton (1978) to 
incorporate covariate information has been suggested by Huster, Brookmeyer 
and Self (1989) in the analysis of the Diabetic retinopathy study. The
marginal modelling approach based on the independent working model to the 
same set of data has also been provided in this paper.
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Oakes (1989) considered the class of bivariate survival distributions 
that can be used to model the frailty within two observed survival times. 
Moreover, it has been shown in this paper that the observable bivariate 
distribution determines the unobservable frailty distribution up to a 
scale parameter.
Using the EM algorithm, Klein (1992) considered the estimation of 
fixed and random effects regression model in survival analysis. Based on 
a profile likelihood construction, the full likelihood consists of the 
observed failure time and the unobservable frailty by assuming the random 
frailties follow a Gamma distribution. In the E-step, the expectation of 
the likelihood with respect to the observable data is considered. In the 
M-step, a partial likelihood is constructed to estimate the covariate 
effects using the profile likelihood technique suggested by Johansen
(1983) . With the Gamma distributed frailty assumption, parameter
estimates are obtained by iterating between the 2 steps.
The gamma distributed frailty model has also been considered by 
Vaupel, Manton and Stallard (1979), Lancaster (1979), Lancaster and
Nickell (1980) and Vaupel and Yashin (1983). As indicated in Hougaard
(1984) , the Gamma distribution constitutes a very convenient family in 
modelling frailty distributions. Moreover, Vaupel and Yashin (1983) have 
proposed other distributions such as the Uniform, Weibull and Lognormal 
distribution to model the frailty.
In Hougaard (1984), the heterogeneity between individuals in the 
population has been modelled by the Inverse Gaussian frailty distribution.
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Hougaard (1986a) considered a three parameter family of distributions on 
positive numbers to model the frailty distribution. This three parameter 
family P(a,8,0) includes the positive stable distribution (0=0), Gamma 
distribution (a=0), degenerate distribution (a=l) and the Inverse Gaussian 
distribution (a=l/2). Basically, the family is derived from the positive 
stable distribution by introducing one more parameter.
A class of continuous multivariate lifetime distributions has been 
proposed by Hougaard (1986b). The dependence between individuals in a 
group is modelled by a group specific quantity, this quantity is assumed 
to follow a positive stable distribution. Moreover, the possibility of 
including covariates into the model is also discussed. Further work in 
modelling heterogeneity in survival data has been given by Hougaard 
(1991). Extension of the models suggested by Hougaard (1986a, 1986b) 
using the compound Poisson distribution can be found in Aalen (1992).
3.3 THE MARGINAL MODELLING APPROACH
The marginal modelling approach, sometimes called the "independence 
working model analysis", to multivariate survival analysis originated with 
Wei, Lin and Weissfeld (1989). Essentially, the method is analogous to 
that of Liang and Zeger (1986) for longitudinal data analysis. In Liang 
and Zeger (1986), a class of estimating equations which is an extension of 
generalised linear models to the analysis of longitudinal data is 
introduced. It has been shown that simple estimating equations can be
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constructed to yield consistent and asymptotically normal estimates for 
regression parameters provided the marginal model is correctly specified.
The marginal modelling approach formulates the marginal distribution 
o f multivariate failure times with the familiar Cox proportional hazards 
models while leaving the dependence structure between related failure 
times completely unspecified. So, in the marginal modelling approach, 
type-specific hazard function hj(t;i) is considered; this may be modelled 
as in 3.3.1 and 3.3.2
3.3.1 hj(t;i) = XQ(t) expCxJfy)
3.3.2 hj(t;i) = Xoj(t) exp(xjßj)
where hj(t;i) is the hazard function corresponding to the j 1*1 type failure 
^Q(t) is the usual baseline hazard function 
Ä.0j(t) is the type-specific baseline hazard function
ßj and x^ correspond to the vector o f j 1*1 type failure regression 
parameter and risk variable o f the j *  type failure in the i1*1 individual 
respectively
Note that in 3.3.1 and 3.3.2, there is no explicit modelling o f the 
dependence structure between the failure events in the same 
patient/cluster. Moreover, 3.3.1 and 3.3.2 differ in that the baseline
hazard functions for the different type o f failures may or may not be 
identical. On the other hand, we may also consider the regression 
parameters ßj to be the same among the marginal submodels 3.3.1 and 3.3.2 
(i.e. ß=ßj, Vj).
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Prentice, Williams and Peterson (1981) proposed a stratified 
proportional hazards function to model the multivariate failure data from 
which it absorbed the model discussed by Gail, Santner and Brown (1980) as 
its 2-sample special case. This method of stratification was illustrated 
by applying the method to analyse the "late infection" in bone marrow 
transplant data. Moreover, in this paper, there is a discussion on using 
the "gap time" or the "total time" as the failure time measure.
Following this stratification technique, Wei, Lin and Weissfeld
(1989) extended the method by modelling the marginal distributions. The 
method’s further development was undertaken by Lee, Wei and Amato (1992). 
Related works by extending the marginal approach to accelerated failure 
time model can be found in Lin and Wei (1992) and Lee, Wei and Ying 
(1993).
Application of the independence working model to the Diabetic 
retinopathy data has been given by Huster, Brookmeyer and Self (1989). 
Moreover, a comparison of the marginal approach and the frailty model of 
Clayton (1978) (incorporating covariate information) in terms of
efficiency was also considered in this paper. The analysis of the
Schizophrenia and the Diabetic retinopathy data using the marginal
approach has been provided by Liang, Self and Chang (1993). The method 
mentioned can be seen as an unstratified version of the marginal approach.
Pepe and Cai (1993) also considered the analysis of recurrent failure 
time problem. An intermediate approach between the intensity method of
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Prentice, Williams and Peterson (1981) and the marginal method of Wei, Lin 
and Weissfeld (1989) was chosen by modelling the rate function. This 
method was applied to analyse a data set from a randomized clinical trial 
of bone marrow transplant patients treated at the Fred Hutchinson Cancer 
Research Centre for leukemia and aplastic anemia.
3.4 THE COUNTING PROCESSES APPROACH
Following the work of Aalen (1976, 1978), the theory of multivariate 
counting processes provided a general framework to analyse censored 
survival data. In fact, it unifies and extends many branches of non- 
parametric survival analysis. The development stems from modem 
martingale and stochastic integral theory.
It has been shown in Andersen and Gill (1982) that, based on the 
statistical theory of counting processes, the concept of partial
likelihood (Cox 1972, 1975) in Cox’s model can be treated as a special 
case of the multiplicative intensity model. Moreover, asymptotic
properties can be derived in a natural way in this general framework.
Essentially, the counting processes approach consists of the 
modelling of an intensity function (or equivalently the hazard function in 
Cox’s model) ^(t) for the ith individual. So, in the univariate case,
the intensity function
3.4.1 ^(t) = Y,(t) X„(t) expU,(t)'ß)
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where i = (n refers to the total number of individuals)
1 if i1*1 individual is under observation at time t-
0 otherwise
?i0(t) is the usual baseline hazard function
ß and JCj(t) are as usual, correspond to the vector of regression 
parameter and risk variable of the i1*1 individual respectively
Basically, this model coincides with the Cox type model in the 
univariate situation and generalises to take into account the information 
from recurrent data in the multivariate case. As to the multiplicative 
intensity model considered in Andersen and Gill (1982), this permits the 
regression analysis of the intensity of a recurrent event allowing for 
complicated censoring patterns and time dependent covariates.
Furthermore, in this paper, the asymptotic properties of the estimators 
were established using martingale techniques.
There has been a non-technical explanation of this approach in Gill 
(1984). A detailed review on the counting processes models for life
history data has been provided by Andersen and Borgan (1985). The 
extension of the two-state survival models to multistate models in
survival analysis by modelling the transition intensity has been explained 
in Andersen (1988). A systematic development of the counting processes 
approach and its application to multivariate failure time data can be
found in two textbooks written by Fleming and Harrington (1991) and 
Andersen, Borgan, Gill and Keiding (1993). One of the criticisms of the
counting processes approach is on the independence assumption of
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transition events conditional on covariates as discussed in Clayton
(1991).
The Maximum Likelihood (ML) estimation in frailty models using the 
martingale approach has been developed by Nielsen, Gill, Andersen and 
Sorensen (1992). The simplest and most commonly used model takes the 
intensity function of the klh observation of the j1*1 type failure in the
Ith cluster/individual as
3.4.2 A^(t) = Zi Yijk(t) X0(t) exp{xijk(t)'ßj)
3.4.3 V t )  = Zi Yük(t) ^oj(t) exp{*ijk(t)'ßj}
where Zj is called the random frailty variable for the i* 
cluster/individual
Yiik(t)
1 if the (i,j,k) failure is under observation at time t- 
0 otherwise
XQ(t) is the overall baseline hazard function 
>.oj(t) is the jth type failure baseline hazard function
ßj and Jtjjj^ t) correspond to the vector of jlh type failure
regression parameter and risk variable of the k* observation of the j* 
type failure in the i^  cluster/individual respectively
Moreover, according to the type of multivariate failure time data 
being considered, modification of these models is made possible by 
adjusting the indices of Ä.(t), Z, Y(t), A.0(t), x(t) and ß in 3.4.2 and 
3.4.3.
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In Nielsen, Gill, Andersen and Sorensen (1992), was assumed to be 
iid Gamma distributed. The risk variable parameters and the parameter in 
the frailty distribution are estimated by maximising the likelihood using 
the EM algorithm. This method of analysis has been illustrated through 
three data sets, the litter matched tumorigenesis experiment data, the 
skin allograft study data and the premature death in adult adoptees study 
data.
3.5 GENERALISED LINEAR MIXED MODEL APPROACH
Estimation and inference in the Linear Models (LM) with normal 
distributed error, are well developed. Let y be an observation vector 
with n components distributed according to the linear model
y = |i + e e ~ N(0,D)
E(y) = \i = Xß
where X is a nxp matrix of regression variables and ß is a p-component 
vector of regression coefficient. The variance matrix of the error vector
e is written as D, while D is considered as a function of some underlying 
parameter set 0.
Estimation and inference techniques on ß and 0 can be adapted from 
likelihood based methods such as Maximum Likelihood (ML) or Residual 
Maximum Likelihood (REML).
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The appearance of the Generalised Linear Model (GLM) technique by 
Neider and Wedderbum (1972) extends the traditional normal error linear 
model to non-linear responses. Setting the error vector to belong to the 
exponential family and connecting the mean to the linear predictor by a 
link function g allows the response to follow a family of distribution 
with non-identity link. Therefore
y = ji + e distribution of e belongs to the exponential family
E(y) = |i, with g(p.) = Xß
Moreover, the introduction of quasi-likelihood in Wedderbum (1974) 
provided further flexibility to the GLM. This so-called quasi-likelihood
can be constructed by specifying the dependence structure of the variance 
on [L without assuming the whole error distribution. Furthermore, such 
quasi-likelihood also has most of the appealing properties of the
likelihood function.
The Linear mixed model (LMM) with Gaussian outcomes were considered 
by Laird and Ware (1982) and Ware (1985) in analysing longitudinal data. 
In LMM,
y = \i + e e ~ N(0,D)
E(y) = (i = Xß + Zu
where X, Z are the corresponding design matrices of ß and u. ß is the 
usual fixed effect parameter and u is a vector of random effects 
distributed as N(0,A) with A containing possibly a parameter set <J).
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In the LMM, the Best linear unbiased prediction (BLUP) method 
developed by Henderson (1963, 1973, 1975) and recently reviewed by 
Robinson (1991) can be used to estimate fixed effect coefficients, 
variance components and to predict random effects. Following the 
introduction of REML estimation by Patterson and Thompson (1971) and 
Thompson (1980), the extension of BLUP to ML and REML has been outlined in 
Harville (1977) and further developed in Fellner (1986, 1987) and Speed 
(1991). LMM with AR(1) or other structured covariance matrices have been 
considered by Mansour, Nordheim and Rutledge (1985), Jennrich and 
Schluchter (1986) and Chi and Reinsel (1989).
For the non-Gaussian outcome mixed model, Williams (1982),
Stiratelli, Laird and Ware (1984) and Anderson and Aitkin (1985) 
considered the logit model, Ochi and Prentice (1984) proposed the probit 
model, Koch et. al. (1977) and Breslow (1984) examined the loglinear 
model. The first order Markov Chain model was developed by Zeger, Liang 
and Self (1985). Methods for maximising the joint likelihood for both 
fixed and random effects have been considered by Leonard (1972) in 
binomial data and Harville and Mee (1984) in ordered categorical data 
using the Baynesian argument. The Gilmour, Anderson and Rae (1985) method 
is somewhat analogous to the BLUP method in a mixed model for binomial 
data and has elements in common with the EM algorithm.
Analysis of longitudinal data for discrete and continuous outcomes 
using GLM by modelling the marginal distribution has been done by Liang 
and Zeger (1986) and Zeger and Liang (1986). Further work by Zeger, Liang
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and Albert (1988) considered subject-specific (SS) and population-averaged 
(PA) models. In the SS model, the heterogeneity in regression parameters 
is explicitly modelled while the aggregate response for the population is 
the main concern in the PA model.
The Generalised linear mixed model (GLMM) approach attempts to 
combine the GLM and LMM technique into a unified framework. Therefore, in 
the GLMM, we have
y = p. + e non-Gaussian outcome y
E(y) = |i, with g(|i) = Xß + Zu
Different approximations in the development of the GLMM have been 
used. The linearisation argument has been given by Schall (1991). The 
quadratic approximation in the likelihood in the region of the maximum has 
been proposed by McGilchrist (1994). Breslow and Clayton (1993) provide 
the Penalised quasi-likelihood (PQL) approximation following Green (1987) 
and Marginal quasi-likelihood (MQL) following Goldstein (1991) and Zeger, 
Liang and Albert (1988). The Solomon and Cox (1992) method was based on 
the Laplace approximation. The Psuedo-likelihood method given by
Wolfinger and O’Connell (1993) make use of the Gaussian approximation and 
Taylor’s theorem. Further development of the GLMM approach, following the 
line of McGilchrist (1994), by considering possibly correlated random 
effects can be found in McGilchrist and Yau (1995a).
As outlined in McGilchrist (1994), by reprogramming the first and 
second derivative of the log-partial likelihood function on the
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conditionally fixed random components, the GLMM technique can be applied 
to solve the multivariate failure time problem. Application of the GLMM 
approach to multivariate survival data can be found in McGilchrist and 
Aisbett (1991b), McGilchrist (1993), McGilchrist and Yau (1995b) and Yau 
and McGilchrist (1995a, 1995b).
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CHAPTER FOUR
GENERALISED LINEAR MIXED MODELS
In the preceding Chapters, the four types of multivariate failure 
time data are described and the four different approaches to the 
multivariate failure time problem are mentioned. However, with its
advantage in preserving the cancellation property and in predicting random 
components, the Generalised Linear Mixed Model (GLMM) approach is adopted. 
The cancellation property in the partial likelihood expression of the Cox 
model is a very convenient feature because it allows the baseline hazard 
function to be unspecified. The prediction of random components, as 
mentioned in Chapter 1, may be of interest when the identification of a 
high risk subpopulation is considered important.
The GLMM begins with the Linear Mixed Model with normally distributed 
random components. The Best Linear Unbiased Prediction (BLUP) method is 
used in the initial step of estimation and extends to obtain Maximum
Likelihood (ML) and Residual Maximum Likelihood (REML) estimators. Then, 
based on the quadratic approximation of the likelihood in the region of 
the maximum, the techniques similar to those developed for normal theory 
models with random components are reflected to the GLMM.
This Chapter is devoted to the derivation of the GLMM, with a brief 
explanation of the application of the GLMM to the multivariate failure 
time problem in the last Section. The estimation and inference techniques
developed in this chapter provides the foundation of development of the
random effect survival models given in the subsequent chapters.
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Moreover, the models considered here extend those given in 
McGilchrist (1994) by allowing possible correlation parameters in the 
variance matrix of the random components. The implementation of such 
extension for the analysis of multivariate failure time data is given in 
Chapter 6 in which the random effects of each individual is assumed to 
follow an AR(1) process.
4.1 INTRODUCTION
For Linear Mixed Models with normally distributed random components, 
Best Linear Unbiased Predictors (BLUP) were developed by Henderson (1963, 
1973, 1975) for simultaneously estimating the fixed components of a mixed 
model as well as the realised values of random components of the model. 
Such estimators or predictors (for the random components) were shown to be 
best, linear, unbiased. The estimation procedure has been reviewed by 
Robinson (1991) who gives an extensive bibliography.
When the BLUP estimators of the random components are used to 
estimate the variances of those random components, it is found that the 
estimated variance components are severely biased towards zero. Harville 
(1977) has noted that the BLUP computational procedure may be used to find 
both Maximum Likelihood (ML) and Residual Maximum Likelihood (REML) 
estimators as described in Patterson and Thompson (1971). The
relationship is fully developed in Thompson (1980) and further in Fellner 
(1986, 1987) as well as Speed (1991).
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On the other hand, the Generalised Linear Model (GLM) technique of 
Neider and Wedderbum (1972) introduced a much more flexible instrument 
for regression analysis in statistical modelling. It extends the
classical Linear Model by specifying an appropriate link function as well
as a particular choice of the error distribution in the exponential 
family. Hence, the GLM can be employed to analyse categorical, discrete 
and non-negative response data with non-normal error distribution.
It is then a natural extension to include random components that
combine with the regression variables and act linearly in the GLM 
framework. This type of model is often called the Generalised Linear
Mixed Model (GLMM). The GLMM starts with the BLUP estimators as the 
initial step and extends to finding ML and REML estimators. Parallel
developments of the GLMM are given by Schall (1991), McGilchrist and
Aisbett (1991a), Solomon and Cox (1992), Breslow and Clayton (1993),
Wolfinger and O’Connell (1993), Wolfinger (1993), McGilchrist (1994) and 
McGilchrist and Yau (1995a).
The subsequent Sections extend the model considered in McGilchrist 
(1994) by putting it in a more general setting for use with correlated 
random components which often appear in a repeated measures setting.
Applications of the approach have been made to multicentre clinical trials 
in McGilchrist and Zhaorong (1990); discordance data in Zhaorong, Matawie 
and McGilchrist (1992); threshold models in Zhaorong, McGilchrist and
Jorgensen (1992); survival analysis in McGilchrist and Aisbett (1991b),
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McGilchrist (1993), McGilchrist and Yau (1995b), Yau and McGilchrist 
(1995a, 1995b).
4.2 NORMALLY DISTRIBUTED RANDOM COMPONENTS
Let y be a response vector which is generated by the linear mixed 
model
y = r\ + e , rj = Xß+Z u
where e is distributed as N(0,azD) , D is a known symmetric matrix of
dimension equal to the number of observations n in the response vector
y and X, Z are matrices of values of regression variables. The unknown 
parameter ß has dimension v while the random component u may be 
partitioned
u = [u[, u2, ... , m'] , Z = [Zjt z 2, ... , ZJ
where Z, u are partitioned conformally and u. are independent random
components distributed as N[0, o^ AX<J>)] . For convenience we write
o^=o20. and the g2, 0^ , <}) are unknown parameters. The parameter <|)
may be a vector parameter of dimension p , which describes the covariance
structure of the vectors u. For example, when u follows and ARMA(1,0)
j j
process with correlation <)),
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1  <}) ( j ) 2  . . . .  <j)ni'1
1  ( j )  . . . .  < t)n j ‘ 2
1 ..........
$ny l (j)nj'2 (j)nj‘3 .... i
Estimation of the parameters of this model is accomplished by firstly 
developing Best Linear Unbiased Prediction (BLUP) estimators and then 
using those estimators as an initial computation in finding Maximum 
Likelihood (ML) and Residual Maximum Likelihood (REML) estimators.
4.3 BLUP ESTIMATION
The loglikelihood of y taking u as conditionally fixed, is 
denoted by /} and the logarithm of the probability density function of
u is denoted by l2 . Expressions for these quantities are
where v is the dimension of u . BLUP estimates of the parameters and j j
the realisations of the random components u , maximise /=/ + / .  For 
convenience let A be the block diagonal matrix
/[ = -(l/2)[n In 2na2 + /n ID I + a'Vxß-Zu)'D1Cy-Xß-Zu)] 
/, = -(1/2) S  [v/n 27C02 + /n|A(<(>)| + o W t t W
2 . J J J J J J J
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V,
e a
2 2
0 Ak kJ
The derivatives with respect to the parameters are
a//aß = aljdf, = a^X'D'ty-Xß-Zu) 
all du = a 2[Z'D'l(>>-Xß-Zu) - A 1«]
3//3CT2 = -(l/2)[na2 - a'Vxß-Zu)'D‘V xß-Zu)]
8//S0 2 = -(l/2)[v a 2 - o V a ;‘u ]
J J J J J J J
all at.|> = -(1/2) S [v (,) - a%'A'\akJd<sf )a ;V]
* , J J J J J s J J
J =  1
where v(s) = d\Jd§  ). 
j  j  j  *
Equating the above derivatives to zero and solving gives the BLUP 
estimators, viz.
4.3.1 ' x 'd  ' x X 'D 'Z r X D V
z 'd ' x z 'd ' z +a 1 u Z V ly
4.3.2 Ö2 = n‘Vxß-ZÜ)'D~Vxß-ZÜ)
4.3.3 ö2 = v.,ü'A',ü. , j = 1, 2, , k
J J J J J
k
4.3.4 I  [v<s> - 5;2M'A;'oAy8<t> )a ;'5] I _ = o , s = l, 2 , . . .  P
j _ J J J J J J s J J < j)= (j)
The BLUP equation for <j>s may not be solvable explicitly. Using the 
first matrix equation and letting
48
I  = D+ZAZ' , K = D 1 - D lX(X'D lX) X'D 1
the matrix equation can be solved to give
4.3.5 ß = (X T lX )'X Tly
4.3.6 ü = (Z'KZ+A'Vz'Ky
Note that K is symmetric and X'KX=0 implies KX=0 .
4.4 SOME MATRIX RESULTS
Definition Given any matrix A, the Moore-Penrose inverse A+ of A is 
defined to be a matrix which satifies
(a) AA+A = A (c) (AA+)' = AA+
(b) A+AA+ = A+ (d) (A+A)' = A+A
Matrix results in this section rely much on the definition and 
properties of Moore-Penrose inverse. The existence and uniqueness 
properties of such an inverse is well-known and has been developed by 
Penrose (1955) based on the foundations laid by Moore (1920).
Let Z and K be defined as in the previous section. A matrix Q 
is introduced in the following theorem.
Theorem 4.4.1. Q = r'[I-X(XT'X)‘X'r'] = K(KXK) K
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Proof: Let W = I-X(X'X)"X' and since W is a symmetric idempotent
matrix, we can choose a rectangular matrix P with columns the normalised 
eigenvectors corresponding to the unit eigenvalues of W. Thus 
W = P F  such that P P=I , WP=P , P'W=P/ 
and P(FZP)’Pr is the Moore-Penrose inverse of WXW. This follows from 
P (F IP ) P'W IW  = WIWP(P IP) P' = W 
Now Q is also the Moore-Penrose inverse of WEW . This follows from 
QWXW = WLWQ = W and WQ = QW = Q .
Since the Moore-Penrose inverse is unique then Q=P(FSP)'P'. Since KX=0 
, P'X=0 and both K, W have rank n-v , it follows that 
Q = P (F IP ) P' = K(KSK) K .
Assuming that matrix A is of full rank, the following results may 
be derived. Let
' X'D lX x d ‘z -1 • •
Z 'D 'X Z 'D 'Z + A 1 . T
where T is that part of the inverse corresponding to Z'D^Z+A'1 in the 
original matrix. Thus T 1 = Z'KZ+A 1 . Also let T* = (Z'D lZ+A l)'‘ •
Theorem 4.4.2
(i) r1 = D 1 - D ‘ZT*Z'D1
(ii) Q = K - KZTZ'K
(iii) Z T 'Z  = A'1 - A''T*A''
(iv) Z'QZ = A'1 - A ’T A 1
(v) A Z T 'Z  = T*Z'D'1Z
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(vi) AZ'QZ = TZ'KZ
Proof.
(i) Since £ = D+ZAZ' and T* = (Z 'D 'Z+A1) 1 ,
£  (D 1 - D ‘ZT*Z'D ‘)
= (D+ZAZO (D 1 - D ‘ZT*Z'D ‘)
= I - ZT*Z'D 1 + ZAZ'D1 - ZAZ'D1ZT*Z'D1 
= I - ZT*Z'D 1 + ZAZ'D 1 - ZA(ZT> ‘z+A l)T*Z'D 1 + ZAA1T*Z'D1 
= I - ZT*Z'D1 + ZAZ'D 1 - ZAZ'D 1 + ZT*Z'D 1 
= I
Therefore, £ -1 = D 1 - D ‘ZT*Z'D1 .
(ii) Let D=PP' where P is of full rank and let X=PX| , Z=PZ| so
that £  = P £ P '  , where £  = I+Z^ZJ and K = P^K  P 1 , where
K =I-X (X'X )'X . Now T 1 = Z'KZ+A 1 = Z'K Z +A 1 , let V = K £ K ,i r  i r  i i l l  2 i i i
V = K - KiZjTZJKi , since K  ^ is idempotent,
V V  = K I K  K Z  TZ'K I  K1 2  1 1 1  11 1 1 1 1
= K I  K - K Z TZ'K (I+Z AZ )Ki l l  l l l r  l v l
= K I  K - K Z TZ'K - K Z TZ'K Z AZ'Ki l l  i i  i i  i i  i l l  i i
= K £ K - K Z TZ'K - K Z T(A '+Z'K Z )AZ'K + K Z TA ' a Z'K1 1 1  1 1 1 1  1 1 V 1 1 V 1 1 11 1 1
= K I K  - K Z TZ'K - K Z AZ'K + K Z TZ'Ki l l  l i i i  l i i i  l i i i
= K I  K - K Z  AZ'Ki l l  i i  i i
= K ( I  -Z AZ')Kr  l l i i
= K IKl l
= Kl
Similarly, = K .
Now, V V2 = ^ 2 ^ 1  = *^ i ’ K symmetric and idempotent, we then have
(a) V V V = K V = V (c) (V V )' = K' = K = V Vv ' i 2 i i i  i v ’ v i r  l l 1 2
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(b) V V V = K V = V (d) (V V )' = K' = K = V V
w  2 1 2  1 2  2 v / v 2 r  1 1 2 1
which satisfy the four Penrose conditions. Hence V is a Moore-Penrose
inverse of V .
2
Since V = K X K , V  = (K X K )' = P‘1(KXK)P/'1, from Theorem 4.4.1 
2 i i i ’ 2 v i i r  v '
Q = K(KZK) K
p mk  v  k  p1 2 1
-1
= P''V V V V V P 1
1 2 2 2 1
= P' 'V V V P 1
1 2 1
= P' 'V P 1 
1
= p' i(ki - k z tz;k )p '
= K - KZTZ'K
Therefore, Q = K(KXK)K = K - KZTZ'K 
(iii) From (i), X'1 = D 1 - D 1ZT*ZD 1 , 
Z'x 'z  = Z'D ‘z  - ZD ‘ZT*Z'D ‘z
= ZD ‘Z - (Z'D 'Z+A ')T*ZD 'Z + A 'T*ZD 'Z 
= A 'T*ZD 'Z
= A''T*(ZD'‘Z+A'‘) - A''T*A'‘ 
= A'1 - A''T*A''
(iv) From (ii), Q = K - KZTZ'K , Z'QZ = Z'KZ - Z'KZTZ'KZ , then
follows similar simplification in (iii), we have Z'QZ = A’1 - a  'TA"1 .
(v) From (i), X'1 = D'1 - D 1ZT*Z'D'1 ,
Z D 1 = ZD 1 - ZD ‘ZT*Z'D 1
= ZD 1 - ZD 1 + A ‘T*ZD 1 
- A°T*ZD 1
Therefore, AZ'X'Z = T *Z D ‘Z
(vi) From (ii), Q = K - KZTZ'K , 
Z'Q = Z'K - Z'KZTZ'K
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= Z'K - Z K + A 'TZ'K
= a 'tz'k
Therefore, AZ'QZ = TZ'KZ 
Theorem 4.4.3
(i) Z T 'Z  = Ö 'V S  - e 'e^A 'T* A'1 , where 8 =Kronecker delta.
1 j 1 1 lj 1 j 1 l j  j lj
(ii) z'qz = e;V8 - ö'V a-'t a:1 .
j j i i ij i j i ij j
Proof. Since Z = [Z^ Z2, ... , Z J and A = diag[0iAj 02A2 ... 0kAJ
(i) from Theorem 4.4.2 (iii), Z X 'Z  = A 1 - A‘'T*A‘‘
Z T 'Z  = (ij) block of Z T ’Z
i J
= {(i,j) block of A 1} - {(ij) block of A^T^A’1 }
= e V s  - e ,e'1A 1T*A ' 1
i i ij i j i i j  j
(ii) from Theorem 4.4.2 (iv), Z'QZ = A*1 - A^TA1 , by similar
argument in (i), we obtain Z'QZ = ©^A^S - O^O^A^T A’1 .
i j i i ij i J i ij J
The following notation is useful in simplifying expressions. Let 
T*=[T*.] be a partition of T* into blocks conformally to the partition
of u . We denote
v= tr A'1 A , v(s) = tr A^aA/atJ) , v(st) = tr dA'Vdcj) aA]d§
j  j j j  j J s J J s J t
r*=e:'tr a;'t* , r*(,)= e:'tr aA:'/a<t> t* ,
J J J JJ J J J s JJ
r*(’° = e 'tr aA'VabT* A^'aA/30 ,
j  j j s j j  j J 1
r* =tr T* A''T* A'1, r*(,)= tr T* aA'Vsd) T* A'1,
l j  l j  j  j l  1 l j  l j  j s j l  1
r*<!°= tr T* aA'Vad) T* aA_1/a<l>
l j  l j  j S j l  1 t
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If T* is replaced by T in the above definitions, then r* is replaced 
by r in all but the first line of the definitions. This is a definition
of the equivalent r, r(s), r(sl) terms with appropriate one or two 
subscripts.
Theorem 4.4.4
(i) a / n i s i  /ae = tr S'aS/aO = tr r ' Z A Z '  = e '(v-r*)
J j J j j J J J
k k
(ii) a /n I s | / a*  = I  0tr S ’Z3A/3* Z' = I  (v(s)+r*<s))
* . . j j J S j . . j j
J = 1 J = 1
(iii) 3 ln I K2K | /30 = tr (K2K)'K(aS/a0 )K = tr QZAZ '  = 0‘‘(v-r)
j j j j j j j j
(iv) a ln I K2K I /a<)> = tr (KXK)'K(ajya* )K = 1 0  tr Q Z(aA /a*)Z '
* s . . J j J S j
J = 1
= Z (v (V s>)
j-1 J 1
4.5 MAXIMUM LIKELIHOOD ESTIMATION
The loglikelihood function for y formed by integration over the 
distribution of u is
L  = -d/2)[n ln 2ito2 + M12 1 + a 'V xß)X '(y -X ß)]
M L
2
The derivatives with respect to the parameters ß, c  , 0 and <J) are 
a/ /aß = a 2X'sVxß)
M L
a/ /ao2 = -(l/2)[no 2 - aVxß)T'(y-Xß)]
M L
a/ML/a0. = -(l/2)[tr r 'a j /a e  + o'2Cv-Xß)'(a2'l/a0j)O'-Xß)]
54
3/ ,/3<t> = -(l/2)[tr r'3l/3<t) + a'2Cy-Xß)'(3r‘/3(t> )tv-xß)]
ML s s s
giving
4.5.1 j L  = B = H’X 'l 'y , where H = X 'Z 'X
ML
4.5.2 = n‘l(y-XßML)'X'l(y-X^ML)
In general the equations for <{> are not explicitly solvable although they 
may be for particular £ . The information matrix /  is
a 2H 0 0 O '
. n/2o4 (l/2a2) [ t r X '13X/59 ] (l/2o*)[tr X' 'sX /S^l
. . (1/2) tr tz  'aX/aO Z'^X/sO] (1/2) tr[X ''3 l/ae £ ''32 /36]
I j I t
. . . ( l/2 )tr[2 ',32/3<t>2'132/3())t]
In the current model the variance matrix has the form
k
£ = D + ZAZ' = D + I0ZA(<t>)Z'
. . j j j j
j = i
so that
k
a£/a0 =ZA(<t>)Z' , al/a<|> = I  0 Z (öA/a<j> )Z' .
J J J j s . , J j J s J
J = 1
Note that if the (j) parameter is not present in A. then that derivative 
is zero.
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Matrix Results
(i) Qy= r '(y -x L )=  D '[I - Z(Z'D'1Z+A'1)'1Z'D1](y-XiL )= D'(y-Xß-ZÜ) 
(ü) Z'Qy = ZX'ry-X^M[ ) = Zir'ty-Xß-Zü) = A‘ u
(iii) Z'Qy = Z T '(y -X $ML) = Z'D'VxP-ZS) = e .V n
(iv) (y-xP)/a r 1/ae.O'-xP) = -0'-xP)T,o s/a e j) r 1cv-xP) = -e.^'A.V
(v) y'QOI/30 )Qy = &2u,a :'u.
J J J J J
(vi) o-x{5)'ax'/att> (y-xP) = i  ei'ü'OA;7a<»)«.
* . . J J J s J
J = 1
(vii) y'Q(aS/a<t>s)Qy = - 1  ^ ‘«'(aAjVatOü.
The prcx>f is direct for each of the results. Using the above, and the 
matrix results of the previous section, we have
4.5.3 o 2 = n 'y T V x j L )  = n '/ D '‘(y-Xß-ZÜ) = n '/Q y
ML ML
a,ML/a0jlß=P= "(*^9.)(v.-r*-a’2M'A‘1M,) = 0, giving
4.5.4 a 2 =uA'luJ(\-r*)
j(ML) J J J J j
giving equations which may be solved iteratively for ({). The information 
matrix, multiplied by 2, becomes
j = i
4.5.5
'2a 2H 0 0
. n/a4 a "2(v -r*)
j j j
a - 2 !  ( v (1)+r*( , ) )
I 1
0
[e:2(v -2r*)8+e:2e:2r*]
i i i ij i j  i j
I[-v  <J , >+2r*<SI>+ x  e ' e  'r * '50 
. j j . j m j m
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4.6 RESIDUAL MAXIMUM LIKELIHOOD ESTIMATION
Let /reml be the loglikelihocxi function for residual maximum 
likelihood techniques. Since the matrix K defined in section 4.3 
satifies KX=0, an expression for / given by Patterson and Thompson
REML
(1971) is
I = -(l/2)[(n-v)/n 2ncT + ln | KXK | + a '2y'K(KZK)"Ky]
REML
where \ KXK \ must be interpreted as the determinant of linearly 
independent rows and columns of KXK . The following development 
parallels Thompson (1980).
The first order derivatives of / are
REML
a/REML/aa2= -(l/2)[(n-v)a‘2V /K (K X K )‘Ky] = -(l/2)[(n-v)a‘2V /Q y ]  , 
3/„„.,/30 = -(l/2){tr[(KXK)"KaS/a9.K] - a 2y'K(K2K)'KaI/a0.K(KXK)'Ky)
REML J j J
= -(l/2)[tr Qaz/a0 - a '2y'QaI/a0.Qy]
a l / a i >  = -(l/2){tr[(KIK)‘KaI/a(t) K] - a '2y'K(KSK)"KaI/3<t> K(KIK)'Ky)
REML s s s
= -(l/2)[tr Qal/a<|) - a ‘2y'QaI/a<t) Qy]
s s
Thus
4 6 1  ®REML =  ( n -V )^ ' 0 - V
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and the REML information matrix fREML is
(n-v)/2a4 ( l ^ a 2) »  Q a l/a e  . (l/2cT)tr Qal/a<t>i
(1/2) tr QaZ/ae.QaZ/ae (l/2)trQ a£/ae.Q aI/a0t
(l/2 )tr Q a I/3 0 sQaS/a0t
k
Using a£/a0 = ZA(<j))Z' , aL/a<J) = £  0 Z (aA/a<j) )Z' and the matrix
j  j  j  j  s  .  j  j  J s  J
j  =  i
results in the previous sections, we have
a/ /a0= -(l^ H v-r-a '^ 'A '1«]
REML j V j j j j j j j
0, giving
4.6.2
4.6.3
S2
j(REML)
al /a<>
REML r s
u'A'xu](y .-*)
J J J J J
= -(1/2)1 [vw+r(s) + a:2U'(aA:‘/a0 )ü] L (
. . J J J J J s J
J = 1
0
Again this last equation may have to be solved iteratively for <J>. The 
REML information matrix, multiplied by 2, is
(n-v)/o4 o"2(v,-r.)
j  j  j
o ‘ I  ( v ( , )+r ( l ) )
j=l
-2r\-2^ ![ 0 (v .-2r.)8. +0 0 r..] 0;‘(v.
j  i  i  i j  i  j  i j  i  i
j
+2r ( ,)- i e : 1e : 1r (,))
i . 1 j uj = i
i [ - v (st)+2r (>t)+ l e W 0]
.  j  j  .  j  m  j m
j = 1 m = 1
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4.7 GENERALISED LINEAR MIXED MODELS
The extension of the theory to generalised linear mixed models has 
now been accomplished for a response vector y , which is not necessarily 
normally distributed, but has a distribution dependent on a vector 
quantity T| which is related to vector regression variables through 
the equation
Ti =  Xß + Z u
If f(y;ß|w) is the probability (density) function of y conditional on
fixed u , then / = /n f(y;ß|w) is the log-likelihood of y conditional 
on fixed u . Taking u to be normally distributed as in the previous 
sections, the logarithm of its probability density is / as given in 
section 4.3. The sum / = l^ +l^  is then termed a penalised likelihood
function and carries over the spirit of B L U P into a non-normal framework. 
In this sense / is a penalty function for the conditional loglikelihood 
/j . The penalised likelihood estimators of ß, u, equivalent to BLU P, 
are obtained by finding the likelihood derivatives
3 //aß = X'd/ /dT| , dH du = Z'd/ /dri -o 2A 'lu , i=l,2,...,k.
1 j  J 1 J J J
and the second order derivatives of / are the same as the second order 
derivatives of /{ except for
a2l/au au' = a2/ lau du - a 2 A '1 = -Z 'B Z -a V 1 
j j 1 j j j j j j j j
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where B=-d /ydridr)' . The Newton-Raphson iterative procedure for 
estimating ß, u is
■ p - = A ' + V X" dZ/dri - V ' 0
u ■ V Z' <j '2A'1u L o-1
where V = X r B[X,Z] + ' 0 0
Z' 0 < * ‘ 2 a ' 1.
If V is replaced by £(V) then the iterative procedure becomes the 
method of scoring.
A heuristic approach in McGilchrist (1994) approximates / by a 
quadratic expression in the region of its maximum, viz.
/ ^ constant + (1/2) p-p '  V - ß - p -
u-u u-u
In that case ß, u have approximately a joint normal distribution with 
mean ß, u and variance matrix V.
An alternative formulation of the problem is given in McGilchrist 
and Aisbett (1991b) in which the component /  ^ of the penalised
A A
likelihood procedure is replaced by the log-likelihood of ß, u as given 
by its approximate asymptotic distribution, viz. normal with mean ß, u
A A
and variance matrix inverse given by the information matrix for ß, u. In 
that case we may consider the BLUP estimation as having been derived from
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the very approximate asymptotic distribution of ß, u . If /(ß,w) is 
the sample information matrix for ß, u derived from then
/(ß,w) X "
Z'
B [X, Z]
Replacing / by /* , the log-likelihood based on the approximate
A A A A
asymptotic distribution of ß, u and letting y*=Xß+Zu gives
/* = constant - (1/2) ß - p  rj  X' ‘ B [X, Z] r p p  i
A
u-u z '
A
u-u
= constant - (l/2)(y*-Xß-ZM)'B(y*-Xß-Zw)
The formulation of the problem is now exactly as described for normal 
theory models with y* replacing y , B in place of D 1 and a 2=l
implying Q^a2 • B follows that estimators ß, u may be used to find 
ML and REML estimators.
The estimation procedure is as follows. For any given application, 
write down the loglikelihood as a function of Tj=Xß+Zw , taking u 
to be conditionally fixed. Using initial estimates of 0, <J) and letting 
ß=ßo , u=uq be initial estimates of ß, u solve equation 4.7.1 for ß, u 
Initial values are replaced by estimates in a new iteration and so on 
until convergence. Estimates of a., <{> are obtained from
4.7.2 S* = u'A''uj(y-r*)
j (ML) J J J j J
4.7.3 G2 = u' A 1uJ(v -t )
j(REML) j j / V j r
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and
4.7.4 £  [v(s) + r*(s) + aVaA^/acj) u] = 0 for 6 , s=l,2,..,p
. . J J J J J s J s(M L)
j = i
4.7.5 £  [v(s) + r(s) + &2u'dA'l/d<\>u] = 0 for <(> , s=l,2,..,p
j  j J J J s j s(REM L)
J =  1
Information matrices are given for ML and REML in previous sections.
4.8 APPLICATION TO THE
MULTIVARIATE FAILURE TIME PROBLEM
As indicated in Chapter 1, the main difficulty in analysing
multivariate failure time data is when a proportional hazards function
including a frailty component is constructed, the marginal failure time 
distribution formed by integrating out the random frailty component loses 
the simple properties of the original hazard function formulation,
particularly the cancellation of the baseline hazard function in the
partial likelihood procedure. The GLMM approach, as outlined in 
McGilchrist (1994), preserves the simple cancellation property of the
baseline hazard function in the partial likelihood as in Cox proportional 
hazards model.
The recurrent failure time data (Type III) is considered here as an 
example to illustrate how the cancellation property is preserved in the
GLMM approach. Suppose each individual has several failure times, the j1*1
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failure or censoring of the ilh individual is denoted by TV. The 
proportional hazards model is
h(tij;Zij,Uij) -  X.(tij)g(r|ij) , Ti- -  Xjjß+Uij
where h(-), M') and g(-) have the usual interpretation as in 3.1.1
xl} and Ujj are the associated risk variable vector and random effect 
respectively
Let u' = (11/  u2' ... uM') u' = (Ujj Ui2 ... Uin.) 
var u = A
Let the failure/censoring times be arranged in ascending order and t„ 
be the nth such time with
1 if patient i with jlh recurrence time fails at t„
0 otherwise
Then the probability that the j1*1 failure observation of patient i is the 
event that occurs at t„ is
Pijn -  hCtjjPq^Ujj)/ £  h(tjjPckl,U kl)
= ^(tij)g(Tlij)/ £  ^'(tij)g(Tlkl) 
tlcMj
= g O lijV  [  g(Tlkl)
k i-k i
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Note that the baseline hazard function X^-) is cancelled out in this 
expression.
Hence, the log-partial likelihood on conditionally fixed U values gives 
' l  =  I  I ID .jn ,n  Pijn
n i j
Followed by differentiating lx with respect to the parameters accordingly, 
the ML and REML estimation of the parameters are obtained from 4.7.1 to 
4.7.5. Inference on parameters are then based on the information matrices 
given in Section 4.5 and 4.6. Therefore, the GLMM technique developed in 
this Chapter serves as a general tool to analyse different types of 
multivariate failure time data. Applications of this technique are 
provided in the subsequent Chapters.
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CHAPTER FIVE
TIME DEPENDENT FRAILTY MODEL 
5.1 INTRODUCTION
In Chapter 4, the estimation and inference techniques in the 
Generalised Linear Mixed Model (GLMM) provide a general method to analyse 
multivariate failure time data. In this and the following Chapter, the 
CGD data set described in Chapter 2 is considered. Note that the CGD data 
belongs to the Type III data, which is the multiple recurrent failure 
events in the same patient. Early work on the Maximum Likelihood (ML) and 
Residual Maximum Likelihood (REML) estimation of this type of data based 
on the GLMM can be found in McGilchrist (1993).
Recall that the CGD study was a placebo controlled randomized trial 
conducted by the International CGD Cooperative Study Group in the late 
1980’s. The main research interest was to study the ability of gamma 
interferon (y-IFN) to reduce the rate of infections in CGD patients. 
During the study, each patient may experience several failures
(infections). Censoring occurs usually due to the termination of the 
study.
The original CGD data set can be found in Fleming and Harrington 
(1993). The first data set contained in Appendix I is the modified CGD 
data set, it is arranged in such a format that it fits the APL programs
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given in Appendix II. The format of the CGD data given in Appendix I is 
described as follows:
Column 1:
Column 2:
Column 3:
Column 4:
Column 5:
Column 6:
Column 7:
Column 8:
Column 9:
Column 10:
Column 11:
Column 12:
Column 13:
Column 14:
Column 15:
Columns 4
Harrington (1993). The hospital category is modified into Column 12 to 14 
by choosing Europe-other as baseline. Column 15 is "time since first 
failure" variable, which is added here when considering time dependent 
frailty models (Model 1 to 3 in Section 5.2). The importance of including 
this variable in the analysis has been noted by Self (1993) and Lindsey 
(1995).
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A time independent and three time dependent frailty models are 
described in the following Section. The time independent frailty model, 
which assumes the frailty of each patient is constant over time, is 
equivalent to the model described in McGilchrist (1993). For the three
time dependent frailty models, a parameter representing change over time 
is introduced and is modelled into a fixed effect, a normally distributed 
random effect and a longitudinal effect in which the random component 
relates to the patient characteristics. The ML and REML estimators for 
these models are derived in Section 5.3. Its application to the CGD data 
is provided in Section 5.4. A comparable stochastic modelling of frailty 
models applied to this data set using the counting processes approach can 
be found in Self (1993). In this paper, the frailty process is described 
as a time independent and time dependent Gamma distributed frailty 
process.
5.2 MODELS
For the Type III data considered in this and the following Chapter, 
each patient is followed until an event termed a "failure" occurs with the 
possibility that there may be a sequence of several such failures for any 
given patient. Usually only the last of these failure times is censored 
due to the termination of study. Let
5.2.1 h(t;i,j) = hazard function for j1*1 failure episode of patient i
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at time t measured from the beginning of the current episode. We 
consider M patients with failures for patient i so that
i=l,2,...,M ; j=l,2,...,ni.
The hazard function at t for any given i,j may also depend on a 
quantity rj- which is taken to be a linear combination of risk variables 
and possibly also random frailty components which reflect variation of the
risk for a given patient which is not accounted for by the measured set of
risk variables. The proportional hazards model is
5.2.2 h(t;i,j) = X ( X ) g ( J \ .X  i = 1,2,...,M; j = 1,2,...,^
where X(t) is a baseline hazard function and gCr^) is the combined effect
of all risk components on that baseline hazard. For the Cox model, 
g(tlij) = exp ti.j •
The combined risk variable T^ j is derived from a v dimensional vector 
of measured risk variables x  ^ and a random (frailty) component Ujj such 
that
5.2.3 Ti- = Xjjß 4- Ujj
where ß is a vector of regression coefficients. The models considered
here differ in the way the frailty components are considered. Note
that here we take the only possible variation of the hazard function, in 
going from one failure episode to the next, to be a variation in the 
frailty of the patient.
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Time independent frailty model: This model assumes the frailty for each
patient to be the same for all episodes as considered by McGilchrist 
(1993) in analysing a kidney patient data set. So, the random frailty 
term is considered to be constant over time for each of the individuals. 
Let
5.2.4 Ujj = Aj , Aj independent N(O,0!)
The term A { can be interpreted as the frailty of the iA patient. It then 
gives
5.2.5 T^ j = Xjjß + A^
where ß are fixed parameters and A( are random components.
Model 1: In this model the frailty Ujj consists of a random patient
effect plus a deterministic change over time which is the same for all 
patients. Specifically
5.2.6 Uy = Aj + TjjY , independent N(O,0!)
The frailty of patient i is denoted by A± initially and changes over
time deterministically where is the time from the first serious
failure until the time of current failure episode. For this model,
5.2.7 rijj = x',fi + TijY + \
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where ß , y are fixed parameters and Aj are random components.
Model 2: A sequence of failure observations on the same person is a
repeated measure and, in this and the subsequent model, extensions to 
model 1 are similar to those considered in repeated measures analysis. 
For model 2, the coefficient of is allowed to vary over patients
giving
5.2.8 Ujj = Aj + , Aj independent N(O,0j) , independent
N(0,G2).
Here, the frailty of patient i is denoted by Aj and changes over time 
linearly but with coefficient different for each patient. Thus
5.2.9 t|,j = x\p + XjjY + A( + t.jB,
where ß , y are fixed parameters and , Bj are random components.
Model 3: A further extension is to relate the coefficients of for
the different patients to the measured patient characteristics, giving
5.2.10 Ujj = Aj + Tjj(y + XjjV + Bj) , Aj, Bj distributed as in model 2.
This frailty model would apply if the coefficient of the time trend in 
frailty could be predicted from patient characteristics, an obviously 
important aspect of the variation in frailty problem. It leads to
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5.2.11 n,j = x[ß + V  + v 'jV  + Ai + TuBi
where ß , y , \j/ are fixed parameters and A{ , B{ are random components.
5.3 ESTIMATION
The basic structure of the estimation process is described in Chapter 
4. In applying the method of estimation, we reorder the r\{■ according to 
the failure time. After reordering, let
5.3.1 r\ = Xb + Zu
where b, u represent vectors of fixed parameters and random components 
respectively. The entries in the matrices X and Z correspond to b and u 
and are reordered according to the reordering pattem of r|.
The estimation process starts with a Newton-Raphson iterative
procedure 5.3.2 which is analogous to 4.7.1 . For fixed value of 0’s and
given a set of initial values b0 , u0 , the BLUP estimators maximize the
partial likelihood of the observed survival times for conditionally fixed
u . This partial likelihood is denoted by and is the usual
expression given by Cox, viz.
h -E D jtrij - /nZexpflip]
i=i j=i
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where is the failure/censoring indicator which is zero if censoring 
occurs and one if failure occurs, r\i is the ilh entry of the reordered
M
vector r\ and N is the total number of observations = X nt .
i = 1
Equation 5.3.2 below gives the first step of the Newton-Raphson 
procedure which becomes iterative by replacing the initial values with the 
result of the previous iteration. Letting A = var u we have
5.3.2 b 0^ . v> 01 + V ''[x  z]
u Uq i__
L J
' d/,
where V
dUdb'
A
dudb'
A
dbdU'
a2;, ,
1 + A'1dUdU'
r \
X' d \ [x z] + 0 0Z drjdTi' L J 0 A 1
The expressions for d/,an
Letting wk = exp T|k ,
and
ak =
d2/i
afjdrf'
N
Dj/X Wj ,
j=k
are simplified below:
k
l \  — X 3j , 
j =  l
W = diag(wj, w2, ... , wN) , A = diag(al5 a2, ... , aN) ,
M = lower triangular matrix with ones on/below the principal 
diagonal,
B = diag(bj, b2, ... , t^) = diag(MA7) , 1 = vector of ones, 
d' = [Dj, D2, ... , Dn] , ti' = [Tij, r|2, ... , tin]
then
5.3.3 - J  = d - WMA1 and drf drjdri' WB - WMA2M'W
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In general, for given 0’s, 5.3.2 gives exactly the same estimates of 
b in BLUP, ML and REML; but since we have different estimating equations 
for 0 in different methods, different values of b estimates are obtained 
from the three different methods in each of the models.
Time independent frailty model and Model 1: The estimation procedure of
these two models are essentially the same except the different components 
contained in the fixed effect parameter b . In time independent frailty 
model, b corresponds to the parameters ß while it corresponds to the
parameters ß and y in model 1. In both models, the random effect u 
contains the random effects described in the previous section. The
matrix V is then partitioned conformally to b\u  as
Letting W22 = V22 > results in Section 4.5 give
5.3.4 var b -  An
5.3.5 0i(ml) = M_1( tr W22 +u'u )
5.3.6 var 01(ML) = 29?[M - 20;‘tr W22 + e;2tr(W22)]'‘
For REML estimation, results in Section 4.6 give
5.3.7 01(REML) = M_1( tr A22 +u'u )
;m l) =  2 0 i  [M - 2 0 i  tr A22 + 0 t tr(A22)]5.3.8 var 01(REML)
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where M is the number of patients.
Models 2 and 3: In model 2 the fixed parameter b corresponds to ß, y
as in model 1 but the random component vector u consists of two 
components corresponding to the random components Aj and B;
respectively. The V matrix is partitioned comformally to b \ ux | ^  as
V
Vn V12 v 13 
V21 V22 v 23 
V3, V32 v 33
V-1
An a 12 a 13
A2i A22 A23
A31 a 32 a 33
Letting W
v 22 v 23'
1 * 7 * 1
w 22 w 2;
v 32 V 3 3 , W  = W32 W33 we have
5.3.9 var b = An .
Model 3 differs from model 2 only in the composition of the fixed 
parameter vector b which then contains ß, y, \\f so that the dimension 
of b in Model 2 is v+ 1  while it is 2v+l in model 3, where v is number of 
risk variables (dim ß). The partition of the V matrix is therefore the 
same for model 3 as it is for model 2 so that, subject only to change in 
the X matrix between the two models, the estimation process is 
essentially the same.
The development of ML and REML estimates of 0 is derived from 4.7.2 
and 4.7.3 respectively. Its asymptotic variances are given in Section 4.5 
and Section 4.6. Expressions for the estimates of 0’s which are similar 
to those in model 1 are obtained as
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5.3.10 01(ML) = M"‘( tr W22 +Z[H0
5.3.11 02(ml) = M ( tr W33 +u2u2)
A A
We have also the variance matrix for 01(ML), 02(ML) as
(1/20,)[M - 20,'tr W2 2 + 0,2tr W22] (1 / 20202)tr W 3 2W23
(1 / 20202)tr W 3 2W23 (1/202)[M - 202‘tr W3 3 + 022tr W23]
Similarly, for REML estimation,
5.3.12 0i(reml) = M ( tr A22 +MjWj)
A ^
5.3.13 02(reml) == M ( tr A33 +u2u2)
A A
We have also the variance matrix for ®2(reml) as
(1/20?)[M - 20j1tr A22 + 0j2tr A22] (1 / 20202)tr A 32A23
(1 / 20202)tr A 32A23 (1/202)[M - 202‘tr A3 3 + 022tr A33]
In each case, we start with a set of initial values bQ , u0 and
0o’s in equation 5.3.2 and then iterate alternately using equation 5.3.2
~  A
and the equation(s) of 0’s. Estimated asymptotic variance of b and 0’s in 
ML and REML are given by putting the estimates into the appropriate 
expression.
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5.4 APPLICATION
All the models described in Section 5.2 are fitted and estimates with 
standard errors are reported in Table 5.4.1. In our analysis, we use the 
whole set of variables, but only those variables which are statistically 
significant are listed.
Table 5.4.1. ML and REML estimates of parameters (with standard errors) 
for the time independent and the three time dependent frailty models 
described in section 5.2.
Time independent frailty model
Estimate (S.E.)
Variables ML REML
y-IFN
Inheritance
Age
Corticosteroid
A
9,
-1.1495 (0.3228)** 
-0.7122 (0.3589)* 
-0.0885 (0.0423)* 
2.1182 (0.8149)**
0.4850 (0.2632)
-1.1435 (0.3463)** 
-0.7120 (0.3988) 
-0.0897 (0.0457)* 
2.1668 (0.9184)*
0.7993 (0.3556)
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Model 1
Estimate (S.E.)
Variables ML REML
y-EFN
Inheritance
Age
Corticosteroid
y
A
e ,
-1.1228 (0.3052)** 
-0.6614 (0.3276)* 
-0.0849 (0.0401)* 
1.9998 (0.7274)**
1.1462 (0.4913)*
0.2373 (0.2114)
-1.1218 (0.3325)** 
-0.6742 (0.3756) 
-0.0870 (0.0441)* 
2.0909 (0.8589)*
0.8770 (0.5082)
0.5933 (0.3162)
Model 2
Estimate (S.E.)
Variables ML REML
y-EFN
Inheritance
Age
Corticosteroid
Y
A
9,
A
92
-1.1232 (0.3053)** 
-0.6674 (0.3279)* 
-0.0848 (0.0400)* 
2.0040 (0.7261)**
1.1456 (0.4970)*
0.2323 (0.2256)
0.0730 (0.8750)
-1.1226 (0.3330)** 
-0.6821 (0.3766) 
-0.0871 (0.0442)* 
2.1002 (0.8603)*
0.8678 (0.5163)
0.5951 (0.3240)
0.1023 (1.1946)
Model 3
Estimate (S.E.)
Variables ML REML
y-EFN
Inheritance
Age
Corticosteroid
Y
A
e i
A
9,
-1.1879 (0.3450)** 
-0.9258 (0.3779)* 
-0.0822 (0.0411)* 
2.1325 (0.8061)**
-2.4659 (7.4474)
0.2650 (0.2316)
0.0610 (0.9452)
-1.1722 (0.3751)** 
-0.9222 (0.4281)* 
-0.0872 (0.0462) 
2.2897 (0.9581)*
-2.2842 (8.1247)
0.7576 (0.3718)
0.0991 (1.9960)
* significant at 5% level ** significant at 1% level.
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In the time independent frailty model, the frailty of a patient is 
assumed to be constant. In model 1, the frailty of a patient is 
represented by an individual random effect which may change linearly over 
time but with the coefficient of the linear term fixed for all patients. 
Model 2 allows that coefficient of the linear time effect to vary randomly 
from patient to patient while model 3 extends model 2 such that variation 
of the linear time effect coefficient may be related also to patient 
characteristics. As can be seen from the results of the analysis, in 
model 1, the longitudinal parameter (y) is significant at 5% level in ML 
and at 10% level in REML. Such significance of y is also reflected by 
the considerable reduction in the variability of patient’s frailty (0t) 
from time independent frailty model to model 1. Moreover, for models 2 
and 3, the estimates of 02 are small compared to their standard errors. 
Also all the regression parameters in y  of model 3 are not statistically
significant. Hence, for this data, it is not necessary to extend the 
model from the deterministic time effect on frailty, as given by model 1,
to the more complex models of random coefficient repeated measure effects 
given in models 2 and 3. Never-the-less, the extension given here is 
useful in that there is an indication of how such models may be fitted and 
the method is then available to encourage its consideration in future data 
collection.
When we examine the significant variables, the presence of y-IFN
decreases the rate of serious infection in CGD patients significantly. 
The X-linked pattem of inheritance is significant in ML but not in REML. 
Age is another significant variable which shows that the rate of serious
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infection is higher in children than in adults. Another important 
variable is corticosteroid, the analysis shows that the using of
corticosteroid at time of study entry will increase the rate of serious
infection in CGD patients. The longitudinal parameter (y) is significant
in ML at 5% level and is significant in REML at 10% level indicating that 
as the time to failure increases, the rate of infection in CGD patient
also increases.
The data have also been analysed in Fleming and Harrington (1991) 
using Cox’s model and Andersen-Gill multiplicative intensity model. While 
not exactly comparable, an idea of the robustness of the estimation may be 
obtained by a comparison of the estimates and standard errors of ß (the
y-IFN) parameter in Table 5.4.2. The estimation of ß is consistent in the 
four models using ML or REML. It also agrees with previous analyses using 
the Cox model and Andersen-Gill multiplicative intensity model. The 
current analysis gives a slightly smaller value of standard error and
which in turn provides narrower 95% confidence interval for the hazard 
ratio in exp ß.
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Table 5.4.2. Estimates (with standard errors) of the effect of y-IFN 
together with an estimate and confidence interval for the equivalent 
hazard ratio.
S.E. Z Stat
A
exp ß 95%  C.I. hazard ratio
Cox m odel -1.2063 0.4398 -2.7428 0.2993 (0.1264, 0.7088)
AG  m odel -1.2765 0.3774 -3.3824 0.2790 (0.1332, 0.5846)
T IF  m odel (M L) -1.1495 0.3228 -3.5424 0.3168 (0.1683, 0.5964)
T IF  m odel (REM L) -1.1435 0.3463 -3.3021 0.3187 (0.1617, 0.6283)
M odel 1 (M L) -1.1228 0.3052 -3.6789 0.3254 (0.1789, 0.5918)
M odel 1 (REM L) -1.1218 0.3325 -3.3738 0.3257 (0.1697, 0.6249)
M odel 2 (M L) -1.1232 0.3053 -3.6790 0.3252 (0.1788, 0.5917)
M odel 2 (REM L) -1.1226 0.3330 -3.3712 0.3254 (0.1694, 0.6251)
M odel 3 (M L) -1.1879 0.3450 -3.4432 0.3049 (0.1550, 0.5995)
M odel 3 (REM L) -1.1722 0.3751 -3.1250 0.3097 (0.1485, 0.6460)
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CHAPTER SIX
AR(1) FRAILTY MODEL
In Chapter 5, a time independent frailty model and three time 
dependent models are introduced. These models are mainly developed for 
Type III data, the multiple recurrent failure time data. The three time 
dependent frailty models are used when the frailty of each patient is 
considered to be varying over time.
In this Chapter, the modelling of recurrent failure time data is 
developed from another direction. Since a sequence of failure
observations on the same patient is a repeated measure, the frailty of 
each patient is considered to follow a time series process. Hence, a 
correlation parameter <J> may be present in the variance matrix of the
random components. A method of estimation for correlated frailty models
in survival analysis is decribed in the following Section. The AR(1)
frailty model, which considers the frailty of each patient follows an 
AR(1) process, will be provided in Section 6.3. It is then applied to 
analyse the effectiveness of gamma interferon (y-IFN) in reducing the 
number of serious infections in Chronic Granulomatous Disease (CGD) 
patients.
6.1 MODEL AND ESTIMATION
For Type III data, patients are followed over time and failure times 
are recorded. In this context, failure refers to serious infection by a
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certain disease. In such a case, each patient may have more than one 
failure observation.
A proportional hazards model for the j “1 observation of patient i at 
time t is given by
6.1.1 h(t;i,j) = X(t) gOl..) ,
M
i = 1,2,...,M; j = 1,2,...,n.; I  n = N
1 i = i 1
where M is the number of patients and N is the total number of 
observations. The function Ä.(t) is the baseline hazard function and for 
the Cox hazard function, g(ri ) = exp(ri ). The combined risk variable
ij Ü
ri is a linear combination of the known risk variables contained in a v 
ij
dimensional vector jc.. having fixed regression coefficient ß , together 
with a random component U.. , viz.
6.1.2 Ti.. = jt'.ß + U..
u ij ij
The random component U„ is the residual variation in risk for the (i,j) 
failure time not accounted for by the regression on known risk variables 
and is termed the frailty of the patient. It is modelled as a time series 
with its variance given by 0 and covariance structure parametrized by a 
vector <J). The frailty vector u is taken to be distributed as N[O,0A] , 
where u = [u\, u'2, ... , u^\ ; u[ = [Uü, Ui2, ... , Uin.] and the 
frailties on different patients are taken to be independent, so that
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A j (<))) 0 ... 0
0 A2(<j)) ... 0
6 6 I Am«»
V /
BLUP estimation maximizes the sum of two components, / = ^ + l , where 
/i is the partial likelihood of failure times taking u fixed and / is
the logarithm of the probability density function of u , viz.
M
/ = constant - (1/2)(N /n0 + Z/n |Aj |  + G'Va ' m)
2 i=  l
By reordering the failure/censoring times (T) of the observations, Tj. 
represents the tj value corresponding to the ilh occurring 
failure/censoring time (Tj). The reorganised values t j . form a vector 
denoted by tj and matrix X has rows of the correspondingly reorganised 
jc„ vectors, while Z is a matrix such that Zu gives the reorganised 
vector of U.. values. Thus rj=Xß+Zu. For Cox proportional hazards 
model with u conditionally fixed,
N N
/ = Z D [TJ. - /nZexp(Tj )]
1 i = 1 1 1 j = i j
where D. is the failure/censoring indicator which is zero if censoring 
occurs and one if failure occurs. The first order derivatives are
a//aß = a/yaß
al/au = al lau - e V u
J I j j j
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For given values of 0 and <j>, the Newton-Rapson iterative procedure gives 
the solution of these equations for ß , u as the iterative application 
of
6.1.3 ? = + v'[x,zr(d/1/dii0) -V ' 0
u -“o. Q lA lu L o-J
where ßQ, uq are initial values and ß, u closer approximations to the 
BLUP estimates. Equation 6.1.3 above is analogous to 4.7.1 in Chapter 4. 
In equation 6.1.3, the vector T|o=Xßo+ZwQ and if B = -d^ljdr\dr\'
V = 7T B[X,Z] + 0 0 '
r o e ' A 1
evaluated at r|=rio.
2
Expressions for dljdr\ and -d /^dridTj' are provided in 5.5.3
Let and [Z'BZ + e'A1] '1 = T*
From equations 4.7.2 and 4.7.3, the maximum likelihood 0 „ and residual
ML
A
maximum likelihood 0 estimators of 0 are respectively given by
6.1.4 6 = N‘‘(tr a  't ’ + u A 'ü)
ML
6-1.5 (Lw, = N''(tr A 'T  + uA' ü )
REML
and a similar derivation following equation 4.7.4 yields estimating 
equations for the ML estimator of (}) as
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6.1.6 «r A -'H  = 0m‘[Ü'A'' ^  A'~u + tr T A 1 §  A 1] 
or equivalently,
 ^ t -  * aA'1 _ A-ir~, aA'1 ~ . rji* aA'\
61J ff A i $ -  " 0mJ “ “ + ff t äijH
and an estimating equation follows from 4.7.5 for the REML estimator of <{> 
as
6.1.8 tr A-iaA3$" 6 '1 [«'A'remll
r ~ /  a  -1 aA A-i~ , 
A “ + tr TA
-l aA 
a$" A 1]
or equivalently,
6.1.9 tr A a<jr
Q  - l  r ~ ,  a A'1 ~ 
0 REML[W W ~  U
+ tr T a$“ J
In section 6.3, these estimating equations are particularised to the 
case of the frailty having a first order autoregressive structure. In
that case, equations 6.1.7 and 6.1.9 reduce to a cubic equation for (J)
which then forms the basis of a Newton-Raphson iterative method to 
estimate <J).
For given 0 and <|>, the ML and REML estimates of ß are the same as the 
BLUP estimates and are obtained using 6.1.3 for a given set of initial 0, 
<{> values. Once u is obtained, equations 6.1.4 and 6.1.5 may be used to 
estimate 0 and equations 6.1.7 and 6.1.9 to estimate $. These estimates 
of 0 and ({> may then serve as initial values for a further iteration of
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the whole process. Asymptotic variances of these estimators are given in 
the next Section.
6.2 ASYMPTOTIC VARIANCES
The asymptotic variance matrix for {$ is V which is part of the 
inverse of the matrix V as defined in section 6.1, i.e.
6.2.1 var ß =
The asymptotic variance matrices for ML and REML estimators of 0, (j) are 
analogous to those given in Section 4.5 and 4.6. For ML,
- y1
( W §  *''§> a/2)tr(2-‘i  S -'§ }
Ti
w J
where X = B'+BZAZ'.
For REML, letting Q = X 1 - X ’XfX 'x’Xi'X'X'1,
var
var
r  \  
A
0
A
<t>
(1/2)ff(Q §  Q §  (l/2)tr(Q §  Q
i
(l/2)tr(Q ®  Q f | )
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These asymptotic variance matrices of 0 and <|> provide the expressions of
A A
the estimated standard error of 0 and <j).
6.3 AR(1) FRAILTY MODEL
In some situations, the frailty of each patient may not be constant 
over time and must be modelled as a time series with a correlation 
structure. In this section, the frailties of the repeated failure times
in each patient are considered to follow an AR(1) process. We have then
The simplification of equation 6.1.4 (0WI) and 6.1.7 (<b t ) in the AR(1)
ML ML
frailty model is given below:
Three matrices ^ , Jj and are defined as the following. Each of 
them is symmetric with n. rows and columns.
I is the identity matrix
J. has diagonals of ones above and below the principal diagonal but 
has all other elements zero
K. has only two non-zero elements, one at each end of the principal
1 <|) (j>2 .... (J)"1' 1
1 $  ....
1 ..........
( ^ ' l  0 ni'2 (j) '^3 .... 1
diagonal
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Using that notation for the AR(1) frailty model,
6.3.1 a :1 =
6.3.2 a\ ' l/86 = 2<t>I-J-2<1>K
1 1 1 1
If T* is the block diagonal component of T* partitioned conformally to 
the partition of u and
A = u u' =
v. Am
then using
(i) I  tr[I(T*+A.)] = U,i l l  2
(ii) I  tr[J.(T*+A.)] = 2Ui l l  3
(iii) S  tr[K (T*+A )] = Udi l l  4
enables the ML estimating equation for 0 to be written as 
0 = N'‘(tr a '1T*+u'A '1m)
ML
M
= N“11  tr[A:'(T*+A)]
1 1 1i = 1
= N-l[( 1 +<t>2)U2-2(t>U3-<t)2U4]
Hence, we have
6.3.3 eML = N-‘[(l-Ht>2)U2-2<t>U3-<t>2U4]
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From equation 6.1.7, the ML estimating equation for <j) may similarly be 
written in terms of the submatrices as
M a M
6.3.4 I  tr (aA;'/3<t>)A = 0 J [  X tr[(3A;7a0)(T*+A)]
Since tr (aAjVs0)A = -20/(l-02), equation 6.3.4 becomes
6.3.5 -2M0/U-02) = 6m^(20U2-2U3-20U4)
A
and by substituting the expression for 0ml (6.3.3) in equation 6.3.5, 
the estimating equation for <J)ml is obtained as a cubic equation.
6.3.6 f«)) = + G,<j) + C4 = 0
where Cj = (N - M)(U2 - U4) , C2 = (2M - N)U3 
C3 = NU4 - (N + M)U2 , C4 = NU3
In solving the cubic equation for we may use Cardan’s formula for
getting the exact solution. Or, in practice, the Newton-Raphson 
approximation is sufficiently good, viz.
6.3.7 0 = 0O - [f(0Q)/f(0o)]
A A
The derivation for REML estimators 0 and A is along parallel 
lines and results in T* being replaced by T and T* by T in the 
above maximum likelihood equations 6.3.3 and 6.3.7. Asymptotic variances
A A
for 0 and <j) are given in section 6.2.
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6.4 APPLICATION
The AR(1) frailty model developed in the previous section is applied 
to analyse the CGD data in Fleming and Harrington (1991). Recall that 
the CGD study is a placebo controlled randomized trial of Gamma interferon 
(y-IFN) in Chronic granulotomous disease and the aim of the trial is to 
test the efficacy of Gamma interferon (y-IFN) in preventing the disease.
Similar to model 1 of Chapter 5, a longitudinal parameter y is 
introduced into the fixed effect regression parameter estimation in 
modelling the time dependent structure of the frailty. The longitudinal 
parameter y, as before, corresponds to the risk variable t.. which is 
defined to be the time from the first failure until the j* failure time 
for patient i. Moreover, we assume that the frailty in each patient
follows an AR(1) process with correlation parameter <j). Then, equations
6.1.3, 6.3.3 and 6.3.7 are used iteratively to perform the analysis. We 
use the whole set of risk variables in our analysis, but only those 
significant variables are listed. Results for fixed effect regression 
parameter are similar to those obtained in Chapter 5. Both ML and REML 
estimates are given in Table 6.4.1.
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Table 6.4.1. ML and REML estimates of parameters (with standard errors) 
for the AR( 1) frailty model.
Estimate (S.E.)
Variables ML REML
y-IFN
Inheritance
Age
Corticosteroid
Y
A
0
A
9
-1.1777 (0.3019)** 
-0.7057 (0.3143)* 
-0.0893 (0.0400)* 
2.1210 (0.7201)**
1.5082 (0.5024)**
0.2870 (0.2556)
-0.0008 (5.0136)
-1.2980 (0.3433)** 
-0.8038 (0.3691)* 
-0.0986 (0.0474)* 
2.4833 (0.9200)**
1.7025 (0.5801)**
1.1772 (0.4014)
-0.0005 (2.3024)
* significant at 5% level ** significant at 1% level
The treatment y-IFN has the highest significance. It indicates that 
the application of y-IFN significantly reduces the rate of infection in 
CGD patients. Consistent results appear in ML and REML estimation which 
shows that X-linked inheritance pattem, age and the presence of 
corticosteroid in the entry of study are also significant variables. The 
longitudinal parameter y is highly significant. It indicates that as the 
time to failure increases, the infection rate in CGD patients also 
increases, a result which agrees with the analysis given in Chapter 5 
which finds a highly significant time dependent frailty. In this 
analysis, the frailty correlation parameter <j> is not significant in both 
ML and REML estimation. One possible reason for such insignificance of <j) 
is discussed in Section 9.2. The estimate of the effect of y-IFN is in
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broad agreement with the results obtained in Fleming and Harrington (1991) 
who use the Cox model and the Andersen-Gill multiplicative model. A list 
of the treatment effect (y-IFN) estimates obtained by theses models, the 
models considered in Chapter 5 and the AR(1) frailty model is given in 
Table 6.4.2.
Table 6.4.2. Estimates (with standard errors) of the effect of y-IFN 
together with an estimate and confidence interval for the equivalent 
hazard ratio.
S.E. Z Stat
A
exp p 95% C.I. hazard ratio
Cox model -1.2063 0.4398 -2.7428 0.2993 (0.1264, 0.7088)
AG model -1.2765 0.3774 -3.3824 0.2790 (0.1332, 0.5846)
TIF model (ML) -1.1495 0.3228 -3.5424 0.3168 (0.1683, 0.5964)
TIF model (REML) -1.1435 0.3463 -3.3021 0.3187 (0.1617, 0.6283)
Model 1 (ML) -1.1228 0.3052 -3.6789 0.3254 (0.1789, 0.5918)
Model 1 (REML) -1.1218 0.3325 -3.3738 0.3257 (0.1697, 0.6249)
Model 2 (ML) -1.1232 0.3053 -3.6790 0.3252 (0.1788, 0.5917)
Model 2 (REML) -1.1226 0.3330 -3.3712 0.3254 (0.1694, 0.6251)
Model 3 (ML) -1.1879 0.3450 -3.4432 0.3049 (0.1550, 0.5995)
Model 3 (REML) -1.1722 0.3751 -3.1250 0.3097 (0.1485, 0.6460)
AR(1) model (ML) -1.1777 0.3019 -3.9010 0.3080 (0.1704, 0.5566)
AR(1) model (REML) -1.2980 0.3433 -3.7809 0.2730 (0.1393, 0.5352)
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CHAPTER SEVEN
RANDOM BLOCK FRAILTY MODEL 
7.1 INTRODUCTION
While Chapters 5 and 6 centre on the development of models for Type 
III data (multiple recurrent events in the same patient), the modelling of 
Type II data (the occurrence of the same type of failure in the member of 
a family/cluster) is the focus of this Chapter. Basically, the models 
developed in this Chapter are based on the results derived from the 
Generalised Linear Mixed Model (GLMM) as given in Chapter 4. The method 
is used to analyse data from a litter matched tumorigenesis experiment.
As mentioned in Chapter 2, this set of data was First presented and 
analysed by Mantel, Bohidar and Ciminera (1977) and by Mantel and Ciminera 
(1979). In the experiment, there are 50 male litters and 50 female 
litters. In each litter, one rat was treated with putative carcinogen 
while the other two rats served as control. The experiment was followed 
for 104 weeks and the measure of failure time was the time to tumor 
occurrence or censoring as recorded to the nearest week. One of the main 
research questions is to investigate whether the exposure to carcinogen 
significantly increases the failure rate of rats while allowing for 
possible correlation between the failure time observations within the same 
litter.
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A subset of the data, for the female rats litter, is provided in the 
second data set of Appendix I. It is arranged in such a format that it 
fits the APL programs given in Appendix II. The format of this data set 
given in Appendix I is described as follows:
Column 1: litter number
Column 2: failure/censoring time, in weeks
Column 3: censoring indicator 0=censored l=failure
Column 4: treatment 0=control l=carcinogen
This subset of data was analysed by Hougaard (1986b) who used a Cox 
type model and a parametric model with Weibull margins. The Bayesian 
approach using Gibb’s sampling was given by Clayton (1991). The 
consideration of Gamma distributed frailty models in the counting 
processes framework was given by Nielsen, Gill, Andersen and S<j>rensen 
(1992).
Section 7.2 considers the baseline frailty model in which each litter 
has a random litter effect. The justification of the exponential relative
risk function is given in Section 7.3. The random block frailty model 
further extends the baseline frailty model by considering both individual 
and litter effects to be random in Section 7.4. The comparison of the 
results from different methods and further discussion of frailty models 
are given in Section 7.5. Simulation results of the baseline frailty 
model and the random block frailty model are presented in Section 7.6.
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As we will see in Section 7.5, estimation of treatment effect 
parameter (carcinogen effect) has good agreement with previous analyses 
obtained in the literature though the dependence structure within a litter 
is modelled in different ways. The variance component estimation provides 
the estimated dispersion of the random effects. Moreover, an important 
feature of the GLMM method is the prediction of random effects. Such 
prediction is useful, for instance, in identifying high risk families and 
individuals when we are interested in the risk of occurrence of a family 
disease in the study population.
7.2 BASELINE FRAILTY MODEL
For the data from the litter matched tumorigenesis experiment 
described in Section 7.1, one may conceive that the genetic and 
environmental conditions shared within litters affect the risk of tumor 
formation, so the most intuitive random effect modelling is to assume that 
an unobservable random frailty is present in each litter.
Therefore, for a total of M litters, T
y
is the observable
failure/censoring time for the jth individual in the ilh litter. In the
proportional hazards model, the hazard function
h(t;i,j) = X(t) exp(n..) , r|.. = *'.ß + U. , 
i=l,2,...,M , j=l,2,...,n
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where is a vector of risk variables corresponding to the
individual in the ith litter, ß is a vector parameter and U. is the
unobservable random effect of the ilh litter taken to be iid N(O,0) while
X(t) is the usual unspecified baseline hazard function. The total number
of observations is N=nm. Let u = [U ,U
The estimation and inference procedure is described in Chapter 4. 
Essentially the setup of the baseline frailty model is the same as the
time independent frailty model given in Section 5.2. The difference is in 
the type of multivariate failure time data being considered. The 
recurrent time to infection for the CGD data (Type III data) is analysed 
by assuming independent random patient effects in the time independent 
frailty model while Type II data is considered here with independent 
litter effects in the baseline frailty model.
Estimators of ß and u are found by maximizing the Best Linear
Unbiased Prediction (BLUP) likelihood in the initial step and then
extended to obtain Maximum Likelihood (ML) and Residual Maximum Likelihood
(REML) estimators of ß, u and 0. Estimated standard errors of ß and 0 are
also given. BLUP estimates, for a given initial value of 0, maximise
/ + / , where 
1 2
/j = partial loglikelihood of failure times with u conditionally fixed
M
/ = -(l/2)[M/n2jt0 + (1/0) [U*]
i=l
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Taking ßQ, uq as initial values for ß, u , the following equations give 
an iterative solution for the BLUP estimates, in which the result of each 
iteration is taken as the initial value of the next.
7.2.1 - V
9 ' mo + T '[XZ] Wo
where V
- - -
x" r i o o
/ B [X Z ] + o 0 ‘rz L J , B = -(d^i/drjdV) and rj = Xß + Zu.
Here I is the identity matrix and X, Z are the design matrices of ß, u 
respectively after reordering according to the failure/censoring time and 
r |o is the value of rj corresponding to ßQ, uQ. The matrix V is 
partitioned conformally to ß |w  as
V
v„ V12
v„ V22 V->
An Aj2
A2i A22
Let W 22 = V22 ; we have
7.2.2 var ß = A n,
7.2.3 e(ML) = M *( tr W 22 +ZH ) ,
7.2.4 var §  = 202(M - 20’'tr  W 22 + 0 '2tr W 22) '‘
For REML estimation, we need only to replace W 22 by A22 to obtain the
A
estimate 0 ^ ^ ^  and its asymptotic variance, viz.
7.2.5
A
0
(REML)
M '!( tr A22 + u'u ) ,
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7.2.6 var Ö = 202(M - 26'‘tr A22 + 0'2tr A22)'‘
The application of the baseline frailty model to the data from the 
litter matched tumorigenesis experiment is given as below:
Estimates of parameters (SE)
Parameter p 0
ML estimates 
REML estimates
0.9169 (0.3229) 
0.9170 (0.3229)
0.4253 (0.3361) 
0.4299 (0.3378)
The ML and REML estimates agree with each other and show a significant 
carcinogen effect with an estimated hazard ratio of 2.502.
The number of failures observed in each litter and the corresponding 
litter effect prediction are shown in Table 7.2.1. The largest 12 
predicted litter effects are highlighted with (**). Comparison with 
Column 2 of Table 7.2.1 shows that those 12 litter effects match with the 
litters that have 2 or more failures observed. This finding agrees with
the intuitive idea that the more frail litters have more failure 
observations observed.
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Table 7.2.1 ML and REML frailty prediction for the data from the Litter 
Matched Tumorigenesis Experiment in the baseline frailty model
Litter Number of Frailty
failure Prediction
ML REML
1 1 0.06 0.06
2 0 -0.36 -0.36
3 0 -0.37 -0.37
4 0 -0.17 -0.17
5 0 -0.30 -0.30
6 2 0.34** 0.34**
7 2 0.29** 0.29**
8 1 -0.02 -0.02
9 0 -0.23 -0.23
10 1 0.16 0.16
11 1 0.09 0.09
12 0 -0.22 -0.22
13 2 0.79** 0.80**
14 1 0.04 0.04
15 0 -0.31 -0.31
16 0 -0.23 -0.23
17 0 -0.33 -0.33
18 0 -0.34 -0.34
19 0 -0.22 -0.22
20 2 0.51** 0.52**
21 0 -0.38 -0.39
22 0 -0.38 -0.39
23 1 0.04 0.04
24 0 -0.30 -0.30
25 0 -0.38 -0.39
Litter Number of Frailty
failure Prediction
ML REML
26 0 -0.31 -0.31
27 0 -0.26 -0.26
28 2 0.32** 0.33**
29 2 0.47** 0.47**
30 2 0.59** 0.60**
31 0 -0.15 -0.15
32 3 0.62** 0.62**
33 1 0.01 0.01
34 1 0.13 0.13
35 1 0.20 0.21
36 1 -0.01 -0.02
37 0 -0.38 -0.39
38 1 -0.04 -0.04
39 2 0.55** 0.55**
40 2 0.52** 0.53**
41 1 0.12 0.12
42 2 0.49** 0.50**
43 2 0.30** 0.30**
44 0 -0.32 -0.32
45 0 -0.23 -0.23
46 0 -0.10 -0.10
47 1 -0.00 -0.00
48 0 -0.23 -0.23
49 1 -0.05 -0.05
50 1 -0.04 -0.04
** The highest 12 litter effect predictions in ML and REML
7.3 JUSTIFICATION OF THE
EXPONENTIAL RELATIVE RISK FUNCTION
In our hazard function specification in Section 7.2, the relative 
risk function is considered to be exponential. In fact, such exponential 
restriction can be relaxed to consider a class of more general relative 
risk functions. Hence, the hazard function
h(t;i,j) = ?i(t) g(r|..) , T|„ = + U. ,
where gCr]..) = exp f(rj..)
The partial likelihood conditional on fixed u is given by
N N
/, = ID.[f(ri.) - /n [ exp f(T|.)]
i=l j=i
where ri is the value of r\ obtained when ri are arranged ini lj
increasing order of the failure/censoring times T , i = 1, 2,..., N.
D denotes the corresponding censoring indicator.
Let f(ri.) = /n(l+kTj.)1/k, note that when k->0, fCrj.)^. which
corresponds to the exponential relative risk function and when k=l, 
f(Tj.)=/n(l+rj.) giving the linear relative risk function. We then have
d/ /dn = F(d-WMA1) , -d2/ /dn dn' = [k£)+(l-k)U/ß]/^ - FWMA2M'WF
where
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N k
wk = exp f(r|k) = (l+krjk)1/k , ak =
d = [Dj,D2,...,Dn]' , W = Diag(wi5w2,...,wN),
A -  Diag(a ,a ,...,a^) , 1 = vector of ones,
M -  lower triangular matrix with ones on/below the principal diagonal,
Substituting these two expressions in equation 7.2.1, the
estimation of J5, u can be obtained by providing initial values of ß, u, k 
and 0. The value of k can be estimated by maximizing the BLUP
likelihood (^+7) for given ß, u and 0. In fact, as the value of / is
not affected by the choice of k, the maximization procedure does not 
involve l^ . The derivative expression of /  ^ with respect to k is quite
complicated; we decide to estimate k by maximizing /  ^ through a linear 
search from 0 to 1. Hence our iterative scheme is
Step 1: Given initial values ßQ, wq, kQ and 0Q, use 7.2.1 to estimate ß, u 
until convergent.
Step 2: Estimate k by maximizing /  ^ through linear search to 2 decimal 
places.
Step 3: Replace kQ by k, repeat Step 1 and 2 until kQ=k.
Step 4: Estimate 0 by 7.2.3 (for ML) or 7.2.5 (for REML).
A
Step 5: Replace 0Q by 0, repeat Step 1, 2 and 3 until convergent.
B = D ia g tb ^ ,. . .^ )  = Diag(MA7) , D = Diag(Di,D2,...,DN) ,
=(n1/n2.-.'nN) ' . f 1 = D iaga +knj, i+icn2 i+ i^ V  •
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Such a scheme is applied to our data set. In ML, the value of / 
decreases monotonically from -167.35 to -170.91, when k goes from 0 to 
1 in the final step of estimation. Similarly, /  ^ decreases from -167.25 
to -170.83 for REML. That means the BLUP likelihood is maximized when k=0 
and confirms that the exponential relative risk function is correctly 
specified at least within the family of functions we consider. In fact, 
we have chosen different starting values of k and they all coincide with a 
final estimate of E=0, ß(S.E.)=0.917(0.323) and 6(S.E.)=0.43(0.34) in both 
ML and REML.
7.4 RANDOM BLOCK FRAILTY MODEL
One of the problems of the baseline frailty model is that it 
assumes the hazards of Cl and C2 individual in each litter to be the same. 
When we examine the original data set in Table 7.4.1, we see that some of 
the individuals are more frail than the others in terms of their short 
failure times as highlighted in Table 7.4.1 with (*).
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Table 7.4.1 Survival time (weeks) of exposed (E) and control rats (C1,C2)
in each of 50 litters
Litter E Cl C2 Litter E Cl C2
1 101.0@ 49.0* 104.0(2) 26 89.0(2) 104.0(2) 104.0(2)
2 104.0(2) 102.0(2) 104.0(2) 27 78.0(2) 104.0@ 104.0(2)
3 104.0(2) 104.0(2) 104.0(2) 28 104.0(2) 81.0 64.0*
4 77.0(2) 97.0(2) 79.0(2) 29 86.0 55.0* 94.0(2)
5 89.0(2) 104.0(2) 104.0(2) 30 34.0* 104.0(2) 54.0*
6 88.0 96.0 104.0@ 31 76.0(2) 87.0(2) 74.0@
7 104.0 94.0(2) 77.0 32 102.8 73.0 83.9
8 95.9 104.0(2) 104.0(2) 33 101.9 104.0(2) 80.0(2)
9 82.0(2) 77.0(2) 104.0(2) 34 79.9 104.0(2) 73.0@
10 70.0 104.0@ 77.0@ 35 45.0* 79.0(2) 104.0@
11 88.9 91.0(2) 90.0(2) 36 94.0 104.0(2) 104.0@
12 91.0(2) 70.0(2) 92.0(2) 37 104.0(2) 104.0(2) 104.0(2)
13 39.0* 45.0(2) 50.0* 38 104.0(2) 101.0 94.0(2)
14 102.9 69.0(2) 91.0(2) 39 76.0(2) 84.0 78.0
15 93.0(2) 104.0(2) 103.0(2) 40 80.0 80.9 76.0@
16 85.0(2) 72.0(2) 104.0(2) 41 72.0 95.0(2) 104.0(2)
17 104.0(2) 63.0(2) 104.0(2) 42 72.9 104.0@ 66.0*
18 104.0(2) 104.0(2) 74.0(2) 43 92.0 104.0(2) 102.0
19 81.0(2) 104.0@ 69.0(2) 44 104.0(2) 98.0(2) 73.0(2)
20 67.0 104.0(2) 68.0 45 55.0(2) 104.0(2) 104.0(2)
21 104.0(2) 104.0(2) 104.0(2) 46 49.0(2) 83.0(2) 77.0(2)
22 104.0(2) 104.0@ 104.0(2) 47 89.0 104.0(2) 104.0@
23 104.0@ 83.0(2) 40.0* 48 88.0@ 79.0@ 99.0(2)
24 87.0(2) 104.0(2) 104.0(2) 49 103.0 91.0(2) 104.0(2)
25 104.0(2) 104.0(2) 104.0(2) 50 104.0(2) 104.0(2) 79.0
@ Right-censored times.
* Individuals corresponding to the 10 smallest failure times.
From Clayton (1991), with some modifications to the original data as
described in his paper.
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Although the baseline frailty model can correctly identify the more 
frail litters, it may not be good enough to model the individual 
variability. We therefore consider the random block frailty model that 
models the litter variability and the individual variability as well. The 
hazard function is given by
h(t;ij) = Ä.(t) expCn..) Tj.. = *'.ß + E.. + F.
where E is the ilh individual effect in litter i distributed iid 
N(O,0 ), and F is the i* litter effect distributed iid N(O,0J. Let
1 i 2
e i .............E J  ’  e  , e 2 ’ - ' e M
/= [F l,F2,...,FM] ,
We have
var u -  A 0,IN 0
o e I2 M
and ß, u can be estimated by
7.4.1 p = ß o - V 1 0i + v 'T x  z l
u w0 A  «o L J
\ d/,
an^
where V
/
x B \X Z l +
o o
=
/ V / _  . 1
Z L J 0 A  1
, B = -(d \/dndr\')  , t| = Xß + Z«
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The matrices X, Z are the design matrices of ß, u respectively after the 
reordering according to the failure/censoring times. The Z matrix here is 
different from that in the baseline frailty model since we are considering 
a different random effect vector u. The expression of dljdr\ and 
-(d /ydridTj') are the same as in the baseline frailty model. The V matrix
is partitioned conformally to ß | u \f as
< < to c uo ___
_
1
II>
A n  ^ 1 2  ^ 1 3
^21 ^22 V23 A2i A22 A23
v „  V32 V 3 3 a 3i a 32 a 33
and
W
v22 v23'
V32 V33
w 2 2  w 2 3 '
W32 W33
We then have
7.4.2 var ß = A
K 11
7.4.3 0i(ML) = N-J( tr W22 + V i  ) ,
7-4.4 8 , = M ‘( tr W33 + 7 7  )2(ML) J  J  t
and the asymptotic variance matrix of these two ML estimators is
l - i
(1/282)(N - 20j'tr W22 + 0;2tr W2.,) (1/20 2 02 ) tr
(1/202)(M  - 202' t  r WJ3 + 0 '2tr W2p
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Replacing Wkk by Akk in the above equations correspondingly, gives similar 
results in REML, viz.
7.4.5
7.4.6
Ae
1(REML)
A
0
2(REML)
N''( tr A22 + e'e ) ,
m  '( tr A33 + 77 )
and the asymptotic variance matrix of these two REML estimators is
r l - i
(1/202)(N - 29"'tr A, + 0 '2tr A2 ) (1/20 2 02 ) tr A A
v l ,v  1 22 1 22'  v 1 2 '  32 23
(1/202)(M  - 202' t r  A3j + 022tr A23)
When the random block frailty model is applied to the data from the 
litter matched tumorigenesis experiment, we obtain the results given as 
below:
Estimates of parameters (S.E.)
Parameter p 9, 0 2
ML estimate 
REML estimate
0.9190 (0.3281) 
0.9193 (0.3288)
0.0933 (0.5507) 
0.1041 (0.5523)
0.4404 (0.4277) 
0.4458 (0.4297)
The estimate ß agrees with our previous results in the baseline frailty
A
model. The variance component estimate of litter effect, 02, can be
A
compared with 0 in the baseline frailty model. The agreement is good.
Moreover, the variance estimate in the individual variability is given by 
0} and, while this is not significantly different from zero, it is 
interesting to consider the estimates of individual effects.
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Table 7.4.2 and 7.4.3 present the ML and REML prediction of litter 
and individual effects in the random block frailty model respectively. 
Both sets of prediction are similar. The random effect predictions 
correctly identify the most frail litters (**) as well as the most frail 
individuals (*), which are highlighted in Table 7.4.2 and 7.4.3. Those 12
litters with largest litter effect prediction match with those 12 litters 
given in Table 7.2.1 and in turn with those 12 litters that have 2 or more 
failures observed. Moreover, on comparing with Table 7.4.1, those 10
individuals with the largest frailty prediction match exactly with those 
10 individuals with the smallest failure times.
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Table 7.4.2 Prediction of litter and individual effects by the Random 
Block Frailty Model (ML)
Litter Litter
Litter Effect E Cl C2 Litter Effect E Cl C2
1 0.07 -0.05 0.09* -0.03 26 -0.31 -0.03 -0.02 -0.02
2 -0.36 -0.04 -0.01 -0.02 27 -0.27 -0.01 -0.02 -0.02
3 -0.37 -0.04 -0.02 -0.02 28 0.35** -0.09 0.08 0.09*
4 -0.18 -0.01 -0.02 -0.01 29 0.47** 0.04 0.09* -0.03
5 -0.30 -0.03 -0.02 -0.02 30 0.61** 0.09* -0.05 0.09*
6 0.34** 0.04 0.06 -0.04 31 -0.15 -0.01 -0.01 -0.01
7 0.29** 0.00 -0.02 0.08 32 0.62** -0.02 0.08 0.07
8 -0.03 0.05 -0.03 -0.03 33 0.00 0.04 -0.03 -0.01
9 -0.23 -0.02 -0.01 -0.02 34 0.13 0.07 -0.03 -0.01
10 0.16 0.08 -0.03 -0.01 35 0.21 0.09* -0.01 -0.03
11 0.08 0.05 -0.02 -0.02 36 -0.02 0.05 -0.03 -0.03
12 -0.22 -0.03 -0.00 -0.01 37 -0.39 -0.05 -0.02 -0.02
13 0.82** 0.09* -0.00 0.09* 38 -0.04 -0.06 0.07 -0.02
14 0.03 0.03 -0.01 -0.02 39 0.56** -0.03 0.07 0.08
15 -0.32 -0.03 -0.02 -0.02 40 0.53** 0.05 0.07 -0.01
16 -0.24 -0.02 0.00 -0.02 41 0.12 0.07 -0.02 -0.03
17 -0.33 -0.05 0.00 -0.02 42 0.50** 0.06 -0.04 0.09*
18 -0.34 -0.05 -0.02 0.00 43 0.29** 0.04 -0.04 0.06
19 -0.22 -0.02 -0.02 0.00 44 -0.32 -0.05 -0.01 -0.01
20 0.52** 0.07 -0.05 0.08 45 -0.23 -0.01 -0.02 -0.02
21 -0.39 -0.05 -0.02 -0.02 46 -0.10 0.00 -0.01 -0.01
22 -0.39 -0.05 -0.02 -0.02 47 -0.01 0.05 -0.03 -0.03
23 0.05 -0.07 -0.01 0.09* 48 -0.23 -0.03 -0.01 -0.02
24 -0.30 -0.02 -0.02 -0.02 49 -0.05 0.03 -0.01 -0.03
25 -0.39 -0.05 -0.02 -0.02 50 -0.03 -0.06 -0.03 0.08
* The largest 10 individual effects (they match with the 10 smallest
failure time individuals).
** The largest 12 litter effects (they match with those litters that have
2 or more failures observed).
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Table 7.4.3 Prediction of litter and individual effects by the Random 
Block Frailty Model (REML)
Litter
Litter Effect E Cl C2
1 0.07 -0.06 0.10* -0.03
2 -0.37 -0.05 -0.02 -0.02
3 -0.38 -0.05 -0.02 -0.02
4 -0.18 -0.02 -0.02 -0.01
5 -0.31 -0.03 -0.02 -0.02
6 0.34** 0.05 0.07 -0.04
7 0.29** 0.00 -0.02 0.09
8 -0.03 0.05 -0.03 -0.03
9 -0.24 -0.02 -0.01 -0.02
10 0.17 0.08 -0.04 -0.01
11 0.09 0.06 -0.02 -0.02
12 -0.22 -0.03 -0.01 -0.01
13 0.83** 0.10* -0.00 0.10*
14 0.03 0.03 -0.01 -0.02
15 -0.32 -0.03 -0.02 -0.02
16 -0.24 -0.03 -0.01 -0.02
17 -0.33 -0.05 -0.00 -0.02
18 -0.34 -0.05 -0.02 -0.01
19 -0.22 -0.02 -0.02 -0.01
20 0.53** 0.08 -0.05 0.09
21 -0.39 -0.05 -0.02 -0.02
22 -0.39 -0.05 -0.02 -0.02
23 0.06 -0.08 -0.01 0.10*
24 -0.31 -0.03 -0.02 -0.02
25 -0.39 -0.05 -0.02 -0.02
Litter Effect E Cl C2
26 -0.32 -0.03 -0.02 -0.02
27 -0.27 -0.02 -0.02 -0.02
28 0.35** -0.10 0.09 0.10*
29 0.48** 0.04 0.10* -0.03
30 0.62** 0.10* -0.06 0.10*
31 -0.15 -0.02 -0.01 -0.01
32 0.63** -0.02 0.09 0.08
33 0.00 0.04 -0.03 -0.01
34 0.13 0.07 -0.03 -0.01
35 0.21 0.10* -0.01 -0.04
36 -0.02 0.05 -0.03 -0.03
37 -0.39 -0.05 -0.02 -0.02
38 -0.04 -0.07 0.08 -0.02
39 0.56** -0.03 0.08 0.09
40 0.53** 0.05 0.08 -0.01
41 0.12 0.08 -0.02 -0.03
42 0.51** 0.07 -0.05 0.10*
43 0.29** 0.04 -0.04 0.07
44 -0.32 -0.05 -0.02 -0.01
45 -0.24 -0.01 -0.02 -0.02
46 -0.10 -0.01 -0.01 -0.01
47 -0.01 0.06 -0.03 -0.03
48 -0.23 -0.03 -0.01 -0.02
49 -0.06 0.03 -0.02 -0.03
50 -0.03 -0.07 -0.03 0.09
* The largest 10 individual effects (they match with the 10 smallest 
failure time individuals).
** The largest 12 litter effects (they match with those litters that have 
2 or more failures observed).
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7.5 DISCUSSION
As mentioned in Section 7.1, the tumour data have been analysed in 
the literature using different methods. A comparison of results is given 
as below:
A S.E. L.R. t L.R. A0l S.E.
A A
0 or 0
2
S.E.
Hougaard Cox 0.898 0.317 7.87 — — —
Weibull 0.944 0.327 8.28 - - - — —
Clayton 0.919 — - - - 0.50 - - - - - - - - -
Nielsen et al. 0.904 - - - 7.16 0.47 1.52 — —
Model 1 ML 0.917 0.323 — — — 0.43 0.34
REML 0.917 0.323 — — — 0.43 0.34
Model 2 ML 0.919 0.328 — — 0.09 0.55 0.44 0.43
REML 0.919 0.329 — — 0.10 0.55 0.45 0.43
The Gamma frailty distribution was considered by Clayton (1991) and by 
Nielsen, Gill, Andersen and Sorensen (1992). So £ is the Gamma 
distribution’s parameter which models the intralitter correlation. L.R. 
is the likelihood ratio test statistic for testing the corresponding null 
hypothesis. On comparing the results from different methods, they all 
give consistent estimates of ß which shows a significant increase in 
failure rate for the rats who are exposed to carcinogen.
An important feature of the current approach when compared with 
other methods is the prediction of random effects. Such prediction will 
be important for early detection of the high risk subgroups in the study 
population. For example, looking for the significance of risk variables 
is as important as identifying the high risk families and individuals for 
some kinds of family disease.
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Generalisations of the method described in this Chapter are
possible in different ways. Firstly, the models given in section 7.2 and 
7.4 are not restricted to Type II data. With corresponding adjustment in 
the design matrix of the random component, we can apply the method to 
analyse Type I data. In fact, Types I and II data are similar when we
treat a patient in Type I data as a cluster in Type II data. The basic
structure of the modelling of these two types of data are essentially the 
same. However, before actually implementing the method, one should 
consider the possible change in the model to fit the particular structure 
of a data set.
Secondly, the method to justify the exponential relative risk
function described in Section 7.3 is not restricted to the baseline 
frailty model only. Essentially, the technique can be carried to any kind 
of frailty model without altering the development in Section 7.3. The 
only modification that needs to be made is the corresponding adjustment in 
the matrix, A = var u.
Lastly, Model 2 can be seen as a two-stage random block frailty 
model. In some practical situations, a k-stage random block frailty model 
may need to be considered. As we can see in Section 7.4, the expressions 
for the 0’s have a symmetric structure and by working through the
information matrix, we obtain the corresponding variance matrix of the 0 
estimators. So, the generalisation to a k-stage model follows exactly the 
same route.
I l l
7.6 SIMULATIONS
In normal error models, it has been noticed that ML estimators of the 
variance components in a regression model are often negatively biased. 
Such bias becomes more serious as the number of regression variables 
increases. The REML procedure following Thompson (1980) has been proposed 
as a method of reducing such biases.
This section provides preliminary exploratory work to compare the 
performance of ML and REML estimators of variance components in the GLMM 
when applied to the analysis of multivariate failure time data. In
particular, it includes a small simulation comparing ML and REML
estimators allowing the variance of random effects to increase and varying 
the number of regression variables in the baseline frailty model and the 
random block frailty model.
For the baseline frailty model, the hazard function is given by
h(t;i,j) = X(t) exp(rj..) , r|.. = x'.ß + U. , 
i=l,2,...,30 , j= l,2,3
That is, there are 30 litters and each litter has 3 individuals. Let
X(t)=0.1 , component of x.. is random selected as 0 or 1 , the litter
effect U. as independent N(O,0) . Assuming there is no censored
observation, 0 is chosen to be 1 or 4 and the dimension of x is one or
u
four.
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Simulation results of ML and REML estimators in the baseline frailty 
model are provided in Tables 7.6.1 and 7.6.2 respectively. For both ML 
and REML, the estimation of regression parameters are rarely significantly 
biased in all cases. The ML estimator of variance component tends to be 
negatively biased as the number of regression variables increases from one 
to four. Such bias becomes more serious with increasing 0. The REML
estimator of variance component are relatively stable and tends to be 
slightly positively biased. Moreover, very good agreement between the 
standard error of estimates over simulations and the average standard 
error of estimates is obtained in both ML and REML.
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Table 7.6.1 Estimated biases and standard errors for 100 simulations of 
ML estimation in the baseline frailty model
Simulation 1: 0=1, x one component
True Average bias Average of S.E.* S.E. of estimates-!" 
Parameter value (S.E. in brackets) of estimates over simulations 
ß 0.5 -0.008 0.438 0.371
(0.037)
0 1 0.029 0.369 0.456
(0.046)
Mean square error in estimation of frailties 0.361
Simulation 2: 0=1, x four component
True Average bias 
Parameter value (S.E. in brackets)
ß , 0.5 0.034
ß2 -0.5
(0.053)
-0.064
ß3 0.8
(0.047)
0.063
ß4 -0.8
(0.045)
0.019
0 1
(0.039)
-0.144
(0.038)
Average of S.E.* S.E. of estimates-!-
of estimates over simulations
0.437 0.534
0.434 0.472
0.441 0.454
0.440 0.392
0.325 0.385
Mean square error in estimation of frailties 0.427
114
Simulation 3: 9=4, x one component
True Average bias Average of S.E.* S.E. of estimates! 
Parameter value (S.E. in brackets) of estimates over simulations 
P 0.5 -0.096 0.765 0.678
(0.068)
0 4 -0.050 1.145 1.478
(0.148)
Mean square error in estimation of frailties 0.693
Simulation 4: 0=4, x four component
True Average bias Average of S.E.* S.E. of estimates!
Parameter value (S.E. in brackets) of estimates over simulations
Pi 0.5 -0.121
(0.073)
0.739 0.729
ß2 -0.5 0.034
(0.079)
0.733 0.788
0.8 -0.091
(0.083)
0.730 0.827
ß4 -0.8 0.105
(0.084)
0.740 0.844
0 4 -0.839
(0.107)
0.937 1.074
Mean square error in estimation of frailties 1.027
* Each simulation gives a S.E. of estimate. Tabular value is the average 
S.E.
t  Tabular value is the S.E. of the 100 simulated estimates.
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Table 7.6.2 Estimated biases and standard errors for 100 simulations of 
REML estimation in the baseline frailty model
Simulation 1: 0=1, x one component
True Average bias Average of S.E.* S.E. of estimatest 
Parameter value (S.E. in brackets) of estimates over simulations 
P 0.5 -0.020 0.450 0.431
(0.043)
0 1 0.106 0.396 0.432
(0.043)
Mean square error in estimation of frailties 0.369
Simulation 2: 0=1, x four component
True Average bias 
Parameter value (S.E. in brackets)
ßl 0.5 -0.007
P2 -0.5
(0.053)
-0.046
P3 0.8
(0.043)
0.085
ß4 -0.8
(0.059)
-0.027
0 1
(0.048)
0.101
(0.048)
Average of S.E.* S.E. of estimatest
of estimates over simulations
0.471 0.532
0.483 0.432
0.480 0.592
0.481 0.479
0.419 0.478
Mean square error in estimation of frailties 0.458
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Simulation 3: 0=4, x one component
True Average bias Average of S.E.* S.E. of estimatesf 
Parameter value (S.E. in brackets) of estimates over simulations 
P 0.5 -0.106 0.770 0.782
(0.078)
0 4 -0.071 1.160 1.411
(0.141)
Mean square error in estimation of frailties 0.726
Simulation 4: 0=4, x four component
True Average bias Average of S.E.* S.E. of estimatest
Parameter value (S.E. in brackets) of estimates over simulations
p . 0.5 0.073
(0.094)
0.843 0.943
Ü2 -0.5 0.103
(0.079)
0.830 0.787
0.8 0.021
(0.093)
0.840 0.933
ß4 -0.8 0.089
(0.076)
0.844 0.757
0 4 0.176
(0.160)
1.299 1.601
Mean square error in estimation of frailties 1.046
* Each simulation gives a S.E. of estimate. Tabular value is the average 
S.E.
f Tabular value is the S.E. of the 100 simulated estimates.
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For the random block frailty model, the hazard function is given by
h(t;i,j) = A,(t) exp(rj. ) , rj.. = jc'.ß + E . + F. ,
U »J ij ij i
i=l,2,...,30 , j=l,2,3
That is, there are 30 litters and each litter has 3 individuals. Let
Ä.(t)=0.1 , component of x.. is random selected as 0 or 1 , the litter 
effect F as independent N(O,0 ) and the individual effect E as
i 2 ij
independent >1(0,0^. Assuming there is no censored observation, 0} and 02
are chosen to be 1 or 4 and the dimension of x is one or four.
ij
Simulation results of ML and REML estimators in the random block 
frailty model are provided in Tables 7.6.3 and 7.6.4 respectively. As in
the baseline frailty model, the estimation of regression parameters are
rarely significantly biased in both ML and REML. Good agreement is also 
obtain between the standard error of estimates over simulations and the 
average standard error of estimates in both ML and REML.
The ML estimation of variance component (0! and 02) tends to be 
negatively biased. The degree of biasedness seems to be not affected by 
the number of regression variables and increases as the value of the
variance parameter (0t and 02) increases. The bias in the REML estimation 
of variance component also tends to be negative when the variance
parameter increases but such bias is reduced when the number of regression 
variables increases. Moreover, REML estimator of variance component also 
has a small tendency of positive biasedness when the variance parameter 
equals to 1.
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Table 7.6.3 Estimated biases and standard errors for 100 simulations of 
ML estimation in the random block frailty model
Simulation 1: 0j=l, 02=1, x one component
True Average bias Average of S.E.* S.E. of estimates!
Parameter value (S.E. in brackets) of estimates over simulations
ß 0.5 -0.041
(0.053)
0.466 0.527
e, 1 -0.062
(0.014)
0.401 0.142
e2 l -0.147
(0.048)
0.458 0.478
Mean square error in estimation of frailties 0.850
Simulation 2: 0t=l, 02=1, x four components
True Average bias Average of S.E.* S.E. of estimatesf
Parameter value (S.E. 
ßi 0.5
in brackets) 
0.032
of estimates 
0.477
over simulations 
0.496
p2 -0.5
(0.050)
-0.030 0.475 0.490
ß3 0.8
(0.049)
-0.021 0.476 0.480
ß4 -0.8
(0.048)
-0.067 0.476 0.525
e , 1
(0.053)
-0.053 0.404 0.186
02 1
(0.019)
-0.295 0.426 0.378
(0.038)
Mean square error in estimation of frailties 0.919
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Simulation 3: 0t= 1, 02=4, x one component
True Average bias
Parameter value (S.E. in brackets)
ß 0.5 -0.192
(0.081)
0i 1 -0.184
(0.021)
02 4 -0.965
(0.128)
Average of S.E.* S.E. of estimates! 
of estimates over simulations
0.711
0.378
0.998
0.809
0.212
1.276
Mean square error in estimation of frailties 1.273
Simulation 4: 0,=1, 02=4, x four components
True Average bias Average of S.E.* S.E. of estimates!
Parameter value (S.E. in brackets) 
ß, 0.5 0.010
of estimates 
0.706
over simulations 
0.705
ß* -0.5
(0.070)
0.069 0.707 0.671
ß3 0.8
(0.067)
-0.072 0.712 0.794
ß4 -0.8
(0.079)
0.226 0.711 0.689
0, 1
(0.069)
-0.182 0.378 0.210
■ ®2 4
(0.021)
-1.415 0.882 1.074
(0.107)
Mean square error in estimation of frailties 1.525
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Simulation 5: 0t=4, 02=1, x one component
True Average bias Average of S.E.* S.E. of estimatest
Parameter value (S.E. in brackets) of estimates over simulations
p 0.5 -0.160 0.424 0.460
(0.046)
0. 4 -2.751 0.468 0.295
(0.030)
0 2 1 -0.522 0.410 0.418
(0.042)
Mean square error in estimation of frailties 2.289
Simulation 6: 0^4 , 02=1, x four components
True Average bias Average of S.E.* S.E. of estimatest
Parameter value (S.E. in brackets) 
ß, 0.5 -0.276
of estimates 
0.437
over simulations 
0.456
ß2 -0.5
(0.046)
0.102 0.438 0.462
P3 0.8
(0.046)
-0.228 0.443 0.492
p4 -0.8
(0.049)
0.221 0.441 0.451
0 . 4
(0.045)
-2.739 0.474 0.372
0 2 1
(0.037)
-0.604 0.398 0.346
(0.035)
Mean square error in estimation of frailties 2.455
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Simulation 7: 0j=4, 02=4, x one component
True Average bias Average of S.E.* S.E. of estimates!
Parameter value (S.E. in brackets) of estimates over simulations
p 0.5 -0.339 0.552 0.620
(0.062)
e , 4 -2.841 0.440 0.283
(0.028)
8 2 4 -2.568 0.618 0.710
(0.071)
Mean square error in estimation of frailties 3.112
Simulation 8: 0^4 , 02=4, x four components
True Average bias Average of S.E.* S.E. of estimates!
Parameter value (S.E. in brackets) 
ß, 0.5 -0.183
of estimates 
0.576
over simulations 
0.618
ß2 -0.5
(0.061)
0.240 0.571 0.594
ß3 0.8
(0.059)
-0.289 0.575 0.619
ß4 -0.8
(0.062)
0.213 0.575 0.565
0i 4
(0.057)
-2.852 0.438 0.332
02 4
(0.033)
-2.659 0.595 0.672
(0.067)
Mean square error in estimation of frailties 3.645
* Each simulation gives a S.E. of estimate. Tabular value is the average 
S.E.
f Tabular value is the S.E. of the 100 simulated estimates.
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Table 7.6.4 Estimated biases and standard errors for 100 simulations of 
REML estimation in the random block frailty model
Simulation 1: 0j=l, 02= 1, x one component
True Average bias Average of S.E.* S.E. of estimatesf
Parameter value (S.E. in brackets) of estimates over simulations
p 0.5 0.048
(0.052)
0.495 0.519
e. 1 -0.047
(0.013)
0.400 0.131
e 2 1 0.033
(0.045)
0.505 0.452
Mean square error in estimation of frailties 0.854
Simulation 2: 01=1. 02=1, x four components
True Average bias Average of S.E.* S.E. of estimatesf
Parameter value (S.E. 
Pi 0.5
in brackets) 
0.196
of estimates 
0.637
over simulations 
0.629
Pr -0.5
(0.063)
-0.163 0.633 0.556
P3 0.8
(0.056)
0.178 0.635 0.608
p4 -0.8
(0.061)
-0.058 0.630 0.589
0, 1
(0.059)
1.263 0.642 1.239
1
(0.124)
0.472 0.792 0.886
(0.089)
Mean square error in estimation of frailties 1.378
123
Simulation 3: 9^1 , 02=4, x one component
True Average bias Average of S.E.* S.E. of estimates!
Parameter value (S.E. in brackets) of estimates over simulations
p 0.5 -0.047 0.747 0.738
(0.074)
0 i 1 -0.137 0.386 0.210
(0.021)
0 2 4 -0.628 1.110 1.132
(0.113)
Mean square error in estimation of frailties 1.180
Simulation 4: 0t=1, 02=4, x four components
True Average bias Average of S.E.* S.E. of estimates!
Parameter value (S.E. in brackets) 
ß, 0.5 -0.037
of estimates 
0.896
over simulations 
0.756
ßr -0.5
(0.076)
-0.011 0.908 0.853
ß3 0.8
(0.085)
0.008 0.904 0.983
ß4 -0.8
(0.098)
-0.023 0.911 0.879
9, 1 (0.088)0.555 0.515 0.692
.02 4
(0.069)
0.497 1.564 2.051
(0.205)
Mean square error in estimation of frailties 1.659
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Simulation 5: 0^4 , 02= 1, x one component
True Average bias Average of S.E.* S.E. of estimatesf
Parameter value (S.E. in brackets) of estimates over simulations
ß 0.5 -0.135
(0.050)
0.467 0.501
6, 4 -2.284
(0.041)
0.567 0.407
02 1 -0.395
(0.051)
0.511 0.512
Mean square error in estimation of frailties 1.940
Simulation 6: 0 ^4 , 02=1, x four components
True Average bias 
Parameter value (S.E. in brackets)
ßi 0.5 0.115
P2 -0.5
(0.066)
-0.008
P3 0.8
(0.063)
0.020
ß4 -0.8
(0.064)
0.015
e, 4
(0.068)
0.320
e 2 1
(0.087)
0.003
(0.063)
Average of S.E.* S.E. of estimates’^
of estimates 
0.670
over simulations 
0.658
0.667 0.627
0.667 0.638
0.667 0.683
1.043 0.867
0.935 0.634
Mean square error in estimation of frailties 1.581
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Simulation 7: 0,=4, 02=4, x one component
True Average bias
Parameter value (S.E. in brackets)
Average of S.E.* 
of estimates
S.E. of estimates'!* 
over simulations
p 0.5 -0.253 0.608 0.688
e .
(0.069) 
4 -2.529 0.498 0.420
0 2
(0.042) 
4 -2.178 0.763 0.965
Mean
(0.097)
square error in estimation of frailties 2.760
Simulation 8: 0j=4, 02=4, x four components
True Average bias 
Parameter value (S.E. in brackets)
p . 0.5 0.018
ßj -0.5
(0.087)
0.095
P3 0.8
(0.084)
-0.024
p4 -0.8
(0.086)
0.129
0 . 4
(0.087)
-0.416
02 4
(0.083)
-0.720
(0.127)
Average of S.E.* S.E. of estimates'!*
of estimates 
0.871
over simulations 
0.867
0.871 0.836
0.869 0.858
0.871 0.867
0.887 0.827
1.432 1.268
Mean square error in estimation of frailties 2.191
* Each simulation gives a S.E. of estimate. Tabular value is the average 
S.E.
f Tabular value is the S.E. of the 100 simulated estimates.
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CHAPTER EIGHT
COMPETING RISK FRAILTY MODEL 
8.1 INTRODUCTION
This Chapter considers the modelling of Type IV data (the occurrence 
of different failure events in the same individual) using the Generalised
Linear Mixed Model (GLMM). As mentioned in Chapter 1, the modelling of 
this type of data is the most complicated among the four types of
multivariate failure time data. The complexity is due to the fact that 
more than one type of failure event may occur in each individual.
The data set being considered in this Chapter is the Dubbo study data 
described in Chapter 2. In the Dubbo study, each individual is followed
until an "failure" (hospital admission or death) occurs with the 
possibility that there may be a sequence of several such failures
(hospital admission) for any given individuals. Possible risk variables 
for each individual are recorded in detail. The two types of failure
times are the time to hospitalization and time to death. Hence,
additional to the modelling of the dependence structure that comes from 
the multiple time to hospitalization in each individual, the possible 
relationship between an individual’s frailty in hospitalization and his 
frailty in death may also need to be considered.
In order to illustrate the competing risk frailty model, only a
subset of the Dubbo study data is used. It contains the failure time
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observations and the risk variables of male individuals of age 70. Such 
subset of the data is provided in Appendix I. As before, it is arranged 
in a format that fits the APL programs given in Appendix II. The Dubbo 
study data given in Appendix I is described as follows:
Column
Column
Column
Column
Column
Column
Column
Column
Column
Column
Column
Column
Column
1: patient number
2: failure/censoring time (hospitalization or death), in days 
3: censoring indicator H 0=censored l=hospitalized 
4: censoring indicator D 0=censored l=death 
5: on BP medication 0=no l=yes 
6: prior CHD 0=no l=yes 
7: cholesterol, in mmol/1 
8: prior diabetes 0=no l=yes 
9: one disability 0=no l=yes 
10: more than one disability 0=no l=yes 
11: married 0=no l=yes 
12: former smoker 0=no l=yes 
13: current smoker 0=no l=yes
The failure time given in column 2 is defined to be the time between 
subsequent hospitalization/death events. These times to subsequent 
failure events are used to construct the risk sets in the log-partial 
likelihood expression. The construction of the risk sets for the two 
types of failure events (hospitalization and death) is investigated in the 
next section. Columns 3 and 4 are the censoring indicators for
hospitalization and death respectively. Columns 5 to 13 are the risk 
variables. In fact, the original Dubbo study data records many other
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variables such as body mass index, BP reading, CESD depression scale, 
education level, friends, alone, regular sport and Self Rated Health (SRH) 
etc. The variables given in Appendix I are those which are possibly
important predictors of hospitalization and death based on univariate Cox 
regression model in survival analysis of the full Dubbo study data.
The focus of this Chapter, however, is neither to provide a complete 
survival analysis with random effects of the full Dubbo study data nor to 
develop a general method to handle Type IV data. The attempt here is to 
establish competing risk frailty models with two types of failure events 
(hospitalization and death) for a subset of the Dubbo study data (male
individuals of age 70) which may then be possible to generalise to develop 
models with more than two types of failure events.
Two competing risk frailty models are considered in the following 
section. Estimation procedures of these two models are developed in
section 8.3. The application of these two models to the subset of the
Dubbo study data given in Appendix I is provided in section 8.4. Some 
discussions of further research on the Dubbo study data are given in the
last section.
8.2 MODELS
In the Dubbo study, individuals bom before 1930 living in the New 
South Wales country town of Dubbo were enrolled and extensive examinations 
were performed in 1988-89 covering medical, social, physiological and
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lifestyle variables. Individuals were followed for a period of 5 years 
with detailed record of hospitalization and death events. Let
hH(tH;ij) = hazard function for jlh hospitalization event of 
individual i
hD(tD;i,j) = hazard function for death event of individual i
where tH is the time measured from the current failure event (in days) and 
tD is the time measured since individual’s study entry (in days).
We consider M individuals with failure events for individual i
so that i=l,2,...,M ; j=l,2,...,ni and the total number of observations
N = S . A proportional hazards model gives
i= 1
hn(tH»iJ) = ^h^h) gOlHij)
= ^ d(^d) S^D ij)
where XH(tH) and ^d(1d) are the baseline hazard functions for
hospitalization and death respectively and for the Cox hazard function 
g(0-exp(-) . The combined risk variables and rj^j are given by
TlHij = * ijß H  +  UHi 
^Dij =  *ijßD +
where x -  is a v dimensional vector, ßH and ßD are the fixed effect 
regression coefficients for hospitalization and death respectively. Um
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and correspond to the frailties for hospitalization and death of
individual i respectively.
Two models are considered. Model 1 assumes that the frailties for 
hospitalization and death are equal. Model 2 extends model 1 by relating 
the frailties for hospitalization and death by a parameter y . So, by
choosing y^ =l , model 1 becomes a special case of model 2. Let
Tl* =  (  V n o  ) '
n S  =  (  n H n ••• ' H m n !  ——  "Hh m i —  ^ H M n j r t  )
n S  =  ( t b u ••• ^ D i n j —  'Hd m i —  ^ D M n j ^  )
Model 1: In this model, the frailties for hospitalization and death of 
individual i are assumed equal. That is, Ui=UHi=UDi for all i. We have
tT
x; o P h z;'
--------------1
*Q
 
P
* 
.
o x; Pd T z;
where X; =
ZI = diagU, ... i M]
7j is a vector of l ’s with dimension
ux = (Uj U2 ... UM)' with Uj independent N(O,0)
Model 2: In this model, the equality restriction on the frailties for
hospitalization and death is relaxed and these frailties are related by a 
parameter y . That is, 0 ^ = 7 ^  . Let 11^=1^ and UHi=yUi , we have
131
%tI d
XJ 0
o x;
Ph
Pd
yz;
z;
where XJ , Z* and are defined as in model 1
8.3 ESTIMATION
"n — ( ^Ih ^ d )
%  = ( t1hi ••••• ‘Hhn)
^Id = ( ^Idi 1^d2 ••••• ^ dn)
where r jH is the reordered vector o f according to the ascending
order o f TH and similarly r\D is the reordered vector o f r)J according 
to the ascending order o f TD . We have
T1
%
tI d
+ Zwj Xß + Zwj
where P = (Ph Pd/  and X , Z are the reorganised design matrices 
according to the reordered pattem of r jH and r\D . Remember that the 
only difference between models 1 and 2 before reordering is on the design 
matrix o f ux . So, after reordering, the only difference between models 
1 and 2 is still on the matrix Z .
The log-partial likelihood on conditionally fixed random components 
is given by
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'■ - + .i.m. - i4rp(\ )]
where DHi and are respectively the censoring indicators for
hospitalization and death of the corresponding ith reordered failure 
event.
Model 1: The estimation procedure given below can be used in model 1 or 
when the y value is known in model 2. For given value of 0 , the 
Newton-Raphson procedure gives the solution of these equations for ß , ux 
as the iterative application of
8.3.1 r = V + V 1[X,Z]'(d/l/dTl0) -V 1' 0 '
“ i. “ ,0. Q'xu L 10-J
where ßQ , u are initial values and ß , u} closer approximations to
the BLUP estimates. In equation 8.3.1, the vector rjQ=Xßo+Zwio and if 
B = -d^/dudrf
V = 7T B[X,Z] + 0 0
Z' 0 e ' i
evaluated at ”n=rl0-
d/j/drj
d//dn„
dVd%
and -d^/dtidri'
A /d\K  0
0 -d^/dT^dri'
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Letting V*1 and [Z 'B Z + 0 ‘i ] '1 = T*
From equations 4.7.2 and 4.7.3, the maximum likelihood 0wl and residualML
A
maximum likelihood 0REML estimators of 0 are respectively given by
8.3.2 0 = M'Vtr T ' + ü[ü.)
8-3.3 ®REML =  M  ' (tr T  +  “ I“ l)
Asymptotic variances of these estimators are derived from the 
information matrix given in sections 4.5 (for ML) and 4.6 (for REML). The 
matrix V is then partitioned conformally to ß | u{ as
V
V „ V12 
V21 ^22
V 1
A n  ^12
A2i A22
Letting W 22 = V22 , we have
8.3.4 var ß = \ n
8.3.5 var 0(ML) = 202[M - 20 ‘tr W 22 + 0 '2tr(W 22)]’‘
8.3.6 var 0 ^ , ^ ,  = 202[M - 2 0 ''tr  A22 + 0 '2tr(A22)]‘'
Model 2: The linear predictor before reordering is written as
tT  =
t1h x; o ß« yz;
o x; Pd
+
z;
ui
134
or equivalently,
1-----o
, *
Ph*Q
 
P* .
o  x ; Pd
where u' = ( g\ g2 ) = ( yu[ u[ ) and the vector u satisfies the
following restrictions
G'u = G[g{ + G'2g2 = 0
where G'=(GJ G2) , G J ^ 1^  , G2=-I, and I, is an MxM identity
matrix.
If u is taken to have a normal distribution with zero mean and 
variance matrix 0,[I2 - G(G'G)’G'] where I2 is a 2Mx2M identity 
matrix, then G'u has zero variance consistent with the restrictions. In
that case,
var g2 = 0,[I, - G2(G'G) G']
= e,[I, - G(II+G'G)1G']
= e,[i, + ggt1
where G = -(G jG ,1) = yl, . Hence, var g2 = var u, = O^l+y2)’1!, .
Note that var w, = 01, in model 1 while here var w, = 0,( l-t-y2)’1!, in
model 2. The BLUP likelihood is then constructed as
/  =  / i  +  l2 =  ( ; ih +  1\ d) +  h
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N N
where = I D ^  - /n X exp(T|Hj)]
/,D = £ D  [T l - /n lexp(ii )]
i = l  1)1 01 j = i DJ
/2 = constant - (l/2)[M/n2ic61 (1-k^ )'1 + /n | It | + G^Cl+y2)u[ux] 
Consequent derivatives are 
a//aß = a/,/aß
dl/dUy = a/j/awj - G^ O+yOwj
dl/aQl = a/2/a0, = - ( l ^ M e ; 1 -
al/ay = a/1H/ay -(1 n)\pfi\xu\ux - 2M y(l+y2)'1]
So, the estimation structure is essentially the same as in model 1 
corresponding adjustment in var ux . Therefore, for given 0! and 
ß and Mj are estimated by maximizing the BLUP likelihood,
8.3.7 1 5 - = P c ' + V 1[X ,Z ]'(d /l/d ti0) - V 1 ' 0
UL “ ,0. e ; ‘( i +f ) “ 10-
In equation 8.3.7, the vector r|o=Xßo+Zwio and if B = -d2l^dr\dr\'
V = 7T B[X,Z] + 0 0
Z' o e i ‘ ( i + f ) i ,
evaluated at 'H=Tlo.
As before,
with 
Y ,
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d//dri
dZ/d^H
dz/dnD
and -d^/drjdri' =
-d2Zi/dnHdri' 0
o -d2z,/dnDdn;
Letting and [Z'BZ + 0,1! , ] 1 = T*
the maximum likelihood 0 and residual maximum likelihood ®1(REML) 
estimators of 0! are respectively given by
8.3.8 ®1(ML) =  M ’1(tr T * +  “ I“ l)
8.3.9 0 = M''(tr T + üjw.)
KREML) v 1
Note that the definition of V here is different from that given in model 
1, so the matrices T* , T defined here and those matrices defined in the 
subsequent paragraph in deriving the asymptotic variances are also 
diffferent from that given in model 1.
Asymptotic variances of these estimators are derived from the 
information matrix given in sections 4.5 (for ML) and 4.6 (for REML). As
before, the matrix V is then partitioned conformally to ß I ux as
V„ V12' X/-1 An a 12
V2, V22 V = A2i A22
Letting W22 = V22 , we have
8.3.10 var ß = An
8.3.11 var 01(ML) = 20?[M - 26;'tr W22 + e;2tr(W22)]''
8.3.12 var 0i(reml) = 20[[M - 20j tr A22 + 0j tr(A22)]
Estimation of y is by choosing a value y which maximizes the BLUP 
likelihood / . As we can see from the expression of dl/dy , the partial
derivative 3/1H/ay is complicated and a closed form expression of y
estimate is not obtainable, so y is chosen to maximize / through a
linear search to 2 decimal places. Moreover, since /1D does not involve
y , to maximize / is equivalent to maximize
8.3.13 /1H + (l/2)[M/n(l+Y2) - ejVl+y2)«;«*,] •
As a result, our iterative scheme is
Step 1: Given initial values ß0 , ul0 , 01O and y0 , use equation 8.3.7 
to estimate J3 and ux until convergent.
Step 2: Estimate 0j by equations 8.3.8 (for ML) or 8.3.9 (for REML).
A
Step 3: Replace 01O by 0! , repeat Steps 1 and 2 until convergent.
Step 4: Estimate y by maximizing the expression 8.3.13 through linear
search to 2 decimal places.
Step 5: Replace y0 by y , repeat Step 1,2 and 3 until y0=y .
8.4 APPLICATION
The two models described in section 8.3 are applied to analyse a 
subset of the Dubbo study data given in Appendix I. In this subset of
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data, M=62 (number of individuals) and N=239 (total number of 
failure/censoring events). The ML and REML estimation for model 1 are 
given in Table 8.4.1.
Table 8.4.1. ML and REML estimates of parameters (with standard errors) 
for model 1.
ML estimation in Model 1
Variable Ph Pd
On BP medication 
Prior CHD 
Cholesterol 
Prior diabetes 
One disability 
More than one disability 
Married 
Former smoker 
Current smoker 
0
0.5941(0.2819)*
0.6358(0.2876)*
0.0007(0.0067)
-0.5408(0.4344)
0.6275(0.3396)@
0.5348(0.3608)
-0.2008(0.3505)
0.8010(0.3019)**
0.5946(0.3913)
0.3965(0.1537)
0.0738(0.9763) 
0.0286(0.9796) 
-0.0095(0.0154) 
-0.4155(1.2537) 
2.7014(1.1285)* 
0.5175(1.1251) 
-3.0728(1.0431)** 
2.4645(1.3319)@ 
1.3639(1.5050)
var Wj = 0 = 0.3965
REML estimation in Model 1
Variable Ph Pd
On BP medication 
Prior CHD 
Cholesterol 
Prior diabetes 
One disability 
More than one disability 
Married 
Former smoker 
Current smoker 
0
0.5940(0.2969)* 
0.6379(0.3057)* 
0.0008(0.0071) 
-0.5334(0.4577) 
0.6285(0.3575)@ 
0.5317(0.3832) 
-0.2151(0.3706) 
0.8009(0.3171)* 
0.5926(0.4112) 
0.5093(0.1945)
0.0702(0.9854) 
0.0325(0.9884) 
-0.0098(0.0157) 
-0.4382(1.2702) 
2.7316(1.1414)* 
0.5253(1.1345) 
-3.1089(1.0558)** 
2.4860(1.3455)(S> 
1.3602(1.5195)
var ux = 0 = 0.5093
@ significant at 10% * significant at 5% ** significant at 1%
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Significant variables are consistent in both ML and REML estimations. 
Results show that at 5% significance level, individuals who are on BP 
medication, former smokers or with prior CHD have a higher risk in 
hospitalization while those individuals who are unmarried or with one 
disability have a higher risk in death. It should be noted that these 
results can only apply to our subset of data but should not be generalised 
to the full Dubbo study data. The estimated variance of individual’s 
frailty is 0.3965 in ML and 0.5093 in REML. Table 8.4.2 below shows 
the results of the ML and REML estimation for model 2.
Table 8.4.2. ML and REML estimates of parameters (with standard errors) 
for model 2.
ML estimation in Model 2
Variable P h Pd
On BP medication
Prior CHD
Cholesterol
Prior diabetes
One disability
More than one disability
Married
Former smoker
Current smoker
e,
0.5948(0.2687)*
0.6350(0.2713)*
0.0005(0.0063)
-0.5497(0.4137)
0.6273(0.3240)®
0.5396(0.3406)
-0.1861(0.3325)
0.7986(0.2882)**
0.5966(0.3736)
0.6199(0.1189)
0.0838(0.9601)
0.0392(0.9649)
-0.0093(0.0151)
-0.3769(1.2282)
2.6385(1.1069)*
0.4775(1.1112)
-2.9948(1.0219)**
2.4237(1.3089)®
1.3594(1.4795)
Y = 1.07
var «, = e,(l+f)-‘ = 0.2890
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REML estimation in Model 2
Variable ßH Pd
On BP medication
Prior CHD
Cholesterol
Prior diabetes
One disability
More than one disability
Married
Former smoker
Current smoker
0i
0.5898(0.3093)@
0.6363(0.3203)*
0.0005(0.0074)
-0.5260(0.4766)
0.6276(0.3726)@ 
0.5356(0.4010) 
-0.2274(0.3865) 
0.7863(0.3292)* 
0.5916(0.4268) 
0.8859(0.1170)
0.0907(0.9538) 
0.0836(0.9618) 
-0.0100(0.0150) 
-0.3797(1.2307) 
2.6076(1.1051)* 
0.4067(1.1110) 
-2.9549(1.0187)** 
2.4186(1.3071)@ 
1.3322(1.4745)
y = 1.35
var Wj = Ö^I+y2)’1 = 0.3139
@ significant at 10% * significant at 5% ** significant at 1%
ML and REML estimated regression coefficients are similar to those 
obtained in model 1. Estimate of y is 1.07 in ML and 1.35 in REML 
indicate that the frailties for hospitalization and death are of 
comparable magnitude in this group of individuals. Estimated variance of 
individual’s frailty for death is 0.2890 in ML and 0.3139 in REML which 
are less than those obtained in model 1. Such decrease in var ux from 
model 1 to model 2 is expected since the y estimates in both ML and REML 
are greater than one.
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8.5 DISCUSSION
The derivation of competing risk frailty models are given in the 
previous sections. Such models are applied to analyse a subset of the
Dubbo study data. There are some points worthy of notice. Firstly, the 
models considered in section 8.2 are for those data which involve two 
types of failure events only, generalisation to problems with more than 
two types of failure events is possible following the development in 
section 8.3.
Secondly, the estimation of y in section 8.3 is by maximizing the 
BLUP likelihood through linear search to 2 decimal places. Such
estimation method is primitive and requires much computer workspace 
especially when the data set becomes large. Approximate ML and REML 
estimation methods to estimate y are still being investigated.
Thirdly, since the parameter y represents the relationship between 
individual’s frailty for hospitalization and death, it is of interest to 
find out the change of y across sex and age groups. Intuitively, we may 
expect that y will decrease from younger age groups to older age groups 
and will be close to one in older age groups. Moreover, we may also 
expect that for the same age group, the parameter y will be higher in 
female than in male since the life expectancy of females is longer than 
male.
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Lastly, the problem which initiates the analysis of the Dubbo study 
data using a mixed model is on the investigation of the relationship 
between individual’s frailty prediction and a variable called Self-Rated 
Health (SRH). Such variable has been hypothesed to be an important 
indicator of survival in elderly people and predict survival independently 
of other indicators. Here, we aim to look for the relationship between 
the frailty prediction for hospitalization and SRH. We expect that 
individual’s frailty prediction will be high for those individuals who 
anticipate a "poor” SRH at their study entry.
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CHAPTER NINE
FURTHER DISCUSSION
9.1 PRELIMINARIES
In the previous chapters, the application of the GLMM is found to be 
useful to analyse multivariate failure time data. On one hand, the method 
is a generalisation of Cox regression model by including random components 
in the linear predictor. On the other hand, it makes use of the quadratic 
approximation in the likelihood in the region of the maximum.
Although the method is based on an approximation in the region of the 
maximum, it works quite well in analysing multivariate failure time data. 
As we can see in previous chapters, consistent results in the estimation 
of fixed effect regression coefficients are obtained. When compared to
other approaches, the current method assumes the random individual effect 
to be independent identically normally distributed with variance 0 . In
most cases, such variance of random effects is significantly different 
from zero, so it is inappropriate to reduce the mixed model to a fixed 
effect model by ignoring random components.
Random effect prediction is another important feature of the current 
method. As indicated in chapters 1 and 7, these predictions are useful, 
for instance, in identifying a high risk family or high risk individual 
when considering a genetic disease.
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9.2 SOME REMARKS
In developing the three time dependent frailty models in chapter 5, 
the parameter representing change over time is modelled into a fixed
effect, a normally distributed random effect and a longitudinal effect in 
which the random component relates to the patient characteristics.
Although models 2 and 3 considered in this chapter do not show significant 
advantage over model 1 in analysing the CGD data, these models are useful 
in indicating how such models may be fitted and the method is then
available to encourage its consideration in future data collection.
In chapter 6, an AR(1) frailty model is fitted to analyse the CGD 
data. We see that the estimate of correlation parameter <j) in the AR(1) 
process is not significant and is very close to zero. Preliminary 
simulations show that the method used in this chapter in the estimation of 
<j) is biased and tends to give an estimate of <J> close to zero.
Extensive simulations are required to validify this effect. On the other 
hand, methods to reduce the bias in the estimation of (}) are now being 
investigated.
9.3 MAIN DIFFICULTY
In the random effect regression model, the dimension of the matrix 
involved in each iteration is greatly inflated due to the fact that random 
components are considered to be conditionally fixed in the BLUP procedure.
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Moreover, the reordering process in the Cox model further complicates the 
problem. In most cases, the design matrix before reordering has certain 
pattem and allows analytic simplification of the matrix involved.
Unfortunately, the reordering mechanism destroys the original pattem of 
the design matrix and gives a completely structureless design matrix which 
prohibits further simplification. Such effect results in the
impossibility of handling large data sets. In fact, for the analysis of 
moderate size data ( ~ 500 individuals), the capability limit of computer
is usually exceeded.
Another problem is about the iteration speed. The programming 
language being used in this research is APL. With a mathematics co­
processor, APL has a relatively high speed. But due to the multiplication 
and inversion of large dimensional matrices involved in each iteration, it 
takes quite a long time for the whole estimation procedure to be 
completed. For example, in the analysis of the CGD data using the AR(1) 
frailty model considered in chapter 6, it takes a few days for the 
estimation procedure to be completed. In the simulation study of the
random block frailty model considered in chapter 7, the number of random 
effects is 120 in each simulation and it takes about three months to 
obtain those results. The computation is carried out on a 486 
microcomputer.
While we are expecting the improvement in computer technology may 
help us to solve this problem, efforts are now being made to develop a 
procedure which preserves the original pattem of the design matrix so 
that it allows analytic simplication. We hope that such development may
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help to save computer time and workspace, and hence make it possible to 
analyse large data sets.
As a whole, the main difficulty in this research is in the handling 
of large data sets, due to the limited workspace and the slow iteration 
speed which are available in our computers.
9.4 UNSOLVED PROBLEMS
During the research process, there are two important problems coming 
up which remain unsolved. The first one is in the development of unbiased 
estimating equations in the variance components estimation. In the linear 
model,
y = Xß + e e ~ N(0,o2Z(<j>))
where y is an observation vector with N components
X is an Nxp matrix of regression variables having rank v 
ß is a p-component vector of regression coefficients 
(j) is a vector of correlation parameters.
For given <j) , ML and REML estimates of ß is given by
ß = (x'x'xyx'rV
the estimation of variance parameter o2 is given by
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-  N ' 1«2°  (ML) -  1N a  
g 2(REML) = (N-v) S
where S2 = (y-Xß) L^Cy-Xß)
It is well-known that the estimating equation of o2 is
asymptotically negatively biased in ML and asymptotically unbiased in
REML. Note that in the above development, <{) is assumed to be known and 
given. In practice, <}> is unknown and needs to be estimated. Therefore, 
the iteration procedure becomes (i) ß and a 2 is estimated based on a 
starting value of <j), (ii) (j) is estimated by maximizing the likelihood 
based on the estimated value of ß and a 2 obtained previously, (iii) such 
estimated value of <j) is substituted back to the estimating equations of ß 
and a 2 and (iv) these iterations continue until the stopping criteria is 
met.
Although the REML technique removes the unbiasedness in the 
estimation of a 2 for given values of <}) , there is no guarantee of such 
unbiasedness when in fact <J> is being estimated by maximizing the 
likelihood and such values are ultimately used to obtain estimates of ß 
and a 2 . Since the development of the GLMM relies on the link between 
BLUP, ML and REML estimation, the biasedness problem in the linear model 
will transfer to the GLMM. So, it is important to develop a set of
simultaneous unbiased estimating equations of ß , G2 and <J) in linear
model and carry those results to the development of the GLMM.
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The second important problem is in the development of Goodness of fit
tests and model diagnostic tools in the GLMM. In chapter 4, we see that
estimates of parameters are obtained by repeated iterations of equations 
4.7.1 to 4.7.5. Their corresponding estimated standard errors are 
provided by the estimated information matrices given in sections 4.5 and 
4.6. Inference procedures are then performed by comparing the parameter 
estimates with their corresponding estimated standard errors. The
development of the GLMM will be more complete if we can have a standard
procedure such as the likelihood ratio test for choosing a parsimonious
model and model diagnostic tools such as the residual analysis.
9.5 RESEARCH SUGGESTIONS
Other than the two unsolved problems mentioned above, further 
research is suggested in the following. Firstly, the random components 
considered in the AR(1) frailty model of chapter 6 are assumed to follow 
an AR(1) process. It is then a natural extension to consider the random 
components to follow in general an ARIMA(p,d,q) process. The ML and REML 
estimating equations of the parameters in the variance matrix are provided 
by equations 4.7.4 and 4.7.5 respectively.
Secondly, extensive simulations are required to justify the 
performance of the estimation procedure in the baseline frailty model and 
the random block frailty model described in chapter 7. Moreover, 
simulations are called for to investigate the biasedness in the estimation
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of the correlation parameter (j) of the AR(1) frailty model described in
section 6.3.
Thirdly, the technique of the justification of the exponential
relative risk function mentioned in section 7.3 can be extended to apply
to other frailty models without altering the development of that section.
The only adjustment to be made is in the variance matrix of the random 
components.
Lastly, in the competing risk frailty models developed in chapter 8,
the estimation procedure of the parameter y that relates the two types 
of failure makes use of the maximization of the BLUP likelihood by linear
search to 2 decimal places. We see in section 8.3 that the estimation of
Y is established by extending the random effect vector. Such extension
of the random effect vector results in restrictions imposed on this 
extended vector. This problem exposes us to a broader class of models
called "the GLMM with restricted random components". Efforts are now 
being made to develop the ML and REML estimating equations of y in the 
GLMM with restricted random components.
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APPENDIX I
DATA SETS
This Appendix contains three data sets. They are the Chronic 
Granulomatuous Disease (CGD) data, the litter matched tumorigenesis 
experiment data and the Dubbo study data. Background of these data sets 
are explained in chapter 2. Detailed format of these three data sets are 
described in chapters 5, 7 and 8 respectively.
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The C h ro n ic  G ranuloznatuous D is e a s e  (CGD) D ata
1 2 9 4 0 1 0 38 1 5 2 . 2 6 6 . 7 0 1 2 0 1 0 0
2 2 5 6 0 0 1 14 1 4 4 3 2 . 8 0 1 1 0 1 0 0
3 2 1 4 0 0 1 2 6 8 1 . 2 5 55 0 1 1 0 1 0 0
4 2 0 4 0 0 1 2 6 1 7 8 . 5 6 9 . 3 0 1 1 0 1 0 0
5 2 2 0 1 1 0 12 1 4 7 62 0 0 2 0 1 0 0
5 1 5 4 1 1 0 12 1 4 7 62 0 0 2 0 1 0 0 . 6 0 2 3
5 41 0 1 0 12 1 4 7 62 0 0 2 0 1 0 1 . 0 2 4
6 9 1 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0
6 18 1 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0 . 0 2 4 6
6 1 2 6 1 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0 . 0 7 3 9
6 8 9 1 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0 . 4 1 8 9
6 8 1 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0 . 6 6 2 6
6 7 3 1 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0 . 6 8 4 5
6 2 8 1 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0 . 8 8 4 3
6 8 9 0 0 0 15 1 5 9 4 7 . 5 0 1 1 0 1 0 0 . 9 6 1
7 3 8 3 0 1 1 19 1 7 1 7 2 . 7 0 1 1 0 1 0 0
8 3 8 9 0 1 1 12 1 4 2 34 0 1 1 0 1 0 0
9 2 1 2 1 0 1 1 7 9 1 0 . 5 0 1 1 0 1 0 0
9 4 9 1 0 1 1 7 9 1 0 . 5 0 1 1 0 1 0 0 . 5 8 0 4
9 5 1 0 1 1 7 9 1 0 . 5 0 1 1 0 1 0 0 . 7 1 4 6
9 4 1 0 1 1 7 9 1 0 . 5 0 1 1 0 1 0 0 . 7 2 8 3
9 3 8 1 0 1 1 7 9 1 0 . 5 0 1 1 0 1 0 0 . 7 3 9 2
9 5 6 0 0 1 1 7 9 1 0 . 5 0 1 1 0 1 0 0 . 8 4 3 3
10 83 1 1 0 9 1 3 4 . 5 3 2 . 7 0 1 1 0 1 0 0
10 3 2 1 1 0 9 1 3 4 . 5 3 2 . 7 0 1 1 0 1 0 0 . 2 2 7 2
10 2 2 3 1 1 0 9 1 3 4 . 5 3 2 . 7 0 1 1 0 1 0 0 . 3 1 4 9
10 30 0 1 0 9 1 3 4 . 5 3 2 . 7 0 1 1 0 1 0 0 . 9 2 5 4
11 19 1 0 1 1 7 9 1 1 . 4 7 0 1 1 0 1 0 0
11 3 4 4 0 0 1 1 7 9 1 1 . 4 7 0 1 1 0 1 0 0 . 0 5 2
12 2 6 8 1 1 1 5 1 0 2 18 0 1 1 0 1 0 0
12 93 0 1 1 5 1 0 2 18 0 1 1 0 1 0 0 . 7 3 3 7
13 3 3 8 0 1 0 2 2 1 6 9 5 2 . 2 0 1 1 0 1 0 0
14 2 7 1 0 0 0 1 9 1 5 9 46 0 0 2 0 1 0 0
1 5 2 7 5 0 0 1 7 1 1 5 . 5 1 9 . 5 0 1 1 0 1 0 0
1 6 2 7 2 0 1 1 2 5 1 8 5 5 8 . 4 0 1 1 0 1 0 0
17 2 5 3 0 0 1 31 1 7 0 8 0 . 5 0 1 1 0 1 0 0
18 2 4 4 0 1 1 3 7 1 5 5 6 7 . 5 0 1 2 0 1 0 0
19 1 0 5 1 0 0 6 1 3 0 2 1 . 6 0 1 2 0 1 0 0
19 1 2 3 0 0 0 6 1 3 0 2 1 . 6 0 1 2 0 1 0 0 . 2 8 7 5
2 0 2 2 8 0 0 0 3 96 1 3 . 1 0 1 2 0 1 0 0
2 1 1 9 9 0 0 0 2 2 1 6 3 4 9 . 1 0 1 2 0 0 0 0
2 2 2 0 8 0 0 1 17 1 6 9 6 3 . 5 0 1 1 0 0 0 0
2 3 1 6 9 1 0 1 1 9 1 8 2 6 3 . 9 0 1 1 0 0 0 0
2 3 3 2 0 0 1 1 9 1 8 2 6 3 . 9 0 1 1 0 0 0 0 . 4 6 2 7
2 4 1 9 8 0 1 0 3 6 1 6 7 6 0 . 8 0 1 2 0 0 0 0
2 5 2 4 7 1 0 1 17 1 6 2 . 5 5 2 . 7 0 1 1 1 0 0 0
2 5 7 1 0 1 17 1 6 2 . 5 5 2 . 7 0 1 1 1 0 0 0 . 6 7 6 2
2 5 1 3 0  -0 0 1 17 1 6 2 . 5 5 2 . 7 0 1 1 1 0 0 0 . 6 9 5 4
2 6 2 9 5 1 0 0 2 7 1 7 6 8 2 . 8 0 1 1 1 0 0 0
2 6 5 5 0 0 0 2 7 1 7 6 8 2 . 8 0 1 1 1 0 0 0 . 8 0 7 7
2 7 3 7 2 0 1 1 5 1 1 3 1 9 . 5 0 1 1 1 0 0 0
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2 8 2 0 1 0 1 2 93 1 3 . 2 0 1 1 1 0 0 0
2 8 8 3 0 0 1 2 93 1 3 . 2 0 1 1 1 0 0 0 . 0 5 4 8
2 9 3 7 4 1 1 1 8 1 2 4 2 5 . 4 0 1 1 1 0 0 0
2 9 15 0 1 1 8 1 2 4 2 5 . 4 0 1 1 1 0 0 1 . 0 2 4
3 0 3 8 9 0 1 1 12 1 4 4 3 6 . 9 0 1 1 1 0 0 0
3 1 3 6 6 0 0 1 27 1 7 4 6 7 . 8 0 1 1 1 0 0 0
32 3 3 5 1 0 1 14 1 4 3 . 5 3 3 . 4 0 1 1 1 0 0 0
32 36 1 0 1 14 1 4 3 . 5 3 3 . 4 0 1 1 1 0 0 0 . 9 1 7 2
3 2 12 0 0 1 14 1 4 3 . 5 3 3 . 4 0 1 1 1 0 0 1 . 0 1 5 7
3 3 3 7 4 0 1 0 11 1 4 9 5 0 . 9 0 1 1 1 0 0 0
34 2 8 1 1 0 0 2 9 1 7 5 7 3 . 1 0 1 1 1 0 0 0
3 4 1 0 5 0 0 0 2 9 1 7 5 7 3 . 1 0 1 1 1 0 0 0 . 7 6 9 3
3 5 3 7 7 0 1 0 3 1 1 6 7 5 1 . 8 0 1 2 1 0 0 0
3 6 3 6 1 0 1 1 7 1 2 1 1 9 . 9 0 1 1 1 0 0 0
37 3 0 7 0 0 0 2 6 1 5 3 4 6 . 9 0 1 2 1 0 0 0
3 8 1 1 9 1 1 1 13 1 4 5 . 2 3 6 . 2 0 1 1 1 0 0 0
38 1 2 2 1 1 1 13 1 4 5 . 2 3 6 . 2 0 1 1 1 0 0 0 . 3 2 5 8
3 8 11 0 1 1 13 1 4 5 . 2 3 6 . 2 0 1 1 1 0 0 0 . 6 5 9 8
3 9 1 8 8 1 1 0 2 5 1 6 8 6 8 . 9 0 1 2 1 0 0 0
3 9 1 6 9 0 1 0 2 5 1 6 8 6 8 . 9 0 1 2 1 0 0 0 . 5 1 4 7
40 3 4 0 0 1 0 9 1 4 0 36 0 1 2 1 0 0 0
41 7 1 0 1 2 8 1 7 4 6 3 . 7 0 1 1 1 0 0 0
41 2 9 5 0 0 1 2 8 1 7 4 6 3 . 7 0 1 1 1 0 0 0 . 0 1 9 2
42 3 3 5 0 1 0 13 1 3 9 3 4 . 8 0 1 2 1 0 0 0
43 2 7 0 0 1 0 2 4 1 7 7 7 8 . 4 0 1 1 1 0 0 0
44 2 7 4 0 0 1 11 1 2 3 2 4 . 3 0 1 1 1 0 0 0
45 1 1 4 1 1 1 4 1 0 3 . 8 1 6 . 8 0 1 1 1 0 0 0
45 1 6 0 0 1 1 4 1 0 3 . 8 1 6 . 8 0 1 1 1 0 0 0 . 3 1 2 1
46 1 0 0 1 0 1 19 1 7 0 7 1 . 2 0 1 1 1 0 0 0
46 2 0 7 1 0 1 1 9 1 7 0 7 1 . 2 0 1 1 1 0 0 0 . 2 7 3 8
47 2 6 4 0 1 1 18 1 6 6 5 8 . 1 0 1 1 1 0 0 0
48 1 6 8 1 1 0 7 1 3 5 4 2 . 9 0 1 1 1 0 0 0
48 7 3 0 1 0 7 1 3 5 4 2 . 9 0 1 1 1 0 0 0 . 4 6
49 2 7 2 0 0 0 12 1 6 6 5 1 . 9 0 1 2 1 0 0 0
5 0 2 5 5 0 1 1 10 1 2 9 2 7 . 4 0 1 1 1 0 0 0
51 2 7 9 0 0 1 9 1 2 9 . 4 2 8 . 7 0 1 1 0 1 0 0
52 2 6 6 0 1 1 5 1 1 2 . 3 2 0 . 7 0 1 1 0 1 0 0
5 3 2 1 8 0 1 1 1 7 6 . 3 1 1 . 3 0 1 1 0 1 0 0
5 4 1 6 6 1 1 1 7 1 1 9 2 0 . 6 0 1 1 0 1 0 0
54 45 0 1 1 7 1 1 9 2 0 . 6 0 1 1 0 1 0 0 . 4 5 4 5
5 5 1 9 3 0 0 0 11 1 3 7 . 5 4 0 . 3 0 1 1 0 1 0 0
5 6 12 1 0 0 4 9 8 . 3 1 4 . 4 0 1 1 0 1 0 0
5 6 1 1 1 0 0 4 9 8 . 3 1 4 . 4 0 1 1 0 1 0 0 . 0 3 2 9
5 6 1 4 7 1 0 0 4 9 8 . 3 1 4 . 4 0 1 1 0 1 0 0 . 0 6 3
56 2 6 0 0 0 4 9 8 . 3 1 4 . 4 0 1 1 0 1 0 0 . 4 6 5 4
57 1 2 1 1 0 0 7 1 1 3 2 0 . 4 0 1 2 0 1 0 0
57 83 0 0 0 7 1 1 3 2 0 . 4 0 1 2 0 1 0 0 . 3 3 1 3
58 1 9 8 0 1 1 15 1 7 8 . 7 6 0 . 5 0 1 1 0 1 0 0
5 9 2 0 7 1 0 1 1 7 9 1 2 . 2 0 1 1 0 1 0 0
5 9 1 4 1 0 0 1 1 7 9 1 2 . 2 0 1 1 0 1 0 0 . 5 6 6 7
60 3 3 6 0 1 1 7 1 1 6 . 6 2 3 . 3 0 1 1 0 1 0 0
61 2 7 5 1 1 1 17 1 7 0 . 2 4 7 . 9 0 1 1 0 1 0 0
61 87 1 1 1 17 1 7 0 . 2 4 7 . 9 0 1 1 0 1 0 0 . 7 5 2 9
61 4 0 1 1 17 1 7 0 . 2 4 7 . 9 0 1 1 0 1 0 0 . 9 9 1 1
62 3 3 7 0 1 1 8 1 2 5 . 4 2 7 . 7 0 1 1 0 1 0 0
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63 5 3 1 0 1 2 0 1 7 3 6 8 . 4 0 1 1 0 1 0 0
63 13 1 0 1 2 0 1 7 3 6 8 . 4 0 1 1 0 1 0 0 . 1 4 5 1
63 1 9 0 1 0 1 20 1 7 3 6 8 . 4 0 1 1 0 1 0 0 . 1 8 0 7
63 1 5 0 0 1 20 1 7 3 6 8 . 4 0 1 1 0 1 0 0 . 7 0 0 9
64 68 1 0 1 5 1 1 4 . 5 23 0 0 1 0 1 0 0
64 1 8 1 1 0 1 5 1 1 4 . 5 23 0 0 1 0 1 0 0 . 1 8 6 2
64 2 1 0 1 5 1 1 4 . 5 2 3 0 0 1 0 1 0 0 . 6 8 1 7
64 3 4 1 0 1 5 1 1 4 . 5 2 3 0 0 1 0 1 0 0 . 6 8 7 2
64 6 3 0 0 1 5 1 1 4 . 5 2 3 0 0 1 0 1 0 0 . 7 8 0 3
65 3 1 9 0 1 1 6 1 0 5 . 5 1 9 . 5 1 1 1 0 1 0 0
66 3 1 9 1 0 1 9 1 2 9 . 6 2 9 . 3 0 0 1 0 1 0 0
66 41 0 0 1 9 1 2 9 . 6 2 9 . 3 0 0 1 0 1 0 0 . 8 7 3 4
67 2 6 0 0 1 1 5 1 1 0 . 4 1 9 . 1 0 1 1 0 1 0 0
68 3 6 5 0 1 0 44 1 5 3 . 3 45 0 0 2 0 1 0 0
69 2 9 3 1 0 1 2 2 1 7 5 5 9 . 7 0 1 1 0 1 0 0
69 7 2 0 0 1 2 2 1 7 5 5 9 . 7 0 1 1 0 1 0 0 . 8 0 2 2
7 0 3 6 4 0 1 1 7 1 1 1 1 7 . 4 0 1 1 0 1 0 0
7 1 3 5 1 0 1 1 19 1 7 3 . 6 6 1 . 4 0 0 1 0 1 0 0
72 2 7 0 0 1 1 34 1 8 2 . 6 9 4 . 8 0 0 1 0 1 0 0
7 3 1 8 6 0 1 1 32 1 7 7 . 9 6 3 . 3 5 0 0 1 0 1 0 0
7 4 92 0 0 1 2 5 1 8 5 7 4 . 5 5 0 0 1 0 1 0 0
7 5 92 0 0 1 2 1 1 8 9 1 0 1 . 5 0 0 1 0 1 0 0
7 6 3 5 8 0 0 1 7 1 0 9 1 4 . 6 5 0 1 1 0 1 0 0
7 7 1 7 6 1 0 1 5 1 0 1 1 5 . 4 0 1 1 0 1 0 0
7 7 1 0 5 1 0 1 5 1 0 1 1 5 . 4 0 1 1 0 1 0 0 . 4 8 1 9
77 7 3 0 0 1 5 1 0 1 1 5 . 4 0 1 1 0 1 0 0 . 7 6 9 3
7 8 3 4 4 0 0 1 2 4 1 6 9 . 7 5 8 . 9 5 0 1 1 0 1 0 0
7 9 2 6 6 1 1 1 12 1 3 8 2 8 . 1 0 1 1 0 1 0 0
7 9 38 0 1 1 12 1 3 8 2 8 . 1 0 1 1 0 1 0 0 . 7 2 8 3
80 2 2 7 1 0 1 5 9 7 . 1 1 5 . 3 0 1 1 0 1 0 0
80 9 6 0 0 1 5 9 7 . 1 1 5 . 3 0 1 1 0 1 0 0 . 6 2 1 5
81 2 5 6 0 1 1 2 4 1 7 1 5 5 . 1 0 1 1 0 1 0 0
82 66 1 1 1 2 6 1 7 6 . 8 66 0 1 1 0 0 0 0
82 2 7 8 0 1 1 2 6 1 7 6 . 8 66 0 1 1 0 0 0 0 . 1 8 0 7
8 3 2 9 5 0 0 1 6 1 0 4 . 4 1 3 . 8 0 1 1 0 0 0 0
84 3 0 4 0 1 0 9 1 2 2 . 8 2 0 . 1 0 1 2 0 0 0 0
8 5 2 4 1 0 1 2 5 1 7 6 . 9 7 3 . 5 0 0 1 0 0 0 0
8 5 2 4 7 0 0 1 2 5 1 7 6 . 9 7 3 . 5 0 0 1 0 0 0 0 . 0 6 5 7
86 2 7 1 0 1 1 2 9 3 . 5 1 4 . 2 0 1 1 0 0 0 0
87 2 4 6 0 0 1 8 1 2 1 . 6 2 2 . 4 0 1 1 0 0 0 0
88 2 6 2 0 0 1 10 1 2 5 . 9 2 9 . 7 0 1 1 0 0 0 0
8 9 2 8 5 0 1 1 2 0 1 6 9 . 8 5 0 . 1 0 1 1 0 0 0 0
90 2 7 7 0 0 0 34 1 6 6 . 5 5 8 . 2 0 1 1 0 0 0 0
91 2 9 5 0 1 1 6 1 1 9 . 9 2 6 . 2 0 1 1 0 0 0 0
92 2 7 8 0 1 1 11 1 3 9 . 2 3 4 . 9 0 1 1 0 0 0 0
93 5 1 0 0 3 9 1 . 7 1 4 . 4 0 1 1 0 0 0 0
93 1 5 5 1 0 0 3 9 1 . 7 1 4 . 4 0 1 1 0 0 0 0 . 0 1 3 7
93 54 1 0 0 3 9 1 . 7 1 4 . 4 0 1 1 0 0 0 0 . 4 3 8 1
93 7 4 0 0 0 3 9 1 . 7 1 4 . 4 0 1 1 0 0 0 0 . 5 8 5 9
94 3 3 2 0 1 1 9 1 3 1 . 3 2 4 0 1 1 0 0 0 0
95 2 8 9 0 0 0 11 1 3 8 . 6 3 6 . 1 0 1 2 0 0 0 0
96 2 7 0 0 0 1 17 1 5 6 . 7 3 6 . 8 0 1 1 0 0 0 0
97 2 7 0 0 0 1 10 1 4 3 3 1 . 3 0 1 1 0 0 0 0
98 3 3 1 0 0 0 17 1 7 1 4 6 . 1 0 1 2 0 1 0 0
99 5 8 1 0 0 8 1 1 5 19 0 1 2 0 1 0 0
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99 64 1 0 0 8 1 1 5 19 0 1 2 0 1 0 0 . 1 5 8 8
99 2 3 0 0 0 0 8 1 1 5 19 0 1 2 0 1 0 0 . 3 3 4
1 0 0 2 9 8 0 1 1 6 1 1 1 . 9 1 7 . 9 0 1 1 0 1 0 0
1 0 1 2 8 2 0 0 0 7 1 1 6 . 2 2 2 . 2 0 1 1 0 1 0 0
1 0 2 2 7 7 0 1 1 7 1 1 9 . 7 2 1 . 5 0 1 1 0 1 0 0
1 0 3 2 8 0 0 1 1 8 1 1 6 . 8 20 0 1 1 0 1 0 0
1 0 4 15 1 0 1 11 1 4 1 . 5 36 0 1 1 0 1 0 0
1 0 4 2 6 4 0 0 1 11 1 4 1 . 5 36 0 1 1 0 1 0 0 . 0 4 1 1
1 0 5 2 0 0 0 1 1 4 1 0 8 . 1 1 7 . 3 0 1 1 0 1 0 0
1 0 6 3 0 9 0 0 0 18 1 7 9 67 0 1 1 0 0 1 0
1 0 7 3 2 8 0 1 1 13 1 5 1 49 0 1 1 0 0 1 0
1 0 8 3 3 0 0 0 1 11 1 3 6 . 5 3 1 . 2 0 0 1 0 0 1 0
1 0 9 3 1 9 0 1 1 2 86 1 3 . 5 0 1 1 0 0 1 0
1 1 0 3 0 5 0 1 1 17 1 8 0 68 0 1 1 0 0 1 0
1 1 1 3 1 7 0 0 0 3 5 1 8 1 . 5 80 0 0 1 0 0 1 0
1 1 2 3 0 1 0 0 1 2 5 1 7 2 . 5 50 0 1 1 0 0 1 0
1 1 3 1 4 7 1 1 1 14 1 4 5 2 9 0 0 1 0 0 1 0
1 1 3 42 1 1 1 14 1 4 5 2 9 0 0 1 0 0 1 0 . 4 0 2 5
1 1 3 1 1 2 0 1 1 14 1 4 5 2 9 0 0 1 0 0 1 0 . 5 1 7 5
1 1 4 3 0 5 1 0 0 2 5 1 8 7 . 5 74 0 1 1 0 0 1 0
1 1 4 8 0 0 0 2 5 1 8 7 . 5 7 4 0 1 1 0 0 1 0 . 8 3 5
1 1 5 92 1 0 1 27 1 6 9 . 5 65 1 0 2 0 0 1 0
1 1 5 30 1 0 1 2 7 1 6 9 . 5 65 1 0 2 0 0 1 0 . 2 5 1 9
1 1 5 82 1 0 1 2 7 1 6 9 . 5 65 1 0 2 0 0 1 0 . 3 3 4
1 1 5 84 0 0 1 2 7 1 6 9 . 5 65 1 0 2 0 0 1 0 . 5 5 8 5
1 1 6 2 9 4 0 0 0 32 1 8 5 95 0 1 1 0 0 1 0
1 1 7 2 9 4 0 1 1 6 1 2 0 2 3 0 1 1 0 0 1 0
1 1 8 2 6 5 1 0 0 8 1 3 8 31 0 0 1 0 0 1 0
1 1 8 2 2 0 0 0 8 1 3 8 31 0 0 1 0 0 1 0 . 7 2 5 5
1 1 9 2 8 7 0 1 0 9 1 4 4 3 4 . 4 0 1 1 0 0 1 0
1 2 0 2 7 4 0 1 0 2 3 1 7 0 49 0 0 2 0 0 1 0
1 2 1 2 3 7 1 0 0 2 3 1 2 2 3 1 . 2 1 1 2 0 0 1 0
1 2 1 3 7 0 0 0 2 3 1 2 2 3 1 . 2 1 1 2 0 0 1 0 . 6 4 8 9
1 2 2 2 7 4 0 1 0 17 1 2 7 27 0 1 2 0 0 1 0
1 2 3 2 0 8 1 1 0 2 1 1 5 8 49 0 1 1 0 0 1 0
1 2 3 66 0 1 0 2 1 1 5 8 49 0 1 1 0 0 1 0 . 5 6 9 5
1 2 4 2 6 5 0 0 1 1 81 1 0 . 4 0 1 1 0 0 1 0
1 2 5 1 6 1 0 1 1 12 1 3 6 . 5 30 0 1 1 0 1 0 0
1 2 6 1 4 7 1 0 1 7 1 2 0 2 3 0 1 1 0 1 0 0
1 2 6 1 7 0 0 0 1 7 1 2 0 2 3 0 1 1 0 1 0 0 . 4 0 2 5
1 2 7 3 1 7 0 0 1 1 7 9 1 0 . 6 0 1 1 0 1 0 0
1 2 8 3 1 6 0 1 1 3 9 7 . 8 13 0 1 1 0 1 0 0
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The Litter Matched Tumorigenesis Experiment Data
1 101 0 1
1 49 1 0
1 104 0 0
2 104 0 1
2 102 0 0
2 104 0 0
3 104 0 1
3 104 0 0
3 104 0 0
4 77 0 1
4 97 0 0
4 79 0 0
5 89 0 1
5 104 0 0
5 104 0 0
6 88 1 1
6 96 1 0
6 104 0 0
7 104 1 1
7 94 0 0
7 77 1 0
8 9 5 .9 1 1
8 104 0 0
8 104 0 0
9 82 0 1
9 77 0 0
9 104 0 0
10 70 1 1
10 104 0 0
10 77 0 0
11 8 8 .,9 1 1
11 91 0 0
11 90 0 0
12 91 0 1
12 70 0 0
12 92 0 0
13 39 1 1
13 45 0 0
13 50 1 0
14 102 .9 1 1
14 69 0 0
14 91 0 0
15 93 0 1
15 104 0 0
15 103 0 0
16 85 0 1
16 72 0 0
16 104 0 0
17 104 0 1
17 63 0 0
17 104 0 0
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18  1 0 4 0 1
18  1 0 4 0 0
18  7 4 0 0
1 9  81 0 1
1 9  1 0 4 0 0
1 9  69 0 0
2 0  67 1 1
2 0  1 0 4 0 0
2 0  68 1 0
2 1  1 0 4 0 1
2 1  1 0 4 0 0
2 1  1 0 4 0 0
2 2  1 0 4 0 1
2 2  1 0 4 0 0
2 2  1 0 4 0 0
2 3  1 0 4 0 1
2 3  83 0 0
2 3  40 1 0
2 4  87 0 1
2 4  1 0 4 0 0
2 4  1 0 4 0 0
2 5  1 0 4 0 1
2 5  1 0 4 0 0
2 5  1 0 4 0 0
2 6  8 9 0 1
2 6  1 0 4 0 0
2 6  1 0 4 0 0
2 7  7 8 0 1
2 7  1 0 4 0 0
2 7  1 0 4 0 0
2 8  1 0 4 0 1
2 8  81 1 0
2 8  64 1 0
2 9  8 6 1 1
2 9  5 5 1 0
2 9  94 0 0
3 0  3 4 1 1
3 0  1 0 4 0 0
3 0  5 4 1 0
3 1  7 6 0 1
3 1  87 0 0
3 1  7 4 0 0
3 2  1 0 2 . 8 1 1
3 2  7 3 1 0
3 2  8 3 . 9 1 0
3 3  1 0 1 ., 9  1 1
3 3  1 0 4 0 0
3 3  80 0 0
3 4  7 9 .. 9  1 1
3 4  1 0 4 0 0
3 4  7 3 0 0
3 5  45 ■ 1 1
3 5  7 9 0 0
3 5  1 0 4 0 0
3 6  94 1 1
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3 6 1 0 4 0 0
3 6 1 0 4 0 0
37 1 0 4 0 1
37 1 0 4 0 0
37 1 0 4 0 0
3 8 1 0 4 0 1
3 8 1 0 1 1 0
38 94 0 0
3 9 7 6 0 1
3 9 8 4 1 0
3 9 78 1 0
40 80 1 1
40 00 o 9 1 0
40 7 6 0 0
41 7 2 1 1
41 9 5 0 0
41 1 0 4 0 0
42 7 2  . 9 1 1
42 1 0 4 0 0
42 66 1 0
43 92 1 1
43 1 0 4 0 0
4 3 1 0 2 1 0
44 1 0 4 0 1
44 98 0 0
44 7 3 0 0
45 5 5 0 1
4 5 1 0 4 0 0
45 1 0 4 0 0
4 6 49 0 1
4 6 8 3 0 0
4 6 7 7 0 0
47 8 9 1 1
47 1 0 4 0 0
47 1 0 4 0 0
48 88 0 1
48 7 9 0 0
48 99 0 0
49 1 0 3 1 1
4 9 91 0 0
49 1 0 4 0 0
50 1 0 4 0 1
50 1 0 4 0 0
50 7 9 1 0
174
The Dubbo Study Data (male individuals o£ age 70)
1 679 1 0 0 0 41.99 0 0 1 1 0 1
1 1389 0 0 0 0 41.99 0 0 1 1 0 1
2 1552 1 0 0 1 35.88 0 0 0 1 0 1
2 520 0 0 0 1 35.88 0 0 0 1 0 1
3 1447 1 0 0 0 28.3 0 0 0 1 0 0
3 565 1 0 0 0 28.3 0 0 0 1 0 0
3 45 0 0 0 0 28.3 0 0 0 1 0 0
4 282 1 0 1 0 40.83 0 1 0 1 1 0
4 1 0 1 1 0 40.83 0 1 0 1 1 0
5 2050 0 0 0 0 51.55 0 1 0 1 0 0
6 319 1 0 0 0 41.6 0 0 1 0 0 0
6 785 1 0 0 0 41.6 0 0 1 0 0 0
6 941 0 0 0 0 41.6 0 0 1 0 0 0
7 760 1 0 0 0 34.22 0 0 0 1 1 0
7 79 1 0 0 0 34.22 0 0 0 1 1 0
7 1211 0 0 0 0 34.22 0 0 0 1 1 0
8 567 1 0 0 0 36.36 0 0 1 1 1 0
8 114 1 0 0 0 36.36 0 0 1 1 1 0
8 483 1 0 0 0 36.36 0 0 1 1 1 0
8 5 1 0 0 0 36.36 0 0 1 1 1 0
8 133 1 0 0 0 36.36 0 0 1 1 1 0
8 54 1 0 0 0 36.36 0 0 1 1 1 0
8 42 1 0 0 0 36.36 0 0 1 1 1 0
8 42 1 0 0 0 36.36 0 0 1 1 1 0
8 119 1 0 0 0 36.36 0 0 1 1 1 0
8 84 1 0 0 0 36.36 0 0 1 1 1 0
8 56 1 0 0 0 36.36 0 0 1 1 1 0
8 332 0 0 0 0 36.36 0 0 1 1 1 0
9 1021 1 0 0 0 27.04 0 0 0 1 1 0
9 390 1 0 0 0 27.04 0 0 0 1 1 0
9 620 0 0 0 0 27.04 0 0 0 1 1 0
10 2029 0 0 1 0 42.38 0 0 0 0 1 0
11 42 1 0 1 0 25.81 1 0 0 0 0 1
11 1242 1 0 1 0 25.81 1 0 0 0 0 1
11 116 1 0 1 0 25.81 1 0 0 0 0 1
11 116 1 0 1 0 25.81 1 0 0 0 0 1
11 12 0 1 1 0 25.81 1 0 0 0 0 1
12 549 1 0 1 0 41.47 0 1 0 1 0 1
12 308 1 0 1 0 41.47 0 1 0 1 0 1
12 38 1 0 1 0 41.47 0 1 0 1 0 1
12 17 1 0 1 0 41.47 0 1 0 1 0 1
12 3 1 0 1 0 41.47 0 1 0 1 0 1
12 10 0 1 1 0 41.47 0 1 0 1 0 1
13 2018 0 0 0 0 55.95 0 0 1 1 0 0
14 263 1 0 1 0 36 0 0 0 0 1 0
14 418 1 0 1 0 36 0 0 0 0 1 0
14 608 1 0 1 0 36 0 0 0 0 1 0
14 42 1 0 1 0 36 0 0 0 0 1 0
14 2 0 1 1 0 36 0 0 0 0 1 0
15 531 1 0 0 1 31.7 0 0 0 1 1 0
15 491 1 0 0 1 31.7 0 0 0 1 1 0
175
15 1 0 1 1 0 0 1 3 1 . 7 0 0 0 1 1 0
1 5 8 7 5 0 0 0 1 3 1 . 7 0 0 0 1 1 0
16 4 1 2 1 0 1 1 2 9 . 3 8 0 0 0 1 0 0
16 5 6 1 1 0 1 1 2 9 . 3 8 0 0 0 1 0 0
16 9 2 2 1 0 1 1 2 9 . 3 8 0 0 0 1 0 0
1 6 2 1 1 0 1 1 2 9 . 3 8 0 0 0 1 0 0
1 6 65 1 0 1 1 2 9 . 3 8 0 0 0 1 0 0
16 5 1 0 1 1 2 9 . 3 8 0 0 0 1 0 0
1 6 88 0 0 1 1 2 9 . 3 8 0 0 0 1 0 0
17 1 4 6 1 0 1 1 4 2 . 2 5 1 0 1 0 1 0
17 2 7 3 1 0 1 1 4 2 . 2 5 1 0 1 0 1 0
17 3 1 1 0 1 1 4 2 . 2 5 1 0 1 0 1 0
17 80 1 0 1 1 4 2 . 2 5 1 0 1 0 1 0
17 9 0 9 1 0 1 1 4 2 . 2 5 1 0 1 0 1 0
17 27 1 0 1 1 4 2 . 2 5 1 0 1 0 1 0
17 4 8 6 0 0 1 1 4 2 . 2 5 1 0 1 0 1 0
18 5 1 2 1 0 1 0 4 2 . 7 7 0 0 0 1 1 0
18 1 4 7 7 0 0 1 0 4 2 . 7 7 0 0 0 1 1 0
19 1 9 5 9 0 0 0 0 4 5 . 2 9 0 1 0 1 1 0
2 0 1 9 8 3 0 0 0 1 4 0 . 2 0 0 0 1 0 0
2 1 3 9 8 1 0 1 1 3 3 . 2 9 0 0 0 1 1 0
2 1 9 4 3 1 0 1 1 3 3 . 2 9 0 0 0 1 1 0
2 1 2 2 1 0 1 1 3 3 . 2 9 0 0 0 1 1 0
2 1 6 1 9 0 0 1 1 3 3 . 2 9 0 0 0 1 1 0
2 2 48 1 0 0 0 3 2 . 3 8 0 0 0 1 0 0
2 2 1 9 1 2 0 0 0 0 3 2 . 3 8 0 0 0 1 0 0
2 3 1 9 5 3 0 0 0 0 3 1 . 5 8 1 0 0 0 0 1
2 4 1 9 5 4 0 0 0 0 4 5 . 4 3 0 1 0 1 0 0
2 5 1 7 4 5 1 0 0 0 7 5 0 0 0 1 0 1
2 5 2 8 0 0 0 0 0 7 5 0 0 0 1 0 1
2 6 6 6 2 1 0 0 0 2 2 . 9 4 0 0 0 1 1 0
2 6 2 4 3 1 0 0 0 2 2 . 9 4 0 0 0 1 1 0
2 6 1 1 2 8 0 0 0 0 2 2 . 9 4 0 0 0 1 1 0
2 7 7 5 0 1 0 1 1 2 1 . 2 5 0 0 0 1 1 0
2 7 30 1 0 1 1 2 1 . 2 5 0 0 0 1 1 0
2 7 16 0 1 1 1 2 1 . 2 5 0 0 0 1 1 0
2 8 5 0 8 1 0 1 0 5 2 . 5 6 0 0 0 1 0 0
2 8 2 4 3 1 0 1 0 5 2 . 5 6 0 0 0 1 0 0
2 8 2 4 1 0 1 0 5 2 . 5 6 0 0 0 1 0 0
2 8 1 1 5 0 0 0 1 0 5 2 . 5 6 0 0 0 1 0 0
2 9 5 1 1 1 0 0 0 5 5 . 9 5 0 1 0 1 0 0
2 9 6 1 8 1 0 0 0 5 5 . 9 5 0 1 0 1 0 0
2 9 7 8 9 0 0 0 0 5 5 . 9 5 0 1 0 1 0 0
3 0 41 1 0 0 1 3 6 . 2 4 0 0 1 1 1 0
3 0 34 1 0 0 1 3 6 . 2 4 0 0 1 1 1 0
3 0 2 0 1 0 0 1 3 6 . 2 4 0 0 1 1 1 0
3 0 1 7 8 1 0 0 1 3 6 . 2 4 0 0 1 1 1 0
3 0 3 2 1 1 0 0 1 3 6 . 2 4 0 0 1 1 1 0
3 0 5 9 0 1 0 0 1 3 6 . 2 4 0 0 1 1 1 0
3 0 2 1 1 0 0 1 3 6 . 2 4 0 0 1 1 1 0
30 3 0 1 0 1 3 6 . 2 4 0 0 1 1 1 0
3 1 1 0 4 1 1 0 1 0 2 5 . 8 1 0 0 0 1 1 0
31 81 1 0 1 0 2 5 . 8 1 0 0 0 1 1 0
3 1 2 3 1 0 1 0 2 5 . 8 1 0 0 0 1 1 0
3 1 3 0 7 1 0 1 0 2 5 . 8 1 0 0 0 1 1 0
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3 1 2 0 0 1 0 1 0 2 5 . 8 1 0 0 0 1 1 0
3 1 51 1 0 1 0 2 5 . 8 1 0 0 0 1 1 0
3 1 2 6 6 0 0 1 0 2 5 . 8 1 0 0 0 1 1 0
3 2 1 6 6 9 1 0 0 1 3 8 . 8 1 0 0 0 1 1 0
3 2 2 1 4 0 0 0 1 3 8 . 8 1 0 0 0 1 1 0
3 3 77 1 0 1 0 7 0 . 7 3 0 0 0 1 1 0
3 3 7 4 4 1 0 1 0 7 0 . 7 3 0 0 0 1 1 0
3 3 1 1 7 5 0 0 1 0 7 0 . 7 3 0 0 0 1 1 0
3 4 1 8 3 4 1 0 1 0 3 6 . 2 4 0 0 0 1 1 0
3 4 9 1 0 1 0 3 6 . 2 4 0 0 0 1 1 0
3 4 47 0 0 1 0 3 6 . 2 4 0 0 0 1 1 0
3 5 1 8 8 3 0 0 0 0 2 8 . 4 1 0 0 0 1 1 0
3 6 14 1 0 1 1 3 7 . 4 5 1 1 0 0 0 0
3 6 42 1 0 1 1 3 7 . 4 5 1 1 0 0 0 0
3 6 1 3 4 1 0 1 1 3 7 . 4 5 1 1 0 0 0 0
3 6 35 1 0 1 1 3 7 . 4 5 1 1 0 0 0 0
3 6 1 4 8 1 0 1 1 3 7 . 4 5 1 1 0 0 0 0
3 6 1 1 6 1 0 1 1 1 3 7 . 4 5 1 1 0 0 0 0
3 7 9 2 8 1 0 1 1 3 1 . 1 4 0 0 0 1 0 0
3 7 6 8 9 1 0 1 1 3 1 . 1 4 0 0 0 1 0 0
3 7 3 1 8 0 0 1 1 3 1 . 1 4 0 0 0 1 0 0
3 8 2 0 5 1 0 0 1 5 4 . 7 6 0 0 1 0 1 0
3 8 7 1 0 0 1 5 4 . 7 6 0 0 1 0 1 0
3 8 4 0 6 0 1 0 1 5 4 . 7 6 0 0 1 0 1 0
3 9 1 3 6 5 1 0 1 0 6 0 . 6 8 0 0 0 1 0 0
3 9 4 9 0 0 0 1 0 6 0 . 6 8 0 0 0 1 0 0
40 3 0 3 1 0 0 0 7 7 . 7 9 0 0 0 1 1 0
4 0 7 4 1 1 0 0 0 7 7 . 7 9 0 0 0 1 1 0
40 9 1 0 0 0 7 7 . 7 9 0 0 0 1 1 0
40 3 1 0 0 0 7 7 . 7 9 0 0 0 1 1 0
40 2 0 1 0 0 7 7 . 7 9 0 0 0 1 1 0
4 1 1 0 0 8 1 0 0 0 2 7 . 9 8 0 0 0 1 0 0
4 1 9 3 3 0 0 0 0 2 7 . 9 8 0 0 0 1 0 0
4 2 1 6 6 9 1 0 1 0 7 5 . 5 2 0 0 0 1 0 1
42 1 6 1 0 0 1 0 7 5 . 5 2 0 0 0 1 0 1
4 3 1 7 6 4 0 0 0 0 2 9 . 8 1 0 0 1 1 1 0
4 4 5 4 9 1 0 0 0 7 . 0 2 1 1 0 0 1 0
4 4 40 0 1 0 0 7 . 0 2 1 1 0 0 1 0
4 5 1 0 1 7 1 0 1 0 3 6 0 1 0 1 0 0
4 5 8 0 4 0 0 1 0 3 6 0 1 0 1 0 0
4 6 1 3 9 1 1 0 0 0 2 6 . 1 1 0 1 0 1 0 1
4 6 46 1 0 0 0 2 6 . 1 1 0 1 0 1 0 1
4 6 18 1 0 0 0 2 6 . 1 1 0 1 0 1 0 1
4 6 2 8 1 0 0 0 2 6 . 1 1 0 1 0 1 0 1
4 6 3 0 8 0 0 0 0 2 6 . 1 1 0 1 0 1 0 1
4 7 1 0 1 7 1 0 0 0 2 6 . 5 2 0 0 0 0 0 1
47 1 0 5 1 0 0 0 2 6 . 5 2 0 0 0 0 0 1
47 2 0 1 0 0 0 2 6 . 5 2 0 0 0 0 0 1
47 6 3 7 0 0 0 0 2 6 . 5 2 0 0 0 0 0 1
48 1 9 6 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
4 8 3 4 7 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 6 2 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 41 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 5 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 7 8 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
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48 7 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 7 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 7 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 1 5 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 5 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 3 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 8 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 14 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 61 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 37 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 9 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 7 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 2 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 3 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 3 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 8 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 5 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 9 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 6 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 45 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 63 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 1 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 4 0 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 38 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 3 6 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 3 9 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 4 5 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 30 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 6 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 3 5 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 8 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 8 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 3 4 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 2 5 1 0 1 1 4 0 . 3 2 0 0 0 1 1 0
48 7 0 0 1 1 4 0 . 3 2 0 0 0 1 1 0
4 9 1 7 5 7 0 0 1 0 3 1 . 2 5 0 0 0 1 1 0
50 7 0 5 1 0 0 0 9 5 . 0 6 0 0 0 1 1 0
5 0 2 2 0 1 0 0 9 5 . 0 6 0 0 0 1 1 0
5 1 1 0 0 8 1 0 1 1 7 8 . 3 2 1 0 1 1 0 0
5 1 9 8 2 0 0 1 1 7 8 . 3 2 1 0 1 1 0 0
52 6 5 3 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
52 1 1 9 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
52 2 4 5 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
52 8 4 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
5 2 2 1 0 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
52 3 3 6 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
52 61 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
5 2 4 3 1 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
52 2 3 9 0 0 0 0 1 1 2 . 3 6 0 1 0 1 1 0
5 3 1 0 2 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
5 3 2 0 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
5 3 42 ‘1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
5 3 3 1 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
5 3 1 0 4 5 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
5 3 88 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
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53
53
53
53
54
54
55
55
56
56
56
57
57
57
58
59
59
60
60
61
61
62
62
10 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
27 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
371 1 0 0 1 3 5 . 0 5 0 0 1 1 1 0
234 0 0 0 1 3 5 . 0 5 0 0 1 1 1 0
1754 1 0 0 0 3 0 . 5 8 0 1 0 1 1 0
222 0 0 0 0 3 0 . 5 8 0 1 0 1 1 0
1464 1 0 0 0 3 2 . 6 0 0 0 0 0 0
489 0 0 0 0 3 2 . 6 0 0 0 0 0 0
1204 1 0 0 0 3 5 . 8 8 0 0 0 1 0 1
282 1 0 0 0 3 5 . 8 8 0 0 0 1 0 1
434 0 0 0 0 3 5 . 8 8 0 0 0 1 0 1
1309 1 0 1 1 4 6 . 5 1 1 1 0 1 0 0
289 1 0 1 1 4 6 . 5 1 1 1 0 1 0 0
273 0 0 1 1 4 6 . 5 1 1 1 0 1 0 0
1875 0 0 0 0 5 7 . 7 6 0 0 0 1 1 0
560 1 0 0 0 3 5 . 7 6 1 1 0 1 0 0
1247 0 0 0 0 3 5 . 7 6 1 1 0 1 0 0
4 1 0 1 0 3 9 . 0 6 0 0 0 1 0 0
1824 0 0 1 0 3 9 . 0 6 0 0 0 1 0 0
308 1 0 1 1 4 6 . 2 4 1 0 0 1 1 0
1526 0 0 1 1 4 6 . 2 4 1 0 0 1 1 0
264 1 0 1 1 5 8 . 5 2 0 0 0 0 0 1
1559 0 0 1 1 5 8 . 5 2 0 0 0 0 0 1
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APPENDIX II
APL PROGRAMS
This Appendix contains those APL programs that has been used to 
analyse the three data sets provided in Appendix I. Main APL programs and 
their corresponding models are listed in the following table.
Chapter Model APL program
Five Time independent frailty model GROWTH
Model 1 GROWTH 1
Model 2 GROWTH2
Model 3 GROWTH3
Six AR(1) frailty model AR
Seven Baseline frailty model GROWTH
Justify the exp. relative risk function GENGROWTH
Random block frailty model RANBLKB
Simulation (baseline frailty model) SIMBASELINE
Simulation (random block frailty model) SIMRANBLK3
Eight Model 1 COMRSK1
Model 2 COMRSK2
The rest are the APL subprograms that appear in one or more of the 
main APL programs.
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GROWTH
V BETA*-GROWTH X -,M-,N ;NV ;MA-,THETA; RHO ;ML ; L ; I  ;AiW;V
[ 1 ]  « F i r s  A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  «OF MATRIX X AS PATIENT NUMBER (NUMBERED CONSECUTIVELY STARTING AT 1)
[ 3 ]  ^FOLLOWED BY TIME TO EVENT, FAILURE /  CENSOR, RISK VARIABLES, COX MODEL 
[4-] « I S  FITTED WITH AN INCLUSION OF A RANDOM FRAILTY TERM FOR EACH PATIENT.
[ 5 ]  M~r / X C ; 1 ]
[ 6 ]  JV-+/1 + PX
[ 7 ]  NV+-+ /~ 3 + ~ 1 + pJf
[ 8 ]  MA*- [ / + / ( \ M ) » . = X [ ; l ]
[ 9 ]  =
[ 1 0 ]  5FrA«-( + / ‘ 3 + l  + pX)p0
[ 1 1 ]  THETA+O.M
[ 1 2 ]  ML+{], 0 p O - ? 0 FOR BLUP,  1 FOR ML,  2 FOR REML'
[ 1 3 ]  X-*-X [ A JT [ ;  2 ] ;  ]
[ 14- ] LBL1:L*-X LL02(  0 31X) + .*BETA
[ 1 5 ]  I + ( \ M ) ' . = \ M
[ 1 6 ]  A - (  (M+NV)NVpQ) , {NV /f p 0 ) , [ 1 ] 0  ( I  * THETA)
[ 1 7 ]  J/«-B((*0 3+JT) + . x ( 0  l U )  + . * 0  3 + X ) + A
[ 1 8 ]  BETA-{V+BETA)+W+.x( ( *0  3 + X ) + . * 1 [ ; l ] ) - A + . »BETA
[ 1 9 ]  'BETA ESTIMATE ' , 6  RND NV+BETA
[ 2 0 ] - ( 0 . 0 1 s r / | K - B r r A ) / I B I l
[ 2 1 ]  -+(ML = 0) /LBL3
[ 2 2 ]  -*{ML*1)/LBL2
[ 2 3 ]  W-{{NV NViW) , (NV M p O ) ) , [ l H M  NVpO),@NV NViQW
[ 24- ] LBL2:A*-(+/ + /(T*-NV NVlW)  x ( iM) • .= iM) + (+/ (NViBETA  )* 2 )
[ 2 5 ]  -*-L 4-
[ 2 6 ]  LBL3 : A-*-+/ (NV\BETA) * 2
[ 2 7 ]  14-: V*-THETA
[ 2 8 ]  THETA-AiM
[ 2 9 ]  ' THETA ESTIMATE' , THETA
[ 3 0 ]  -►( 0 . 0001< I THETA-V) /  LBLl
[ 3 1 ]  (ML = 0 ) / 1 5
[ 3 2 ]  ' SE OF BETA ESTIMATE' , ( + / {NV NViW)x ( iN V ) • . = i N V ) + 0 . 5
[ 3 3 ]  A*-M+( ( + /  + / ( r + . * D x (  i M ) » , = i M ) i T H E T A » 2 ) - ( 2 * + / + / T * (  i M ) • . = iM)+THETA 
[34-] ' S F  OF THETA ' , ( ( 2*THETA+ 2 ) * A ) * 0 . 5
[ 3 5 ]  « ' ESTIMATION OF FRAILTY'
[ 3 6 ]  « (M l p \ M) , M IpNV\BETA
[ 3 7 ]  1 5 :  1 THE END' 
v
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GR0WTH1
V BETA-*-GROWTHl X , M , N , N V , M A ; THETA; RHO-,ML ; L ; I ; A ; W; V
[ 1 ]  « F I T S  A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  «OF MATRIX X A S  PATIENT NUMBER (NUMBERED CONSECUTIVELY STARTING AT  1)
[ 3 ]  «FOLLOWED BY TIME TO EVENT,  FAILURE/ CENSOR, R I S K  VARIABLES,  TIME TO 
[ 4- ] m FAILURE  ( MEASURES FROM THE F I R S T  FAILURE EPI SODE) .  COX MODEL I S
[ 5 ]  nFITTED WITH AN INCLUSION OF A RANDOM FRAI LTY TERM FOR EACH PATIENT.
[ 6 ]  pTHE LONGITUDINAL PARAMETER I S  ASSUMED TO BE FIXED.
[ 7 ]  M-*- r/JT[ ; 1 ]
[ 8 ]  N++/  1 + pJf
[ 9 ]  j m - + / ' 3 + _ l t p X
[ 1 0 ]  J £A- r /  + / ( t t f ) « . = X [ ; l ]
U i ]  j w r , j r [ ; i ] » .  = i tf
[ 12 ] £ E r A - (  + / - 3 + l  + pjf)pO
[ 1 3 ]  THETA+-0.W1
[ 1 4 ]  WI ^ - O. Op O' O FOR BLUP,  1 FOR ML,  2 FOR REML1
[ 1 5 ]  J M f U J r [ ; 2 ] { ]
[ 1 6 ]  LBL1-.L+-X L L 0 2 ( 0  3+X) +.  *BETA
[ 1 7 ]  I - ( i t f ) « . = i t f
[ 1 8 ]  A-*-( (M+NV)NVpQ ) , (NV MpO ) , [ l  ] ®( I* THETA)
[ 1 9 ]  3 + X ) + . * ( 0  l U )  + . * 0  3+JH+A
[ 2 0 ]  B ET A- ( V*- BE TA )+W+. *( ( $0  3 + A ) + . * L [ ; l ] )  - A + . *BETA
[ 2 1 ]  ' BETA E STI MATE1 , 6 RND NV\BETA
[ 2 2 ]  -*•( 0 . 01 s  T/ I V - BE TA ) / LBL1
[ 2 3 ]  + ( M L =0 ) /L BL 3
[ 2 4 ]  -* (ML*1) /LB L2
[ 2 5 ]  W+-( (NV N V i W) , ( N V  M p O ) ) , [ l ] ( M  NVpO) , ®NV NV\QW
[ 2 6 ]  LBL2:A<-(+/+/ (T*-NY N V \W ) « ( \M) • .  = \ M ) + ( + / ( N V l B E T A ) * 2 )
[ 2 7 ]  - 1 4
[ 2 8 ]  L B L 3 : A* - +/ ( NV \B ET A) * 2
[ 2 9 ]  L±:V*-THETA
[ 3 0 ]  THETA+-A±M
[ 3 1 ]  ' THETA ES TI MATE1 , THETA
[ 3 2 ]  —( 0 . 0  0 0 1 < I T H E T A - V ) / LBL1
[ 3 3 ]  —( ML = 0 ) / 1 5
[ 3 4 ]  ' SE OF BETA E STI MATE1 , ( + / (NV NV tW) * ( \ N V ) • . = \ NV)  * 0 . 5
[ 3 5 ]  A -/f+ ( ( + /  + / ( T+.  * D * (  iM)  • . = \ M ) + T H E T A * 2 ) - ( 2 *  + /  + / T * (  iM)  • . = \M) +THETA
[ 3 6 ]  ' S E  OF THETA1 , ( ( 2*2V/FrA* 2 ) *A) * 0 . 5
[ 3 7 ]  « ' ESTIMATION OF F R A I L T Y 1
[ 3 8 ]  « (M l p i M) , M 1 pNV\BETA
[ 3 9 ]  1 5 :  ' THE END1 
v
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GROWTH2
V GROWTH2 X;M;N\NV ;BETA; T A I ; TA2 \ML ; L ; A W; A l ; A2
[ 1 ]  *FITS A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  aOF MATRIX X AS PATIENT NUMBER (NUMBER CONSECUTIVELY STARTING AT 1 )
[ 3 ]  aFOLLOWED BY TIME TO EVENT, FAILURE/CENSOR, RISK VARIABLES, TIME TO
[ f ]  aFAILURE (MEASURES FROM THE FIRST FAILURE EPISODE).  COX MODEL I S
[ 5 ]  aFITTED WITH AN INCLUSION OF A RANDOM FRAILTY TERM FOR EACH PATIENT.
[ 6 ]  a THE LONGITUDINAL PARAMETER I S  ASSUMED TO BE RANDOM.
[ 7 ]  r / x c ; 1 ]
[ 8 ]  * - + /  1 + p*
[ 9 ]  NV*-+/~ 3 + ~ l  + pJf
[ 1 0 ]  X^X.W,  U [ ; U K + 3 ) ] » . * t f p l  ) ** / -*[  ; l ] .  . = i tf
[ 1 1 ]  B E r A - ( + / “ 3 + l+pJOpO
[ 1 2 ]  F A l —0 . 2 1 9 8
[ 1 3 ]  T A 2 - 0 . 0 5
[ 1 4 ]  ML*{], 0 pCH“ ’ 0 FOR BLUP,  1 FOR ML, 2 FOR REML 1
[ 1 5 ]  J M T U X t  s 2]  * ]
[ 1 6 ]  LBL1:L*-X LL 0 2 ( 0  3+Jf) + .*BETA
[ 1 7 ]  A - (  ( ( ( \M)o . = i / f ) + r > l l )  ,M t f p 0 ) , [ l ] ( t f  Mp 0 ) , ( ( iM) • . = iM) *TA2
[ 1 8 ]  A - (  ( (2*M)+NV)NVf>0) , {NV( 2*M) pO ) , [ 1 ]A
[ 1 9 ]  J / - 0 ( U O  3+JT) + . x ( 0  l U )  + . * 0  3+J()+A
[ 2 0 ]  BETA*-(V-BETA)+W+.  x(  (*0  3*JT) + . x £ [  ; i ]  ) - A + .  *BETA
[ 2 1 ]  ' BETA ESTIMATE ' , 6  RND NViBETA
[ 2 2 ]  - ( 0 . 0 1 s r / l V-BETA)/LBL1
[ 2 3 ]  — ( / f l  = 0 ) /  LBL3
[ 2 4 ]  -*(ML*L)/LBL2
[ 2 5 ]  W*-((NV NV+W) , (NV ( 2x / f ) p 0 ) ) , [ 1 ] ( ( 2»/f )JVKp0 ) ,
[ 2 6 ]  LBL2:
[ 2 7 ]  A l - ( + / + / ( t f  M+NV NViW)x{ \M )* . = \M) + { + / ( M*NVlBETA)* 2)
[ 2 8 ]  A2—( + / + / [M M\NV NVlW) *(  iM) • .  = iM) + ( + / (MlNVlBETA ) * 2 )
[ 2 9 ]  - 1 4
[ 3 0 ]  LBL3:A1*-+/(M*NV\BETA)*2
[ 3 1 ]  A2+-+/(MINVIBETA)*2
[ 3 2 ]  1 4 : L+-TA1
[ 3 3 ]  A+TA2
[ 3 4 ]  TAl*-AliM
[ 3 5 ]  TA2*-A2iM
[ 3 6 ]  ' THETA1 ESTIMATE' , TA1
[ 3 7 ]  1 THETA2 ESTIMATE' ,TA2
[ 3 8 ]  - (  ( O . O O O K i r A l - I ) v ( O . O O O K  ITA2-A)  ) / L B L l
[ 3 9 ]  - ( / f l  = 0 ) / l 5
[ 4 0 ]  ' SE OF BETA ESTIMATE' , ( + / (NV NV\W)x ( i NV ) . .  = \NV ) * 0 . 5
[ 4 1 ]  I B I 4 : L+-M MtNV NV\W
[ 4 2 ]  A-Jf M\NV NV\W
[ 4 3 ]  W+-M{ -M)*NV NViW
[ 4 4 ]  ( + /  + / ( X + . x I ) x (  i / f ) .  . = i / f ) f r A l * 2 ) - ( 2 « + /  + / I x (  iM) o .= i J f ) * r A l )  + ( 2 x r A l * 2 )
[ 4 5 ]  A - (  M+ ( ( + / + / ( A+. xA) x(  iM) • . = \M) 4TA2* 2 ) -  ( 2* + / + / A «  ( i M) • . = \M) i  7A2 ) + ( 2« TA2* 2 )
[ 4 6 ]  J / - ( + /  + / ( V + .  x ^ ) „ (  lW) . . = » # ) * ( 2 x ( 2V11*2) x ( T A 2 * 2 )  )
[ 4 7 ]  ' SE  OF THETA1' , (Af  ( A « I ) -J/* 2 ) * 0 . 5
[ 4 8 ]  ' S F  OF THETA2' , ( I *  (Ax£ ) -J/* 2 ) * 0 . 5
[ 4 9 ]  L5 : 'T HE  END'
9
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GROWTH3
V GROWTHS X ;M i N i V ;N Vi I ;B E T A iT A l i T A2 iM L ;L iA ;W ;A l ; A 2
[ 1 ]  « F IT S  A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  «OF MATRIX X AS PATIENT NUMBER (NUMBERED CONSECUTIVELY STARTING AT  1 )
[ 3 ]  «FOLLOWED BY TIME TO EVENT, FAILURE/CENSOR, RISK VARIABLES, TIME TO
[ 4 ]  «FAILURE (MEASURES FROM THE FIRST FAILURE EPISODE).  COX MODEL I S
[ 5 ]  «FITTED WITH AN INCLUSION OF A RANDOM FRAILTY TERM FOR EACH PATIENT.
[ 6 ]  *THE LONGITUDINAL PARAMETER I S  ASSUMED TO BE RANDOM AND RELATES TO THE
[7]  «PATIENT CHARACTERISTICS.
[ 8 ]  M~r / J [ ; l ]
[ 9 ] N*~+/1 + pX
[ 1 0 ]  K-*-+/~4+~l + pX
[ 1 1 ]  NV*-$0 "1  + 0 3+Jf
[ 1 2 ]  2 > + \ + / ( i / f ) » . = J C [ i l ]
[ 1 3 ]  A+-V 1 p JVV [ j I  [ 1 ] ]
[ 14- ] I -  2
[ 1 5 ]  L l : A + A ,N V [ ;L [ I ] ]
[ 1 6 ]  I - I + l
[ 1 7 ]  - ( I s t f ) / I 1
[ 18 ] W+W, [ ; ( K + 4 ) ] • .  x / f p l ) xl / -X[  ; 1 ] • . *■»M
[ 1 9 ]  X - X , K + . * M
[ 2 0 ]  NV^-+/~3+~UpX
[ 2 1 ]  X+X,W
[ 2 2 ]  £ F T 4 - ( + / " 3 + l + p X ) p O
[ 2 3 ]  2V11-0.225
[ 24- ] r A 2 - 0 . 0 4 3
[ 2 5 ]  ML*{], OpO- '  0 FOR BLUP,  1 FOR ML, 2 FOR REML '
[ 2 6 ]  J M T [ 4 X [ j 2 ] t ]
[ 2 7 ]  LBL1-.L+-X LL0 2 ( 0  3+X) +.  *BETA
[ 2 8 ]  A - (  ( ( ( i t f )»  . = i # ) + T A l )  ,Jf J f p 0 ) , [ l ] ( / f  MpO ) , { { \M)* .= \M )*T A2
[ 2 9 ]  A ^ ( ( (2*M)+NV)NVpO), (NV{2*M)pO) . [ 1 ]A
[ 3 0 ]  W*- 0
[ 3 1 ]  V - 0 ( U O  3 + X ) + .* ( 0 l  + D  + .xO 3 IX)+A
[ 3 2 ]  BETA*-(V*-BETA)+W+. * ( (*0  3 \ X ) +.  *L [ ; 1 ] ) -A+ . *BETA
[ 3 3 ]  'BETA ESTIMATE ' , 6  RND NVtBETA
[ 3 4 ]  A-0
[ 3 5 ]  I - 0
[ 3 6 ]  -►(0.01s  r / l  V-BETA ) I LB L i
[ 3 7 ]  - ( t f £ = 0 ) / I B I 3
[ 3 8 ]  - U f L * l ) / L £ L 2
[ 3 9 ]  W*-{{NV NV*W) , {NV{2*M)pO))  , [ l ]{ {2*M)NVf>0)  ,$NV JVK+0J/
[ 4 0 ]  I BI 2 : Al «- ( - t - /  + / ( t f  M\NV NV\W) * ( \M) • . = \M) + ( + / {MiNViBETA ) * 2 )
[ 4 1 ]  A 2 - ( + /  + / ( t f  M\NV NV\W)* ( i M ) • .  = iM) + ( + / (MiNViBETA)* 2)
[ 4 2 ]  - I 4
[ 4 3 ]  L BL3: Al «- +/ ( MiNVi BETA) »2
[ 4 4 ]  A2*-+/ (M+NViBETA)*2
[ 4 5 ]  £ 4 :  L*-TAl
[ 4 6 ]  V+-TA2
[ 4 7 ]  TA1+-AHM
[ 4 8 ]  TA2*-A2*M
[ 4 9 ]  ' THETA1 ESTIMATE' , TA 1
[ 5 0 ]  ' THETA2 ESTIMATE' , TA2
[ 5 1 ]  - ( ( 0 . 0 0 0 1 < l r x i - £ ) v ( 0 . 0 0 0 1 < \ T A 2 - V ) ) / L B L l
[ 5 2 ]  -► (ML = 0 ) / 1 5
[ 5 3 ]  1SE OF BETA ESTIMATE' , ( + / (NV NVtW)* ( i N V ) • . = iNV) * 0 . 5
[ 5 4 ]  L-M M*NV NV\W
[ 5 5 ]  A+-M M\NV NV\W
[ 5 6 ]  W-*-M( -M) \NV NV\W
[ 5 7 ]  I - ( J ¥ + ( ( + / + / ( I + . * I ) * ( i t f ) « .  = i t f ) + T A l * 2 ) - ( 2 *  + /  + / I * (  i / f ) » .  = i / f ) + T A l ) * ( 2 * m * 2 )
[ 5 8 ]  A - ( t f + (  ( + /  + / U + .  * A) *(  \M)» . = i t f ) + T A 2 * 2 ) - ( 2 * + / + / A * (  \M)» . = i t f )+TA2 ) * (  2 * r A2* 2 )
[ 5 9 ]  */«-(+/ + / ( { / + .  * W ) * (  \ M ) » . -  i # ) * (  2* ( r A l * 2 ) « ( r A 2 * 2 )  )
[ 6 0 ]  1 SE OF THETA!'  , U f  U * I ) -V* 2 ) * 0 . 5
[ 6 1 ]  ' SE OF THETA2' A L H A * L ) - W * 2 ) * 0 .5
[ 6 2 ]  L i : ' T H E  END' 
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AR
7 AR X ; M ; N i NV i H A; B ET A i T HE T A ; RH O ; ML ; L ; A i W ; V ; U 2 i U 3 ; U ± i C U C 2 ; C 3 i C*
[ 1 ]  * F I T S  A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  aOF MATRIX X AS  PATIENT NUMBER (.NUMBERED CONSECUTIVELY STARTING AT  1 )
[ 3 ]  ^FOLLOWED BY TIME TO EVENT,  FAILURE/ CENSOR, R I S K  VARIABLES,  TIME TO
[ 4 ]  * FAILURE  (MEASURES FROM THE F I R S T  FAILURE EPISODE ) .  COX MODEL I S
[ 5 ]  hFITTED WITH AN INCLUSION OF A RANDOM FRAILTY TERM AT EACH FAILURE.
[ 6 ]  *SUCH RANDOM FRAILTY TERM I S  ASSUMED TO FOLLOW AN A R ( 1)  PROCESS.
[ 7 ]  / f - r / J t s l ]
[ 8 ]  5 - + / i  + pjr
[ 9 ]  5 7 « - + / ‘ 3+_ l  + p*
[ 1 0 ]  5 A - [ / + / ( i 5 ) * . = * [ ; l ]
[ 1 1 ]  X<-X, ( i 5 ) » . = i 5
[ 1 2 ]  ££TA«-( + / - 3 + l  + p jnpO
[ 1 3 ]  THETA+-1 
[ I f ]  RHO+ 0
[ 1 5 ]  J»f l<-[] ,0p[>'0 FOR BLUP,  1 FOR ML,  2 FOR REML '
[ 1 6 ]  M [ 4 X [ ; 2 ) ; ]
[ 1 7 ]  1 5 1 1 : 1 - *  L L 0 2 ( 0  3 + * ) + . * 5 F r A
[ 1 8 ]  A - (  i 5 ) » . = i 5
[ 1 9 ]  / - I
[ 2 0 ]  1 3 :  V - ( 5 5 0 * / ) * ( $ V ) + f c M * [  ; 1 ] *  . = * [  ; l ]  ) * ( / + i 5 ) .  . = i 5
[ 2 1 ]  A-A+V
[ 2 2 ]  7 - / + 1
[ 2 3 ]  - ( / < 5 A ) / I 3
[ 24- ] A—( ( 5 + 5 / ) 5 / p 0  ) , (NV 5 p 0  ) , [ 1 ]®(A*THETA* 1-RHO* 2 )
[ 2 5 ]  J / - § ( ( $ 0  3 + * ) + . * ( 0  l U )  + . » 0  3+*)+A
[ 2 6 ]  BETA*-(V<-BETA)+W+.*(  ( $0  3 + * ) + .  * I [  ; 1 ] ) -A+.  »BETA
[ 2 7 ]  'BETA ESTIMATE ' , 6  RND NV+BETA
[ 2 8 ]  —( 0 . 0 1 s  T /  I V -BETA ) /  LB L I
[ 2 9 ]  - ( 5 I = 0 ) / I 5 I 3
[ 3 0 ]  -+(ML*1) /LBL2
[ 3 1 ]  J / - ( ( 5 /  NY+W) , (NV 5 p 0 ) ) , [ l ] ( 5  5 / p 0 ) , S 5 /  5 / +B t f
[ 3 2 ]  I 5 I 2 : A - ( 5 7  NV\W) + (NViBETA)  • . »NV+BETA
[ 3 3 ]  - I f
[ 3 f  ] 1 5 1 3  : A—( 5 / + 5 5 T A )  • . *NV\BETA
[ 3 5 ]  I f :  1/2—+ /  + / A x ( i 5 ) » . = t 5
[ 3 6 ]  (/3—+ /  + /A* ( * [  ; 1  ] • . = * [  ; 1 ]  ) * ( (  i 5 )  • . = 1 + i 5 )
[ 3 7 ]  / - + \ + / ( x M ) » . = X[ - , l ]
[ 3 8 ]  I - l , ' l + l + /
[ 3 9 ]  Of —+ / + / ( A [ / ; 7 ] + A [ I ; I ]  ) * ( \M) • . = \M 
[ f O ]  ÄSTHETA
[ f  1 ] THETA<-( ( U2 *U- RHO*2) -( 2*U3*RHO) +U±*RHO*2) tN  
[ f  2]  ' THETA ESTIMATE' , THETA
[ f 3 ]  C l - ( 5 - 5 ) * 0 2 - 0 f
[ f f ]  C 2 - ( ( 2 * M ) - N ) * U 3  
[ f  5 ] C 3 - ( 5 * 0 f  ) - (N+M)*U2
[ f  6 ] Cf -5 *£ /3
[ f 7]  1 - 5 5 0
[ f 8]  U3+(Cl*RHO*3)  + (C2*RHO*2)  + ( C3*RHO) +Cf
[ f 9 ]  Of—( 3*Cl *RHO*2)  + ( 2*C2*RHO) +C3
[ 5 0 ]  5 5 0 - 1 - 0 3 * O f
[ 5 1 ]  ' RHO ESTI MATE' ,RHO
[ 5 2 ]  - ( ( 0  . O K \ T H E T A - A ) v ( O . O K \ R H O - L ) ) / L B L l
[ 5 3 ]  - ( 5 I = 0 ) / I 5
[ 5 f ] I - *  1 1 0 2 ( 0  3 + * ) + . »BETA
[ 5 5 ]  A - ( t 5 ) » . = i 5
[ 5 6 ]  7 - 1
[ 5 7 ]  16 : * / - ( 5 5 0 * 7 )  *($*/ )  + V - ( * [  ; 1 ] .  . =*[  ; l ]  ) * ( 7 + i 5 ) *  . = t 5
[ 5 8 ]  A-A+V
[ 5 9 ]  7 - 7 + 1
[ 6 0 ]  - ( 7 < 5 A ) / I 6
[ 6 1 ]  A - A + l - 5 5 0 * 2
[ 6 2 ]  I - S ( ( 0 O  l U ) + r 5 F r A * ( 0 ( 3 + 5 7 ) + * )  + . * A + . * $ 0 ( 3 + 5 / ) + * )
[ 6 3 ]  V - 5  57 + 0 3+JT
[ 6 f ] ' S E  OF BETA ES TI MATE ' , ( + / ( 0 ( $ V )  + . * 1  + . *W)x ( x NV ) • .  = i 5 7 ) * 0 . 5  
[ 6 5 ]  —( ML = 1 ) / 1 7
[ 66 ] I —I - I + .  x J / + . * ( S ( W )  + . x I + . x J / )  + . x ( i )J/) + . x I
[ 6 7 ]  17 : ! / - ! + .  * ( 0 ( 3 + 5 / ) + * )  + . *A+. * $ 0 ( 3 + 5 / ) + *
[ 6 8 ]  02—2 *55 0 *  ( i 5 ) • . = i 5
[ 6 9 ]  0 3 - ( $ 0 3 ) + 0 3 - (  ( i 5 ) » . = l + i 5 ) * ( * [ ; l ] » . = * [ ; 1 ] )
[ 7 0 ]  C l - + \ + / (  i 5 ) *  . =Jf[ $ 1 ]
[ 7 1 ]  0 f - 2 * 5 5 0 * ( $ 0 f  ) + . *Of-Cl<> . = »5
[ 7 2 ]  C l - l , _ l + l + C l
[ 7 3 ]  O f - O f + 2 « M O *  ( $ C l ) + . * C l - C l  • . = i 5
[ 7 f  ] 7 - 0 2 - 0 3 - Of
[ 7 5 ]  /•<—THETA*L + . * ( 0 ( 3 + 5 7 ) + * ) + . * A + , * / + .  *A+. * $ 0 ( 3 + 5 / ) + *
[ 7 6 ]  0 2—( 0 . 5 ) *  + /  + / ( J / + . * J / ) x (  i 5 ) • . = i 5
[ 7 7 ]  0 3 - (  0 . 5  )* + /  + / (  J/+. * / )  * ( i t f ) .  . = i 5
[ 7 8 ]  O f - (  0 . 5  )* + /  + / ( / + . * / ) * (  i 5 ) » .  = i 5
[ 7 9 ]  ' S F  OF THETA AND RHO' , ( ( I/f * C 1 ) , 0 2 * C l - (  0 2 * O f ) - i /3* 2 ) * 0 . 5
[ 8 0 ]  1 5 : ' ESTIMATE OF F R A I L T Y ' , N V \ B E T A
v
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GENGROWTH
V GENGROWTH X ,M-,N ;NV\HA\BETA-, THETA; RHO\Ml; L ; I ;A ;W;V; K-.Kl
[1] «firs A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[2] «Of MATRIX X AS CLUSTER NUMBER (NUMBER CONSECUTIVELY STARTING AT 1)
[3] «FOLLOWED BY TIME TO EVENT, FAILURE/CENSOR, RISK VARIABLES. A FAMILY
[if] «Of RELATIVE RISK FUNCTIONS IS CONSIDERED IN WHICH COX MODEL IS
[5] «INCLUDED AS A SPECIAL CASE WHEN K TENDS TO 0. K IS CHOSEN BY
[6] «MAXIMIZING THE BLUP LIKELIHOOD.
[7] tf«-l7*[;l]
[8] *-+/ 1 + pX
[9] NV+-+/' 3+_ 1 ♦ pJf
[10] MA+-[/ + /( \M)' ,=X[ s 1 ]
[11] =
[12] KlMJ.OpQ*-' CHOOSE THE STARTING VALUE OF K FROM 0 TO 1, 0 FOR LOGLINEAR, 1 FOR LINEAR'
[13] Sfr^(+/"3+l + pJnpO
[ 14- ] THETA-0.43
[15] Jfl-a.OpQ-'O FOR BLUP, 1 FOR ML, 2 FOR REML'
[16] X*-X[ AX[ ; 2 ] ; ]
[17] LBL1:K*-K1
[18] -(K=0)/I6
[19] L*-X LL03(0 3*X)+.*BETA
[20] -L7
[21] L6-.L+X 1102(0 3*X)+.*BETA
[22] 17 :!-( \M) • . = \M
[23] A*-UM+NV)NVf>0 ) ANV Jfp0 ) , [ 1 ] 0 (I* THETA)
[24] J/-0(UO 3+X) +. * ( 0 lU) + .«0 3+JO+A
[25] BETA-(V-BETA)+W+.*A*0 3+X)+.*L[;1])-A+.»BETA
[26] 'BETA ESTIMATE',6 RND NVtBETA
[27] -(0.0KI7I K-£frA)/IBIl
[28] £1-101(0 2 IN 3 + X ) , ( 0 3*X)+.*BETA 
-[29] «— (XliO.l) / LB L 3
[30] «£1-0
[31] LBLB:'ESTIMATE OF K',Kl
[32] -+(K*K1)/LBL 1
[33] -+{ML = Q)/LBL3
[34] -*-(ML*l) /LBL2
[35] W*-( (NV NV*W)ANV /fpO ) ) , [l] (Ä NVpO),®NV NV\®W
[36] LBL2-.A~[+/ + /[T+-NV NV*W) * ( \M) • . = \M) + ( +/[NV\BETA ) * 2 )
[37] -14
[38] ISI3 :A-+/(NViBETA)* 2
[39] 14: V+-THETA
[40] THETA+AtM
[41] 'THETA ESTIMATE',THETA
[42] -(0.0001«\THETA-V)/LBL1
[43] -(WI=0)/I5
[44] 'SE OF BETA ESTIMATE' ,(+/(££ NV* W) * ( \NV) • . = \NV) *0.5
[45] A—/<+ ((+/+/(r+.»D*( \M)»,=\M)+THETA*2)-(2*+/+/T*{ iM) •. = iM) +THETA
[46] 'SE OF THETA’ A(2*THETA*2)+A)*0.S
[47] 15:'ESTIMATE OF FRAILTY',NV\BETA v
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RANBL KB
V RANBLKB X -.BETAiM-.N -,NV ;TA1;TA2 ;ML ; L ;A;W ;X1; X2 ;V
[ 1 ]  *FITS A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  *0F MATRIX X AS CLUSTER NUMBER (NUMBERED CONSECUTIVELY STARTING AT  1)
[ 3 ]  aFOLLOWED BY TIME TO EVENT, FAILURE/CENSOR, RISK VARIABLES. COX MODEL 
[ 4- ] rI S  FITTED WITH AN INCLUSION OF A RANDOM CLUSTER EFFECT AS WELL AS AN
[ 5 ]  aRANDOM INDIVIDUAL EFFECT.
[ 6 ]  * - l 7 J f [ ; l ]
[ 7 ]  *«-+/  1 + pX
[ 8 ]  JVK—t-/_ 3-t-"l + pX
[ 9 ]
[ 1 0 ]  £ S r X - ( + / ' 3 + l + p X ) p O
[ 1 1 ]  1 X1 -0 . 10 4- 1
[ 1 2 ]  1X2-0.4-4-58
[ 1 3 ]  W l - d . O p O ' O  FOR BLUP,  1 FOR ML,  2 FOR REML'
[ 14- ] X - X [ i X [ ; 2 ] » ]
[ 1 5 ]  I S I l s I - X  LL02(  0 3 IX)  + .*BETA
[ 1 6 ]  x - ( ( ( ( i j n » .  = i / 0 * r x i ) , / r  ifp o ) ,  [ 1 ] (xf N o o ) ,  ( ( \M) • .  =\m )±t a 2
[ 1 7 ]  X - (  (N+M+NV)NV pO ) , (NV(N+M) p 0 ) , [ 1 ]X
[ 1 8 ]  V - S ( ( * 0  3+JO + . * ( 0 l U )  + . « 0  3 + JO+X
[ 1 9 ]  BETA*(V+-BETA)+W+.*((kO 3+X) + .  *1 [ ; 1 ] )  - X + . »BETA
[ 2 0 ]  'BETA ESTIMATE ' , 6  RND NV*BETA
[ 2 1 ]  -+(0,01<[/ \V-BETA) /LBL1.
[ 2 2 ]  -*(ML = 0 ) /  LBL 3
[ 2 3 ]  -+{ML*L)/LBL2
[24-] I/—( (NV NV*W) , (NV(N+M)pQ)) , [ l ] ( (N+M)NV?Q) ,$NV NV*®W
[ 2 5 ]  LBL2:
[ 2 6 ]  X l - ( + / + / ( t f  N*NV NV \W )* ( \N )» . = \N )+ (+ / {N *N Vl B ET A )*2 )
[ 2 7 ]  X 2 - ( + /  + / U  N*NV NV*W)»(\M)  ».  = iW)-(- { + / (N*NV\BETA) *2)
[ 2 8 ]  - I f
[ 2 9 ]  LBL3 : X I —+ / (N*NV*BETA)* 2
[ 3 0 ]  X 2 - + / ( J V + j m B £ T X ) * 2
[ 3 1 ]  14-: I —1X1
[ 3 2 ]  V*-TA2
[ 3 3 ] t a i - a u -n
[34-] r X2 -X 2* tf
[ 3 5 ]  ’ THETA 1 ESTIMATE' , TA 1
[ 3 6 ]  • THETA2 ESTIMATE' , TA2
[ 3 7 ]  - ( ( 0 . 0 0 0 1 < l r X l - I ) v ( 0 . 0 0 0 1 < l r X 2 - K ) ) /LBL 1
[ 3 8 ]  —(ML = 0 ) / 1 5
[ 3 9 ]  ' SE OF BETA ESTIMATE' , ( + / {NV NV*W)* ( i NV ) . .  = iNV) * 0 . 5
[4-0] I - t f  N\NV NV\W
[ f l ]  X-JV N\NV NV\W
[ 4-2 ] W+-N{ -M) \NV NV\W
[ 4  3]  L*-(N+( ( + /  + / ( I  + . * I ) * (  \ N ) o , = \N)  i I X l * 2 ) - ( 2 *  + / + / ! * (  \N)  • . = i tf)  f l X l ) f  ( 2 *1X1*2 )
[ 4-4- ] X - ( t f + (  ( + /  + / ( X + .  « X) «(  \M) * . = i t f ) H X 2 * 2 ) - ( 2 *  + /  + / X *(  iTf) • . = i t f ) * I X 2  ) * (  2*1X2* 2 )
[4-5] V - ( + /  + / ( l / + .  * *>!/)*( iW)* , = iM ) t  ( 2 * ( 1 X 1 * 2 ) * ( 1 X 2 * 2 )  )
[4-6] ’ SE Of7 THETA1'  , ( X * ( X * I ) - V * 2 ) *  0 . 5
[4-7] ' SE OF THETA2' , ( L  + (A * L ) - W * 2) * 0 . S  
[4-8] 1 5 :  ' 2V/F £WD'
V
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SIMBASEL INE
V PR SIMBASELINE MVB; I -.OUT; FR-.W-.C; V ;M; U ,X; K; EST; SE; SQE; SS; J
[I] ftRUNNING SIMULATIONS OF THE BASELINE FRAILTY MODEL
[ 2 ] /«-1
[3] IX : 1-*-+/1 + (>PR
[4-] OUT+-PR
[5] 'SIMULATION {ML)'
[6] LOOP-.FR+30 N0RMALR{2*MVB[ ‘,J] )
[7] JA-90 OpO
[8] C-0
[9] II:K<-,("1 + 73 0p2) • . *3pi
[10] — (0= r/K)/II
[II] — (1= L/K)/II
[12] W+W,V
[13] C-C+l
[14] -(C* + /p2*#K£[;.T])/Il
[15] M+-W+. x [ iJ]
[16 ] U*-{ -«0.0 00 0 01*?90p999999)+0.1**M+,FR* . *3pi
[17] J!M,(i30)..*3pl).(M90pl),J/
[18] fÄ-((ifKB[j/])[2]),rÄ
[19] K+-FR BASELINE X
[20] «-ft(02 + /"lt( (+/'2+ptfKKB[ ;/] )+K) )/II
[21] ft-(0i + /_l + ( (+/"l + p/£KKB[ ;/])tK))/II
[22] OUT+-OUT.K
[23] I-+/l + pO£/r
[24] 'JVO. OF SIMULATION : ',1
[25] -(I*1OO)/I0OP
[26] FS2*-(+/-p*K£[ ;/] )0 + O(/r
[27] SP^(+/_l+pWV£[;/])0+(”l 0WUT)
[28] SQE*-~L IWUT
[29] «'PARAMETER ESTIMATE'
[30] «EST
[31] «'STANDARD ERROR'
[32] «SE
[33] «'SQUARE ERROR IN FRAILTY'
[34] «SQE
[35] 'ASSIGNED BETA',2iMYB[;J]
[36] 'ASSIGNED THETA',{MVB[;J])[2]
[37] 'AVERAGE BIAS OF ESTIMATE'.((+/EST)*I)-£V(2IMVB[;/]),({MVB[;J])[2])
[38] 'AVERAGE OF SE OF ESTIMATE',(+/SE)*1
[39] 'SE OF ESTIMATE OVER SIMULATION' ,SS-(( + /(EST-((4/ESDll)•.*Ipl)* 2)*1)* 0.5
[40] 'SE IN BRACKET',SSiI*0.5
[41] 'MEAN SQUARE ERROR IN FRAILTY',(+/SQE)*1
[42] JW+l
[43] -(Ji+/~l*pMVB)/LL 
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SIMRANBLK3
V PR SIMRANBLK3 MVVB; I ; OUT;FR;W;C •, V;M\ U ;XK;EST; SE; SQE;SS-,J
[I] * RUNNING SIMULATIONS OF THE RANDOM BLOCK FRAILTY MODEL
[ 2] J-l
[3] LL:I*-+/UpPR 
[ 4- ] OUT+PR
[5] 1 SIMULATION (REML)'
[6] LOOP:FR*-{90 NORMALR{2\MVVB[;J ]))+,(30 NORMALR{0,[MVVB[;/])[3]))».*3pl
[7] f/-90 OpO
[8] C-0
[9] 11: V-*-, (~l + ?30p2) • . * 3 p 1
[10] -(0=r/K)/Il
[II] ^(1=L/K)/I1
[12] W+W,V
[ 1.3 3 C-4“C+1
[14] -+{C* + /p3lMVVB[ ;/] )/Il
[15] M+W+. *3+tfKKB[ ;/]
[16] (/-(-•0.000 001*?90p999999)+0.1**J¥+FB
[17] X-*- (,(i30)».*3pl),(7,(90pl),l/
[18] FÄ^((ÄKKB[;/])[2]),((/fV,KB[;/])[3]).ri?
[19] K+FR RANBLK3 X
[20] -(0i + /‘l+(( + /"2 + p MVVB[tJ])*K))/LL
[21] -(0i+/"lt((+/_l+p/fKKB[;/])tJO)/II
[22] OUT*-OUT ,K
[23] I++/Uf>OUT
[24] 'NO. OF SIMULATION : ',1
[25] -(1*100)/LOOP
[26] EST+(+/-pMVVB[;J])OlOUT
[27] SE*{+/~l + pMYVB[;/])0 + (~1 O + OUT)
[28] 50F-"1 I*OUT
[29] *'PARAMETER ESTIMATE'
[30] *EST
[31] *'STANDARD ERROR'
[32] «SF
[33] *'SQUARE ERROR IN FRAILTY'
[34] «SQE
[35] 'ASSIGNED BETA',3\MVVB[;J]
[36] 'ASSIGNED THETA1',(MVVB[;J))[2]
[37] 'ASSIGNED THETA2',{MVVB[;J ])[3]
[38] ' AVERAGE BIAS OF ESTIMATE' , ((+/EST) +1)-E*-( 3+JfKKBC ; J]) , ((JfKKBf ;/]) [ 2 ] ) . (MVVB[ ;/]) [ 3 ]
[39] 'AVERAGE OF SE OF ESTIMATE',(+/SE)*1
[40] 'SE OF ESTIMATE OVER SIMULATION' , SS-( ( +/(EST- ( (+ /EST) *1) • . *Ipl) * 2 ) 4-1) * 0.5
[41] 'SE IN BRACKET',SS*I*0.5
[42] 'MEAN SQUARE ERROR IN FRAILTY' , (+/SQE)i-I
[43] J-J+1
[44] — («fs + /_l + pMVVB) ILL v
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C0MRSK1
V Ul+COMRSKl X ; M ; N i N V ; B E T A ; T A l ; M L ; Y iZ ; X l ; X 2 ; X X iL l \L 2 iL i A iW ; V ; A l ; T T ; r i i T 2
[ 1 ]  »FITS A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  »OF MATRIX X AS PATIENT NUMBER (NUMBERED CONSECUTIVELY STARTING AT 1)
[ 3 ]  »FOLLOWED BY TIME TO EVENT, HOSPITALISED/CENSOR, DEATH/CENSOR, RISK
[ 4 ]  »VARIABLES. COX MODEL I S  FITTED WITH AN INCLUSION OF A RANDOM FRAILTY
[ 5 ]  »TERM FOR EACH PATIENT. SUCH RANDOM FRAILTY TERM FOR EACH PATIENT I S
[ 6 ]  »ASSUMED TO BE EQUAL FOR HOSPITALISATION AND DEATH.
[ 7 ]  M+r / X t s l ]
[ 8 ]  +
[ 9 ]  * / - + / ' 4 + ' 1 + pJT
[ 1 0 ]  JM+fl.OpCH-'O FOR BLUP,  1 FOR ML, 2 FOR REML'
[ 1 1 ]  TT+PROC* N 2\X
[ 1 2 ]  Y+-N 4+X
[ 1 3 ]  Yl+N  3 + 7
[ 1 4 ]  Y2+TT.N  l p r [ ; 4 ]
[ 1 5 ]  X+-0 4+Jf
[ 1 6 ]  Z ^ 7 [ ; l ] » . = i t f
[ 1 7 ]  BETA*-(M+2*NV)oO
[ 1 8 ]  r A l - 0 . 5 1
[ 1 9 ]  X2*-(N NVpO) , jr,Z
[ 2 0 ]  X 2 + X 2 [ i Y 2 [ ; 2 ] ; ]
[ 2 1 ]  X l + X A N  NVpO),Z
[ 2 2 ]  J n .< -J T l[m [ ;2 ]  ; ]
[ 2 3 ]  XX*-X1, [ l ] X 2
[ 2 4 ]  7 l ^ 7 l U 7 l [  ; 2 ]  ; ]
[ 2 5 ]  7 2 ^ 7 2 U r 2 [  ; 2 ]  ; ]
[ 2 6 ]  £ B £ l : £ l + - ( Y l , X l ) £ £ 0 2  XU-.*BETA
[ 2 7 ]  I 2 - C T 2 , X2)LL02 X2+.*BETA
[ 2 8 ]  I - ( ( 2 * / f ) l p ( I l [ ; l ] . J ; 2 [ ; l ] ) ) , ( ( 0  1 + 1 1 )  ,N NpO ) , [ 1 ] (N NoO 1 , 0  1 + Z2
[ 2 9 ]  A - ( ( i t f ) * .=xM)*TAl
[ 3 0 ]  A*-( ( t f + 2 * / r n ( 2 * J V n p O )  . ( (2*NV)MpO) , [ l ] A
[ 3 1 ]  J H 3 (  (***)+- .  « ( 0  l  + D  + .xJfJH+A
[ 32 ] BETA*-{ V+-BETA) +I /+. * ( ( WUT) +.  *L [ ; 1 ] )  - A + . *BETA
[ 3 3 ]  ' BETA ESTIMATE' , 6 RND{2*NV)\BETA
[ 3 4 ]  - » ( 0 . 0 1 s  T /  I V-BETA) /LB LI
[ 3 5 ]  -»( / f i  = 0 ) /  LBL3
[ 3 6 ]  +(ML*1)/LBL2
[ 3 7 ]  (/»-(( (2*NV) (2*NV)*W) , ( (2x/fV)Mp0 ) ] , [ 1 K  M( 2 *N V) p 0 ) , 0  ( 2 *NV ) ( 2 »WV ) + 01/
[ 3 8 ]  LBL2:
[ 3 9 ]  A l - ( + / + / ( *  MA2*NV)  (2*NV)lW)*{  i M) • . = \M) 4 ( + / ( M\ ( 2 *NV) \BETA) * 2 )
[ 4 0 ]  -»14
[ 4 1 ]  LBL3:A1*-+/(M* (2*NV) \BETA)*2
[ 4 2 ]  Z 4 : L-*-TAl
[ 4 3 ]  TAl+Al iM
[ 4 4 ]  ' THETA1 ESTIMATE' ,TA1
[ 4 5 ]  - » ( 0 . 0 K i r A l - I ) / I B I l
[ 4 6 ]  -♦ (ML = 0 ) / 1 5
[ 4 7 ]  ' SE OF BETA ESTIMATE'  , ( + / ( (  2*NV)  ( 2*NV)  + V) x ( i 2*NV)  . .  = i ( 2*NV) ) * 0 . 5
[ 4 8 ]  L*-M Mi (2*NV) {2*NV)\W
[ 4 9 ]  L+-M+ ( ( + /  + / ( !  + . x l ) * (  \M)> . = t / f ) f r A l * 2 ) - ( 2 x  + /  + / I x (  i / f ) .  . = :M)iTA l
[ 5 0 ]  ' SE  OF THETA1 ' , ( ( 2 «TAI* 2 )•*■!)* 0 . 5
[ 5 1 ]  ' '
[ 5 2 ]  l 5 : ( / l - 4  RND MA2*NV) \BETA
v
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C0MRSK2
v U1-C0MRSK2 X;M;N;NV-,BETAiTAl;TA2;CAMMA;DCiML- .Y;Z;Xl ;X2- ,XX;Ll iL2;L;A;W- ,ViAl iA2;U2;TT;  
Yl- ,Y 2-.YY1
[ 1 ]  *FITS A GENERALISED MIXED MODEL TO SURVIVAL DATA WITH COLUMNS
[ 2 ]  *0F MATRIX X AS PATIENT NUMBER (NUMBERED CONSECUTIVELY STARTING AT 1)
[ 3 ]  «FOLLOWED BY TIME TO EVENT, HOSPITALISED/CENSOR, DEATH/CENSOR, RISK
[ 4 ]  «VARIABLES. COX MODEL I S  FITTED WITH AN INCLUSION OF A RANDOM FRAILTY
[ 5 ]  *TERM FOR EACH PATIENT, THE FRAILTY OF HOSPITALISATION I S  RELATED TO
[ 6 ]  *THE FRAILTY OF DEATH BY A PARAMETER GAMMA FOR EACH PATIENT.
[ 7 ]  M-  r/JfC ; 1 3
[ 8 ]  JV-+/ l t pJf
[ 9 ]  NV-+/~  4 + ' l  + pJf
[ 1 0 ]  tfl-HO.OpCh-'O FOR BLUP, 1 FOR ML, 2 FOR REML'
[ 1 1 ]  TT-PROG* N 2 iX
[ 1 2 ]  Y-N  4+JT
[ 1 3 ]  YY1-N  3 + r
[ 1 4 ]  Y2-TT .N  l p T [ ; 4 ]
[ 1 5 ]  X-0  4+JT
[ 1 6 ] Z - r [ ; l ] » . = i Ä
[ 1 7 ]  B E T A - ( (2*NV)+M)pO
[ 1 8 ]  TA1- 0 . 6
[ 1 9 ]  GAMMA-1.5
[ 2 0 ]  X2- ( N NVpO),X,Z
[ 2 1 ]  X2—X 2 [ i J 2 [ ; 2 ] ;  ]
[ 2 2 ]  LBL±: Xl - X, ( N NVpO), (CAMMA*Z)
[ 2 3 ] x i - j r i u m [ ; 2 ] s ]
[ 2 4 ]  X X - X 1 , [ l ] X 2
[ 2 5 ] r w r i [ * m [ i i ] | ]
[ 2 6 ]  r 2 ^ r 2 [ 4T2[ ; 2 ]  i ]
[ 2 7 ]  L B L 1 :L 1 - ( Y 1 , X 1 ) L L 0 2  X1+.*BETA
[ 2 8 ]  L 2 - ( Y 2 , X 2 ) L L 0 2  X2+.*BETA
[ 2 9 ]  L—{ ( 2 * / O l p ( I l [  ; 1 ] , 1 2 [ ; 1 ] )  ) , ( ( 0  1 + 1 1 ) ,N NpO ) , [ 1 ] (N NpO ) , 0 1 U 2
[ 3 0 ]  A - ( ( \M) ' ,=\M)*{ l+CAMMA*2) iTA l
[ 3 1 ]  A - (  ( (2*NV)+M) (2*NV)pO)  , ( ( 2 *NV) Mp 0 ) , [ 1 ]A
[ 3 2 ]  J/-S ( ( ^ J f )  + . x ( 0  l  + I )  + .xj r jn+A
[ 3 3 ]  BETA-(.V-BETA)+W+.  *( ( * * / ) + .  * I [  ; 1 ]  )-A + . »BETA
[ 3 4 ]  'BETA ESTIMATE' , 4 RND(2*NV)iBETA
[ 3 5 ]  ^ ( O . O l s r / l V-BETA)/LBL1
[ 3 6 ]  - ( M L = 0 ) /LBL3
[ 3 7 ]  - (ML *1) /L BL2
[ 3 8 ]  W - { ( ( 2 *N V ) ( 2 *N V ) i W ) , ( (2*NV)MpO) ) , [ 1 ] (M(2*NV)pO) ,Q(2*NV)(2*NV) i®W
[ 3 9 ]  LBL2:
[ 4 0 ]  A l - [  1+GAMMA*2 ) * ( + /  + / (  ( 2* / f / )  (2«/ rK)U/ )*(  i M) • . = \M) + ( + / (  ( 2 *NV) \BETA ) * 2 )
[ 4 1 ]  - L 4
[ 4 2 ]  I £ I 3 : A l - ( l + C A Mt f A * 2 ) * + / ( [2*NV) \BETA)*2
[ 4 3 ]  L 4 : L—TA1
[ 4 4 ]  TAl—Ali-M
[ 4 5 ]  'THETA ESTIMATE' , 4 RND TA1
[ 4 6 ]  - ( 0 . 0 1 < l r X l - I ) / I B I l
[ 4 7 ]  - {M L=0) /LS
[ 4 8 ]  ' SE  OF BETA ESTIMATE' , 4  RND{ + / ( ( 2*NV) ( 2*NV)iW)  x ( i 2*NV) • .  = t 2*NV)* 0 . 5
[ 4 9 ]  L - ( 2* NV ) ( 2 * NV ) i W
[ 5 0 ]  L-M+( ( + / + / ( ! + .  * I ) x (  iM) > . = iM )* ( ( l+ C A M M A * 2 ) t T A l )* 2 ) - 2 * (+ /+ / L * (  i M)> . = iM) * ( 1+CAMMA* 2)+TA
1
[ 5 1 ]  ' SE OF THETA' , 4  RND[( 2*TA1*2 ) * ( 1+CAMMA*2 )* 2 ) * 0 . 5
[ 5 2 ]  L 5 : V—GAMMA
[ 5 3 ]  GAMMA—Y1 [ ; 3 ]PROGS BETA
[ 5 4 ]  'GAMMA ESTIMATE' , GAMMA
[ 5 5 ]  -(GAMMA*V)/LBL4
[ 5 6 ]  U1 - 4  RND(2*NV)+BETA 
v
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101
V K1-I01 J/;I;K;Il;I;IO
[I] £*-( 1100)4-100
[ 2 ] I-1
[3] LO-*-+/V[ ; 1 ] * (f/[ ; 2 ]-•4>+\4>*»/C 5 2 ] )
[4-] II-*-2 lp(I0,0)
[5] LBLl:-(0>L/1-HC[I] *V[ s 2 ])/IBI2
[6] I-+/l/[ ;i]*( ((H-IC[I])x*l+i:[I]*I/C ;2] )-*4>-*-\ + (1+JCCX3 **/[ ; 2 ]) *14-IC[I] )
[7] Il-Il.I.Ktl]
[8] LBL 2 : I—I+l
[9] -(Isl00)/IBI1
[10] I*-Il[;tH[l;]]
[II] 'NO. OF LIKELIHOOD EXIST' ,+/UpL
[12] -*-(0 = + /l+pI)/I3
[13] K 1 - +/1U[ ;1]
[ 14-] 'LIKELIHOOD' ,+/lU[ ; 1 ]
[15] -14-
[16] 1 3:Kl— 0
[17] 14-: I— 1
V
1102
V I-X 1102
[1] B*-+\A*I[i3]^+\^*l/
[2] L+-{N, 0 ) p (N*-pB) , (I—1) ,C—+\A*2
[3] IBI1:I-I, (.V*B*I=\N)-W*W{.I]*(C*Ii ) +C[ I ] *I<
[4-] -(tfil-I+n/IBIl
[5] I-U[;3]-{/*B).Iv
1103
V I- Jf  1 1 0 3  V ; / r ; A ; £ ;C ;I ;F ; <7[1] F*-ltl+X*V
[ 2 ]  £ - + \ A - X [  ; 3 ] +$ +\ $f / —( 1+IC*I/) * 14-K
[3] G-*-F*W
[ 4 ]  I - U . O ) p ( t f - p B )  , ( 1 - 1 )  , C - + \ A * 2
[ 5 ]  LB LI: L*-L , ( ( ( £ * * [  ; 3 ] ) + ( 1-J£) *F*C*B) *1= \N) -C*C[I] * ( C * I i  i B ) -f-C[I] *I< i/f
[ 6 ]  - ( B i l - I + 1 ) / I B I 1
[ 7 ]  I - ( F * J T [ ; 3 ] - V * B )  , 1
7
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NORMALR
[ 1 ]
[ 2 ]
[ 3 ]
[ 4 ]
[ 5 ]
V R+-N NORMALR PA-.V
R+-(?( 2 ,  f/Tf 2 ) p 2 1 4 7 4 8 3 6 4 7  ) f  214748364-7 
R o -N U .l  2» .o R [ 2 i  ] * o 2 ) x K , K « - ( ' 2 * * £ [ l ; ] ) * 0 . 5  
- ( a / P X = 0 l ) / 0  
R+-PA[1]+R*PA[2]*0.5
A
V
RND
v R*N RND X
[ 1 ] / ? ^ ( i o * - / n * L o . 5  + ( i o * ^ ) * j r
v
BASELINE
V K+FR BASELINE X\M\N\NV\MA\ THETA; RHO; ML ; L ; I  iA;W ;V ; C C
[ 1 ]  M*- T /  JT [ ; 1 ]
[ 2 ]  * - + /  l t p X
[ 3 ]  * / « - + / - 3 + - 1  + PX
[ 4 ]  / C* - l 7  + / ( i J f ) * . - X [ | l ]
[ 5 ]  X*-X,X[
[ 6 ]  P E r ^ ( + / _ 3 + l  + pJnpO
[ 7 ] r i / m - m i ]
[ 8 ] CC-0
[ 9 ] ML*-1
[ 1 0 ]  X * X [ U C ; 2 ] ; ]
[ 1 1 ]  LB L I : L*-X LL 0 2 ( 0  3+JT) +.  «PSPA
[ 1 2 ] l 4 - { \ M) ' .  = \M
[ 1 3 ]  A+{{M+NV)NVpO) A N V  Ä p O ) , [ l ] 0 ( I *  THETA)
[ 1 4 ]  J / - 0 ( ( * O  3 + X ) + . * ( 0  l U )  + . * 0  3+X)+A
[ 1 5 ]  BETA*-{V*-BETA)+W+.x((*0 3+X) +.  *1 [ ; 1 ] ) -A + . »BETA
[ 1 6 ]  - ( 2 5 s C C - C C + l ) / l 7
[ 1 7 ]  - * ( Q .0 H [ / \ V - B E T A ) / L B L 1
[ 1 8 ]  - ( ML=0)/LBL3
[ 1 9 ]  - ( ML*1) /LBL2
[ 2 0 ]  W*-{ (NY NV+W) , (NV M p O ) ) , [ l ] ( M  NVpO) ,B#V NV+BV
[ 2 1 ]  LBL2:A*-( + /  + /(T*-NV NYU/)  * ( \M) • . = xM) + ( + / (NViBETA ) * 2 )
[ 2 2 ]  - 1 4
[ 2 3 ]  LBL3' .A*-+/(NV\BETA)*2
[ 2 4 ]  L±:V+-THETA
[ 2 5 ]  THE?A*-AIM
[ 2 6 ]  - ( 0 .01<\THETA-V) /LBLi .
[ 2 7 ]  C2—( +/ (NV NV*V )x ( iNV )»  , = iNV)*O.S
[ 2 8 ]  A*-M+((+/+/ (T+.xT ) x ( i M)» . = i M)+THETA*2) - (2x + / + / T x ( iM) > , = \M)iTHETA
[ 2 9 ]  C 3 - ( {2xTHETA*2)*A)*0 .5
[ 3 0 ]  C 4 - ( + / (  ( j m p r : M ) - i + ™ ) * 2 H J Y
[ 3 1 ]  K+(NV*BETA)  , THETA,  C 2 , C3 ,C ,4
[ 3 2 ]  - 1 8
[ 3 3 ]  L 7 :X-*(3+2 *NY) 0 p 0
[ 3 4 ]  I 8 : K - K  
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RANBLK3
v K—FR RARBLK3 X ,M\N ; RV-,BETA ; T A I ; TA2 -,ML ; L ;A ; W,A1 ;A2 ■, V ; C2 ; C3 ; C 4 ; CC
t i l  / f - r / x c  s i  ]
[ 2 ]  JV-+/1+P*
[ 3 ] w - + / ' 3 + ' i  + px
[ 4 ] x * - x , ( ( x # r ) » . * x j r ) , x [ * i ] « . * t j f
t 5 ]  £ r r / - ( + / ' 3 + i + p X ) p o
[ 6 ]  T A l ^ F R l l ]
[7] TA2-FR[2]
[ 8 ] CC- 0
[ 9 ]  ML-2
[ 1 0 ]  X—X [ | X [ ; 2 ] ;  ]
[ 1 1 ]  LBL1 : L—X LL0 2 ( 0  3\X)+.*BETA
[ 1 2 ]  A-{  ( ( ( I * ) »  . = \N)*TA1)  ,N Ä p 0 ) , [ l ] ( t f  J\TpO) , ( ( » * ) •  . = x / f )+rA2
[ 1 3 ]  A - (  (N+M+NV)NVf>0) , (NV{N+M) p 0 ) , [ 1 ]A
[ 1 4 ]  V - B ( ( * 0  3+X) +.  * ( 0 1 + 1 )  + . * 0 3+JO+A
[ 1 5 ]  BETA-{V-BETA)+W+ . * ( ( * 0  3 \ X ) + . * 1 [ ; 1 ] ) - A+. »BETA
[ 1 6 ]  — ( SiCC—CC+1) /L7
[ 1 7 ]  - ( 0 .01 <[ / \V - BE TA) /LB L i .
[ 1 8 ]  — (ML = 0 ) /  LBL3
[ 1 9 ]  /LBL2
[ 2 0 ]  W- AN V  NV+W) , {NV{N+M)pO) ) , [ l ]  ( {N+M)NVpO) .BtfK NVlQW
[ 2 1 ]  LBL2:
[ 2 2 ]  A l - ( + / + / ( t f  N*NV R V \ W )* { x N )o . = \N)+[+/(N<NV+BETA)*2)
[ 2 3 ]  A 2 - ( + / + / ( t f  N\NV \M ) • . = \M)+{+/(N±NV\BETA)*2)
[ 2 4 ]  - 1 4
[ 2 5 ]  LBL3:A1-+/(N+NV\BETA)*2
[ 2 6 ]  A2-+/(NlNV±BETA)*2
[ 2 7 ]  LW-.L-TAl
[ 2 8 ]  V-TA2
[ 2 9 ]  T A l - A l i N
[ 3 0 ]  TA2-A2iM
[ 3 1 ]  - ( ( ( 0 . 0 1 < l r X l - I ) v ( 0 . 0 1 < i r > l 2 - K ) ) ) / I B I l
[ 3 2 ]  C 2 - ( + / ( N V  NV* W)*( \NV) • . = \ N V ) * 0 . 5
[ 3 3 ]  L-N N*NV NV\U
[ 3 4 ]  A-N N*NV NV\W
[ 3 5 ]  U—S { -M)+NV NViU
[ 3 6 ]  ! - ( * + (  ( + / + / ( ! + .  * ! ) * (  \N)o  . = i 7 n + 2 V l l * 2 ) - ( 2 *  + /  + / i ; * (  \N)  • . = \ N ) + TA1 ) + ( 2 *TA1 * 2 )
[ 3 7 ]  A-{M+(  ( + / + / ( A + .  *A) *(  \M) '  . = i t f ) + r A 2 * 2 ) - ( 2 * + / + / A * (  i t f)  • . = \M)+TA2) H 2 * T A 2 * 2 )
[ 3 8 ]  4 M + /  + / ( ! / + .  \M)» . = \ M ) t ( 2 * ( T A l * 2 ) * ( T A 2 * 2 )  )
[ 3 9 ]  C 3 - (  ( A + ( A x I ) - J / * 2 ) * 0 . 5 ) , ( ( I + ( A * I ) - X / * 2 ) * 0 . 5 )
[ 4 0 ]  C 4 - ( + / (  ( ( imiV*BETA) + , (NlNVlBETA  ) • . * 3 p l ) - 2  + FJ?) * 2 )*tf
[ 4 1 ]  K -{N ViB ETA) ,TAL ,TA2 ,C2 ,C3 ,C±
[ 4 2 ]  - 1 8
[ 4 3 ]  L 7 : X—( 5 + 2 *JVK) 0 p 0
[ 4 4 ]  1 8 : '  '
V
PROGS
V C-A PROGS D\ L i U; H; B } I ; K ; G
[ 1 ]  C—200
[ 2 ]  t / - ( K - l )  , ( K - l )  + ( ; C ) + 1 0 0
[ 3 ]  I - 1
[ 4 ]  K-OpO
[ 5 ]  L B L U H - X A *  NV?0)  , ( W [ I ] * Z )
[ 6 ]  W U m [ i 2 ] ; ]
[ 7 ]  B—H+ ■*.D
[ 8 ]  I - ( + / A * B - * < f r + \ $ * 3 ) + 0 . 5 * ( t f > < « l + V [ I ] * 2 ) - (  + / ( j m £ E 3 ,A ) * 2 ) * ( l + V [ I ] * 2 ) + : r A l
[ 9 ]  K - K . I
[ 1 0 ]  I - I + l
[ 1 1 ]  - ( I * G+2 ) / L B L l
[ 1 2 ]  C - 2 ( G + l ) p » / , K
[ 1 3 ]  C - l + , 2  1 + C [ ; t C [ 2 ; ] ]
V
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